=========a1990263.txt=========	=========a1990263.txt=========	LS	B-LST	O

Nuclear	Nuclear	JJ	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
kappa	kappa	NN	I-NP	I-protein
B	B	NN	I-NP	I-protein
activates	activate	VBZ	B-VP	O
proenkephalin	proenkephalin	NN	B-NP	O
transcription	transcription	NN	I-NP	O
in	in	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
.	.	.	O	O

Upon	Upon	IN	B-PP	O
activation	activation	NN	B-NP	O
,	,	,	O	O
T	T	NN	B-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
accumulate	accumulate	VBP	B-VP	O
high	high	JJ	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
neuropeptide	neuropeptide	NN	I-NP	O
enkephalin	enkephalin	NN	I-NP	O
which	which	WDT	B-NP	O
correlate	correlate	VBP	B-VP	O
with	with	IN	B-PP	O
high	high	JJ	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
proenkephalin	proenkephalin	NN	B-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
in	in	IN	B-PP	O
the	the	DT	B-NP	O
cells	cell	NNS	I-NP	O
.	.	.	O	O

Here	Here	RB	B-ADVP	O
we	we	PRP	B-NP	O
investigated	investigate	VBD	B-VP	O
the	the	DT	B-NP	O
transcriptional	transcriptional	JJ	I-NP	O
basis	basis	NN	I-NP	O
for	for	IN	B-PP	O
these	these	DT	B-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
proenkephalin	proenkephalin	NN	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
contains	contain	VBZ	B-VP	O
a	a	DT	B-NP	O
sequence	sequence	NN	I-NP	O
GGGGACGTCCCC	GGGGACGTCCCC	NN	I-NP	O
,	,	,	O	O
named	name	VBN	B-VP	O
B2	B2	NN	B-NP	B-protein
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
kappa	kappa	NN	I-NP	B-DNA
B	B	NN	I-NP	I-DNA
sequence	sequence	NN	I-NP	I-DNA
GGGGACTTTCC	GGGGACTTTCC	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
binding	bind	VBG	I-NP	B-DNA
site	site	NN	I-NP	I-DNA
of	of	IN	B-PP	O
the	the	DT	B-NP	O
transcription	transcription	NN	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
nuclear	nuclear	JJ	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
(	(	(	O	I-protein
NF	NF	NN	B-NP	I-protein
)	)	)	O	I-protein
-kappa	-kappa	NN	B-NP	I-protein
B	B	NN	I-NP	I-protein
.	.	.	O	O

Activation	Activation	NN	B-NP	O
of	of	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
induces	induce	VBZ	B-VP	O
an	an	DT	B-NP	O
NF-kappa	NF-kappa	NN	I-NP	O
B-like	B-like	JJ	I-NP	O
binding	binding	NN	I-NP	O
activity	activity	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
B2	B2	NN	I-NP	B-DNA
site	site	NN	I-NP	O
,	,	,	O	O
concomitant	concomitant	JJ	B-ADJP	O
with	with	IN	B-PP	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
proenkephalin	proenkephalin	NN	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
.	.	.	O	O

Mutations	Mutation	NNS	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
B2	B2	NN	I-NP	B-DNA
site	site	NN	I-NP	O
abolish	abolish	VBP	B-VP	O
this	this	DT	B-NP	O
transcriptional	transcriptional	JJ	I-NP	O
activation	activation	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
purified	purify	VBN	I-NP	O
homodimer	homodimer	NN	I-NP	B-protein
(	(	(	O	O
two	two	CD	B-NP	O
p50s	p50	NNS	I-NP	B-protein
)	)	)	O	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
DNA-binding	DNA-binding	JJ	I-NP	B-protein
subunit	subunit	NN	I-NP	I-protein
of	of	IN	B-PP	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
binds	bind	VBZ	B-VP	O
the	the	DT	B-NP	O
B2	B2	NN	I-NP	B-DNA
site	site	NN	I-NP	O
of	of	IN	B-PP	O
proenkephalin	proenkephalin	NN	B-NP	O
relatively	relatively	RB	B-ADVP	O
better	well	RBR	I-ADVP	O
than	than	IN	B-SBAR	O
does	do	VBZ	O	O
the	the	DT	O	O
heterotetramer	heterotetramer	NN	B-NP	B-protein
(	(	(	O	O
two	two	CD	B-NP	O
p65s	p65	NNS	I-NP	B-protein
plus	plus	CC	O	O
two	two	CD	B-NP	O
p50s	p50	NNS	I-NP	B-protein
)	)	)	O	O
form	form	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
factor	factor	NN	I-NP	O
.	.	.	O	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
it	it	PRP	B-NP	O
appears	appear	VBZ	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
T-cell-specific	T-cell-specific	JJ	I-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
proenkephalin	proenkephalin	NN	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
is	be	VBZ	B-VP	O
mediated	mediate	VBN	I-VP	O
by	by	IN	B-PP	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
is	be	VBZ	B-VP	O
ubiquitous	ubiquitous	JJ	B-ADJP	O
and	and	CC	O	O
the	the	DT	B-NP	O
transcriptional	transcriptional	JJ	I-NP	O
activation	activation	NN	I-NP	O
through	through	IN	B-PP	O
the	the	DT	B-NP	O
B2	B2	NN	I-NP	B-DNA
site	site	NN	I-NP	I-DNA
is	be	VBZ	B-VP	O
T	T	NN	B-NP	O
cell	cell	NN	I-NP	O
specific	specific	JJ	B-ADJP	O
,	,	,	O	O
yet	yet	RB	B-NP	O
another	another	DT	I-NP	O
T-cell-specific	T-cell-specific	JJ	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
which	which	WDT	B-NP	O
synergizes	synergize	VBZ	B-VP	O
with	with	IN	B-PP	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
should	should	MD	B-VP	O
be	be	VB	I-VP	O
considered	consider	VBN	I-VP	O
.	.	.	O	O

=========a1903417.txt=========	=========a1903417.txt=========	LS	B-LST	O

Transforming	Transform	VBG	B-NP	B-protein
growth	growth	NN	I-NP	I-protein
factor-beta	factor-beta	NN	I-NP	I-protein
suppresses	suppress	VBZ	B-VP	O
human	human	JJ	B-NP	B-protein
B	B	NN	I-NP	I-protein
lymphocyte	lymphocyte	NN	I-NP	I-protein
Ig	Ig	NN	I-NP	I-protein
production	production	NN	I-NP	O
by	by	IN	B-PP	O
inhibiting	inhibit	VBG	B-VP	O
synthesis	synthesis	NN	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
switch	switch	NN	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
membrane	membrane	NN	I-NP	B-RNA
form	form	NN	I-NP	I-RNA
to	to	TO	B-PP	O
the	the	DT	B-NP	O
secreted	secrete	VBN	I-NP	B-RNA
form	form	NN	I-NP	I-RNA
of	of	IN	B-PP	O
Ig	Ig	NN	B-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
.	.	.	O	O

Transforming	Transform	VBG	B-NP	B-protein
growth	growth	NN	I-NP	I-protein
factor-beta	factor-beta	NN	I-NP	I-protein
(	(	(	O	O
TGF-beta	TGF-beta	NN	B-NP	B-protein
)	)	)	O	O
inhibits	inhibit	VBZ	B-VP	O
B	B	NN	B-NP	B-cell_type
cell	cell	NN	I-NP	I-cell_type
Ig	Ig	NN	I-NP	B-protein
secretion	secretion	NN	I-NP	O
and	and	CC	O	O
reduces	reduce	VBZ	B-VP	O
B	B	NN	B-NP	B-cell_type
cell	cell	NN	I-NP	I-cell_type
membrane	membrane	NN	I-NP	O
Ig	Ig	NN	I-NP	O
expression	expression	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
addition	addition	NN	I-NP	O
of	of	IN	B-PP	O
TGF-beta	TGF-beta	NN	B-NP	B-protein
to	to	TO	B-PP	O
human	human	JJ	B-NP	B-cell_line
B	B	NN	I-NP	I-cell_line
lymphocyte	lymphocyte	NN	I-NP	I-cell_line
cultures	culture	NNS	I-NP	I-cell_line
stimulated	stimulate	VBN	B-VP	O
with	with	IN	B-PP	O
Staphylococcus	Staphylococcus	FW	B-NP	O
aureus	aureus	FW	I-NP	O
Cowan	Cowan	NN	I-NP	O
strain	strain	NN	I-NP	O
I	I	CD	I-NP	O
and	and	CC	O	O
IL-2	IL-2	NN	B-NP	B-protein
completely	completely	RB	B-ADVP	O
inhibited	inhibit	VBD	B-VP	O
B	B	NN	B-NP	B-cell_type
cell	cell	NN	I-NP	I-cell_type
Ig	Ig	NN	I-NP	B-protein
secretion	secretion	NN	I-NP	O
(	(	(	O	O
greater	great	JJR	B-ADVP	O
than	than	IN	B-PP	O
90	90	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
decreased	decrease	VBD	B-VP	O
B	B	NN	B-NP	O
cell	cell	NN	I-NP	O
surface	surface	NN	I-NP	O
IgM	IgM	NN	B-NP	B-protein
,	,	,	O	O
IgD	IgD	NN	B-NP	B-protein
,	,	,	O	O
kappa	kappa	NN	B-NP	B-protein
L	L	NN	I-NP	I-protein
chain	chain	NN	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
lambda	lambda	NN	B-NP	B-protein
L	L	NN	I-NP	I-protein
chain	chain	NN	I-NP	I-protein
expression	expression	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
,	,	,	O	O
TGF-beta	TGF-beta	NN	B-NP	B-protein
had	have	VBD	B-VP	O
only	only	RB	B-NP	O
minimal	minimal	JJ	I-NP	O
effects	effect	NNS	I-NP	O
on	on	IN	B-PP	O
two	two	CD	B-NP	O
other	other	JJ	I-NP	O
B	B	NN	I-NP	B-protein
cell	cell	NN	I-NP	I-protein
membrane	membrane	NN	I-NP	I-protein
proteins	protein	NNS	I-NP	I-protein
,	,	,	O	O
HLA-DR	HLA-DR	NN	B-NP	B-protein
and	and	CC	O	O
CD20	CD20	NN	B-NP	B-protein
.	.	.	O	O

Internal	Internal	JJ	B-NP	O
labeling	labeling	NN	I-NP	O
with	with	IN	B-PP	O
[	[	(	O	O
35S	35S	NN	B-NP	O
]	]	)	I-NP	O
methionine	methionine	NN	I-NP	O
and	and	CC	I-NP	O
immunoprecipitation	immunoprecipitation	NN	I-NP	O
with	with	IN	B-PP	O
anti-IgM	anti-IgM	JJ	B-NP	B-protein
,	,	,	I-NP	O
anti-kappa	anti-kappa	JJ	I-NP	B-protein
,	,	,	I-NP	O
and	and	CC	I-NP	O
anti-lambda	anti-lambda	JJ	I-NP	B-protein
antibodies	antibody	NNS	I-NP	I-protein
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
striking	striking	JJ	I-NP	O
reduction	reduction	NN	I-NP	O
in	in	IN	B-PP	O
kappa	kappa	NN	B-NP	B-protein
L	L	NN	I-NP	I-protein
chain	chain	NN	I-NP	I-protein
in	in	IN	B-PP	O
the	the	DT	I-PP	O
presence	presence	NN	I-PP	O
of	of	IN	I-PP	O
TGF-beta	TGF-beta	NN	B-NP	B-protein
.	.	.	O	O

A	A	DT	B-NP	O
less	less	RBR	I-NP	O
pronounced	pronounced	JJ	I-NP	O
reduction	reduction	NN	I-NP	O
in	in	IN	B-PP	O
lambda	lambda	NN	B-NP	B-protein
L	L	NN	I-NP	I-protein
chain	chain	NN	I-NP	I-protein
and	and	CC	O	O
microH	microH	NN	B-NP	B-protein
chain	chain	NN	I-NP	I-protein
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
noted	note	VBN	I-VP	O
.	.	.	O	O

Northern	Northern	NN	B-NP	O
blot	blot	NN	I-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
RNA	RNA	NN	B-NP	B-RNA
purified	purify	VBN	B-VP	O
from	from	IN	B-PP	O
B	B	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
TGF-beta	TGF-beta	NN	B-NP	B-protein
for	for	IN	B-PP	O
varying	vary	VBG	B-NP	O
time	time	NN	I-NP	O
intervals	interval	NNS	I-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
significant	significant	JJ	I-NP	O
decrease	decrease	NN	I-NP	O
in	in	IN	B-PP	O
steady	steady	JJ	B-NP	O
state	state	NN	I-NP	O
kappa	kappa	NN	I-NP	O
and	and	CC	I-NP	O
lambda	lambda	NN	I-NP	O
L	L	NN	I-NP	O
chain	chain	NN	I-NP	O
mRNA	mRNA	NN	I-NP	O
levels	level	NNS	I-NP	O
.	.	.	O	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
a	a	DT	B-NP	O
significant	significant	JJ	I-NP	O
decrease	decrease	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
switch	switch	NN	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
membrane	membrane	NN	I-NP	B-RNA
forms	form	NNS	I-NP	I-RNA
of	of	IN	B-PP	O
mu	mu	NN	B-NP	O
and	and	CC	O	O
gamma	gamma	NN	B-NP	O
to	to	TO	B-PP	O
their	their	PRP$	B-NP	O
respective	respective	JJ	I-NP	O
secreted	secreted	JJ	I-NP	B-RNA
forms	form	NNS	I-NP	I-RNA
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	I-PP	O
presence	presence	NN	I-PP	O
of	of	IN	I-PP	O
TGF-beta	TGF-beta	NN	B-NP	B-protein
.	.	.	O	O

Nuclear	Nuclear	JJ	B-NP	O
run-on	run-on	JJ	I-NP	O
experiments	experiment	NNS	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
decreased	decrease	VBN	B-NP	O
transcription	transcription	NN	I-NP	O
of	of	IN	B-PP	O
kappa	kappa	NN	B-NP	B-protein
L	L	NN	I-NP	I-protein
chain	chain	NN	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
TGF-beta	TGF-beta	NN	B-NP	B-protein
on	on	IN	B-PP	O
two	two	CD	B-NP	O
transcriptional	transcriptional	JJ	I-NP	B-protein
regulatory	regulatory	JJ	I-NP	I-protein
factors	factor	NNS	I-NP	I-protein
,	,	,	O	O
Oct-2	Oct-2	NN	B-NP	B-protein
and	and	CC	O	O
nuclear	nuclear	JJ	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
(	(	(	O	I-protein
NF	NF	NN	B-NP	I-protein
)	)	)	O	I-protein
kappa	kappa	NN	B-NP	I-protein
B	B	NN	I-NP	I-protein
,	,	,	O	O
known	know	VBN	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
important	important	JJ	B-ADJP	O
in	in	IN	B-PP	O
Ig	Ig	NN	B-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
transcription	transcription	NN	I-NP	O
were	be	VBD	B-VP	O
examined	examine	VBN	I-VP	O
.	.	.	O	O

Oct-2	Oct-2	NN	B-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
levels	level	NNS	I-NP	O
and	and	CC	O	O
both	both	CC	O	O
Oct-2	Oct-2	NN	B-NP	B-protein
and	and	CC	O	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
proteins	protein	NNS	I-NP	I-protein
in	in	IN	B-PP	O
nuclear	nuclear	JJ	B-NP	O
extracts	extract	NNS	I-NP	O
were	be	VBD	B-VP	O
not	not	RB	I-VP	O
altered	alter	VBN	I-VP	O
by	by	IN	B-PP	O
treatment	treatment	NN	B-NP	O
with	with	IN	B-PP	O
TGF-beta	TGF-beta	NN	B-NP	B-protein
.	.	.	O	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
,	,	,	O	O
levels	level	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
transcriptional	transcriptional	JJ	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
AP-1	AP-1	NN	I-NP	B-protein
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
not	not	RB	I-VP	O
known	know	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
important	important	JJ	B-ADJP	O
in	in	IN	B-PP	O
B	B	NN	B-NP	B-cell_type
cell	cell	NN	I-NP	I-cell_type
Ig	Ig	NN	I-NP	B-protein
production	production	NN	I-NP	O
,	,	,	O	O
were	be	VBD	B-VP	O
reduced	reduce	VBN	I-VP	O
by	by	IN	B-PP	O
TGF-beta	TGF-beta	NN	B-NP	B-protein
.	.	.	O	O

These	These	DT	B-NP	O
findings	finding	NNS	I-NP	O
demonstrate	demonstrate	VBP	B-VP	O
that	that	IN	B-SBAR	O
TGF-beta	TGF-beta	NN	B-NP	B-protein
decreases	decrease	VBZ	B-VP	O
B	B	NN	B-NP	B-cell_type
lymphocyte	lymphocyte	NN	I-NP	I-cell_type
Ig	Ig	NN	I-NP	B-protein
secretion	secretion	NN	I-NP	O
by	by	IN	B-PP	O
inhibiting	inhibit	VBG	B-VP	O
the	the	DT	B-NP	O
synthesis	synthesis	NN	I-NP	O
of	of	IN	B-PP	O
Ig	Ig	NN	B-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
and	and	CC	O	O
inhibiting	inhibit	VBG	B-VP	O
the	the	DT	B-NP	O
switch	switch	NN	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
membrane	membrane	NN	I-NP	B-RNA
form	form	NN	I-NP	I-RNA
to	to	TO	B-PP	O
the	the	DT	B-NP	O
secreted	secrete	VBN	I-NP	B-RNA
forms	form	NNS	I-NP	I-RNA
of	of	IN	B-PP	O
mu	mu	NN	B-NP	B-RNA
and	and	CC	O	I-RNA
gamma	gamma	NN	B-NP	I-RNA
mRNA	mRNA	NN	B-NP	I-RNA
.	.	.	O	O

The	The	DT	B-NP	O
mechanism	mechanism	NN	I-NP	O
by	by	IN	B-PP	O
which	which	WDT	B-NP	O
TGF-beta	TGF-beta	NN	B-NP	B-protein
inhibits	inhibit	VBZ	B-VP	O
Ig	Ig	NN	B-NP	B-protein
chain	chain	NN	I-NP	I-protein
synthesis	synthesis	NN	I-NP	O
is	be	VBZ	B-VP	O
unclear	unclear	JJ	B-ADJP	O
although	although	IN	B-SBAR	O
it	it	PRP	B-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
involve	involve	VB	I-VP	O
inhibition	inhibition	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
binding	binding	NN	I-NP	O
of	of	IN	B-PP	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
or	or	CC	O	O
Oct-2	Oct-2	NN	B-NP	B-protein
to	to	TO	B-PP	O
their	their	PRP$	B-NP	O
respective	respective	JJ	I-NP	O
target	target	NN	I-NP	B-DNA
sequences	sequence	NNS	I-NP	I-DNA
.	.	.	O	O

=========a2005404.txt=========	=========a2005404.txt=========	LS	B-LST	O

Kappa	Kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
binding	binding	NN	I-NP	I-protein
proteins	protein	NNS	I-NP	I-protein
are	be	VBP	B-VP	O
constitutively	constitutively	RB	I-VP	O
expressed	express	VBN	I-VP	O
in	in	IN	B-PP	O
an	an	DT	B-NP	O
IL-2	IL-2	NN	I-NP	B-cell_line
autocrine	autocrine	JJ	I-NP	I-cell_line
human	human	JJ	I-NP	I-cell_line
T	T	NN	I-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
.	.	.	O	O

The	The	DT	B-NP	O
IL-2	IL-2	NN	I-NP	B-protein
and	and	CC	O	O
the	the	DT	B-NP	O
IL-2-R	IL-2-R	NN	I-NP	B-DNA
alpha	alpha	NN	I-NP	I-DNA
genes	gene	NNS	B-NP	I-DNA
are	be	VBP	B-VP	O
both	both	DT	O	O
expressed	express	VBN	B-VP	O
transiently	transiently	RB	B-ADVP	O
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
after	after	IN	B-PP	O
Ag	Ag	NN	B-NP	B-protein
or	or	CC	O	O
mitogen	mitogen	NN	B-NP	B-protein
activation	activation	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	B-cell_line
T	T	NN	I-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
,	,	,	O	O
IARC	IARC	NN	B-NP	B-cell_line
301	301	CD	I-NP	I-cell_line
,	,	,	O	O
expresses	express	VBZ	B-VP	O
these	these	DT	B-NP	O
two	two	CD	I-NP	O
genes	gene	NNS	I-NP	O
constitutively	constitutively	RB	B-ADVP	O
and	and	CC	O	O
we	we	PRP	B-NP	O
have	have	VBP	B-VP	O
previously	previously	RB	I-VP	O
demonstrated	demonstrate	VBN	I-VP	O
that	that	IN	B-SBAR	O
its	its	PRP$	B-NP	O
growth	growth	NN	I-NP	O
depends	depend	VBZ	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
autocrine	autocrine	JJ	I-NP	O
production	production	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
T	T	NN	I-NP	B-protein
cell	cell	NN	I-NP	I-protein
growth	growth	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
and	and	CC	O	O
high	high	JJ	B-NP	B-protein
affinity	affinity	NN	I-NP	I-protein
IL-2R	IL-2R	NN	I-NP	I-protein
.	.	.	O	O

To	To	TO	B-VP	O
dissect	dissect	VB	I-VP	O
the	the	DT	B-NP	O
molecular	molecular	JJ	I-NP	O
basis	basis	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
unusual	unusual	JJ	I-NP	O
persistent	persistent	JJ	I-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	O	O
IL-2	IL-2	NN	B-NP	B-DNA
and	and	CC	O	I-DNA
IL-2-R	IL-2-R	NN	B-NP	I-DNA
alpha	alpha	NN	I-NP	I-DNA
genes	gene	NNS	B-NP	I-DNA
in	in	IN	B-PP	O
these	these	DT	B-NP	O
IARC	IARC	NN	I-NP	B-cell_line
301	301	CD	I-NP	I-cell_line
T	T	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
,	,	,	O	O
we	we	PRP	B-NP	O
have	have	VBP	B-VP	O
analyzed	analyze	VBN	I-VP	O
the	the	DT	B-NP	O
interactions	interaction	NNS	I-NP	O
of	of	IN	B-PP	O
constitutively	constitutively	RB	B-NP	O
expressed	express	VBN	I-NP	O
nuclear	nuclear	JJ	I-NP	B-protein
proteins	protein	NNS	I-NP	I-protein
with	with	IN	B-PP	O
the	the	DT	B-NP	O
5	5	CD	I-NP	B-DNA
'	'	SYM	I-NP	I-DNA
flanking	flanking	NN	I-NP	I-DNA
regions	region	NNS	I-NP	I-DNA
of	of	IN	B-PP	O
the	the	DT	O	O
IL-2	IL-2	NN	B-NP	B-DNA
and	and	CC	O	I-DNA
IL-2-R	IL-2-R	NN	B-NP	I-DNA
alpha	alpha	NN	I-NP	I-DNA
genes	gene	NNS	B-NP	I-DNA
using	use	VBG	B-VP	O
both	both	CC	O	O
DNase	DNase	NN	B-NP	B-protein
I	I	CD	I-NP	I-protein
footprinting	footprinting	NN	I-NP	O
and	and	CC	O	O
gel	gel	NN	B-NP	O
retardation	retardation	NN	I-NP	O
techniques	technique	NNS	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
found	find	VBN	I-VP	O
that	that	IN	B-SBAR	O
a	a	DT	B-NP	O
region	region	NN	I-NP	O
in	in	IN	B-PP	O
both	both	DT	B-NP	O
genes	gene	NNS	I-NP	O
(	(	(	O	O
-276	-276	CD	B-NP	B-DNA
to	to	TO	O	I-DNA
-250	-250	CD	B-NP	I-DNA
for	for	IN	B-PP	O
IL-2-R	IL-2-R	NN	B-NP	B-protein
alpha	alpha	NN	I-NP	I-protein
and	and	CC	O	O
-203	-203	CD	B-NP	B-DNA
to	to	TO	B-PP	I-DNA
-183	-183	CD	B-NP	I-DNA
for	for	IN	B-PP	O
IL-2	IL-2	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
which	which	WDT	B-NP	O
corresponds	correspond	VBZ	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
kappa	kappa	NN	I-NP	B-DNA
B	B	NN	I-NP	I-DNA
enhancer	enhancer	NN	I-NP	I-DNA
element	element	NN	I-NP	I-DNA
,	,	,	O	O
is	be	VBZ	B-VP	O
specifically	specifically	RB	I-VP	O
protected	protect	VBN	I-VP	O
by	by	IN	B-PP	O
nuclear	nuclear	JJ	B-NP	B-protein
proteins	protein	NNS	I-NP	I-protein
from	from	IN	B-PP	O
IARC	IARC	NN	B-NP	B-cell_line
301	301	CD	I-NP	I-cell_line
.	.	.	O	O

In	In	IN	B-PP	O
agreement	agreement	NN	I-PP	O
with	with	IN	I-PP	O
this	this	DT	B-NP	O
finding	finding	NN	I-NP	O
,	,	,	O	O
both	both	CC	O	O
the	the	DT	O	O
IL-2	IL-2	NN	B-NP	B-DNA
and	and	CC	O	I-DNA
IL-2-R	IL-2-R	NN	B-NP	I-DNA
alpha	alpha	NN	I-NP	I-DNA
promoters	promoter	NNS	B-NP	I-DNA
are	be	VBP	B-VP	O
active	active	JJ	B-ADJP	O
in	in	IN	B-PP	O
transient	transient	JJ	B-NP	O
transfection	transfection	NN	I-NP	O
assays	assay	NNS	I-NP	O
in	in	IN	B-PP	O
IARC	IARC	NN	B-NP	B-cell_line
301	301	CD	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
.	.	.	O	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
,	,	,	O	O
mutation	mutation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
kappa	kappa	NN	I-NP	B-DNA
B	B	NN	I-NP	I-DNA
enhancer	enhancer	NN	I-NP	I-DNA
results	result	VBZ	B-VP	O
in	in	IN	B-PP	O
markedly	markedly	RB	B-NP	O
attenuated	attenuate	VBN	I-NP	O
activities	activity	NNS	I-NP	O
of	of	IN	B-PP	O
both	both	DT	B-NP	O
promoters	promoter	NNS	I-NP	B-DNA
.	.	.	O	O

Two	Two	CD	B-NP	O
proteins	protein	NNS	I-NP	O
binding	bind	VBG	B-VP	O
the	the	DT	B-NP	O
kappa	kappa	NN	I-NP	B-DNA
B	B	NN	I-NP	I-DNA
sequence	sequence	NN	I-NP	I-DNA
,	,	,	O	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
and	and	CC	O	O
KBF1	KBF1	NN	B-NP	B-protein
,	,	,	O	O
are	be	VBP	B-VP	O
constitutively	constitutively	RB	I-VP	O
expressed	express	VBN	I-VP	O
in	in	IN	B-PP	O
IARC	IARC	NN	B-NP	B-cell_line
301	301	CD	I-NP	I-cell_line
nuclei	nucleus	NNS	I-NP	O
and	and	CC	O	O
induced	induce	VBN	B-VP	O
by	by	IN	B-PP	O
PMA	PMA	NN	B-NP	O
and	and	CC	O	O
PHA	PHA	NN	B-NP	B-protein
in	in	IN	B-PP	O
Jurkat	Jurkat	NN	B-NP	B-cell_line
.	.	.	O	O

They	They	PRP	B-NP	O
bind	bind	VBP	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
kappa	kappa	NN	I-NP	B-DNA
B	B	NN	I-NP	I-DNA
motifs	motif	NNS	I-NP	I-DNA
with	with	IN	B-PP	O
different	different	JJ	B-NP	O
relative	relative	JJ	I-NP	O
affinities	affinity	NNS	I-NP	O
that	that	WDT	B-NP	O
may	may	MD	B-VP	O
reflect	reflect	VB	I-VP	O
their	their	PRP$	B-NP	O
different	different	JJ	I-NP	O
contribution	contribution	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
various	various	JJ	B-NP	O
promoters	promoter	NNS	I-NP	B-DNA
.	.	.	O	O

=========a1827138.txt=========	=========a1827138.txt=========	LS	B-LST	O

Cloning	Cloning	NN	B-NP	O
of	of	IN	B-PP	O
murine	murine	JJ	B-NP	B-protein
TCF-1	TCF-1	NN	I-NP	I-protein
,	,	,	O	O
a	a	DT	B-NP	O
T	T	NN	I-NP	B-protein
cell-specific	cell-specific	JJ	I-NP	I-protein
transcription	transcription	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
interacting	interact	VBG	B-VP	O
with	with	IN	B-PP	O
functional	functional	JJ	B-NP	B-DNA
motifs	motif	NNS	I-NP	I-DNA
in	in	IN	B-PP	O
the	the	DT	B-NP	O
CD3-epsilon	CD3-epsilon	NN	I-NP	B-DNA
and	and	CC	I-NP	I-DNA
T	T	NN	I-NP	I-DNA
cell	cell	NN	I-NP	I-DNA
receptor	receptor	NN	I-NP	I-DNA
alpha	alpha	NN	I-NP	I-DNA
enhancers	enhancer	NNS	I-NP	I-DNA
.	.	.	O	O

CD3-epsilon	CD3-epsilon	NN	B-NP	O
gene	gene	NN	I-NP	O
expression	expression	NN	I-NP	O
is	be	VBZ	B-VP	O
confined	confine	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
T	T	NN	I-NP	B-cell_type
cell	cell	NN	I-NP	I-cell_type
lineage	lineage	NN	I-NP	I-cell_type
.	.	.	O	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
recently	recently	RB	I-VP	O
identified	identify	VBN	I-VP	O
and	and	CC	O	O
cloned	clone	VBN	B-VP	O
a	a	DT	B-NP	O
human	human	JJ	I-NP	B-protein
transcription	transcription	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
,	,	,	O	O
TCF-1	TCF-1	NN	B-NP	B-protein
,	,	,	O	O
that	that	WDT	B-NP	O
binds	bind	VBZ	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
functional	functional	JJ	I-NP	O
element	element	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
T	T	NN	I-NP	B-DNA
lymphocyte-specific	lymphocyte-specific	JJ	I-NP	I-DNA
enhancer	enhancer	NN	I-NP	I-DNA
of	of	IN	B-PP	O
CD3-epsilon	CD3-epsilon	NN	B-NP	B-protein
.	.	.	O	O

In	In	IN	B-PP	O
a	a	DT	B-NP	O
panel	panel	NN	I-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	B-cell_line
cell	cell	NN	I-NP	I-cell_line
lines	line	NNS	I-NP	I-cell_line
,	,	,	O	O
TCF-1	TCF-1	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
was	be	VBD	B-VP	O
restricted	restricted	JJ	B-ADJP	O
to	to	TO	B-PP	O
T	T	NN	B-NP	B-cell_type
lineage	lineage	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

TCF-1	TCF-1	NN	B-NP	B-protein
belonged	belong	VBD	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
family	family	NN	I-NP	O
of	of	IN	B-PP	O
genes	gene	NNS	B-NP	O
that	that	WDT	B-NP	O
contain	contain	VBP	B-VP	O
the	the	DT	B-NP	O
so-called	so-called	JJ	I-NP	O
high	high	JJ	I-NP	O
mobility	mobility	NN	I-NP	O
group	group	NN	I-NP	O
1	1	CD	I-NP	O
(	(	(	I-NP	O
HMG	HMG	NN	I-NP	B-protein
)	)	)	I-NP	O
box	box	NN	I-NP	O
.	.	.	O	O

Here	Here	RB	B-ADVP	O
we	we	PRP	B-NP	O
report	report	VBP	B-VP	O
the	the	DT	B-NP	O
cloning	cloning	NN	I-NP	O
of	of	IN	B-PP	O
murine	murine	JJ	B-NP	B-protein
TCF-1	TCF-1	NN	I-NP	I-protein
.	.	.	O	O

Two	Two	CD	B-NP	O
splice	splice	NN	I-NP	O
alternatives	alternative	NNS	I-NP	O
were	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
that	that	WDT	B-NP	O
were	be	VBD	B-VP	O
not	not	RB	I-VP	O
previously	previously	RB	I-VP	O
observed	observe	VBN	I-VP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	B-protein
TCF-1	TCF-1	NN	I-NP	I-protein
.	.	.	O	O

Murine	Murine	JJ	B-NP	B-protein
and	and	CC	I-NP	I-protein
human	human	JJ	I-NP	I-protein
TCF-1	TCF-1	NN	I-NP	I-protein
displayed	display	VBD	B-VP	O
a	a	DT	B-NP	O
95.5	95.5	CD	I-NP	O
%	%	NN	I-NP	O
overall	overall	JJ	I-NP	O
amino	amino	JJ	I-NP	O
acid	acid	NN	I-NP	O
homology	homology	NN	I-NP	O
.	.	.	O	O

Recombinant	Recombinant	JJ	B-NP	B-protein
murine	murine	JJ	I-NP	I-protein
and	and	CC	I-NP	I-protein
human	human	JJ	I-NP	I-protein
TCF-1	TCF-1	NN	I-NP	I-protein
recognized	recognize	VBD	B-VP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
sequence	sequence	NN	I-NP	O
motif	motif	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
CD3-epsilon	CD3-epsilon	NN	I-NP	B-DNA
enhancer	enhancer	NN	I-NP	I-DNA
as	as	IN	B-SBAR	O
judged	judge	VBN	B-VP	O
by	by	IN	B-PP	O
gel	gel	NN	B-NP	O
retardation	retardation	NN	I-NP	O
and	and	CC	O	O
methylation	methylation	NN	B-NP	O
interference	interference	NN	I-NP	O
assays	assay	NNS	I-NP	O
.	.	.	O	O

With	With	IN	B-PP	O
the	the	DT	B-NP	O
murine	murine	JJ	I-NP	B-DNA
cDNA	cDNA	NN	I-NP	I-DNA
clones	clone	NNS	I-NP	I-DNA
several	several	JJ	B-NP	O
aspects	aspect	NNS	I-NP	O
of	of	IN	B-PP	O
TCF-1	TCF-1	NN	B-NP	B-protein
were	be	VBD	B-VP	O
analyzed	analyze	VBN	I-VP	O
.	.	.	O	O

First	First	RB	B-ADVP	O
,	,	,	O	O
deletion	deletion	NN	B-NP	O
analysis	analysis	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
that	that	IN	B-SBAR	O
a	a	DT	B-NP	O
region	region	NN	I-NP	O
of	of	IN	B-PP	O
TCF-1	TCF-1	NN	B-NP	B-protein
containing	contain	VBG	B-VP	O
the	the	DT	B-NP	O
HMG	HMG	NN	I-NP	B-DNA
box	box	NN	I-NP	I-DNA
was	be	VBD	B-VP	O
sufficient	sufficient	JJ	B-ADJP	O
for	for	IN	B-PP	O
sequence-specific	sequence-specific	JJ	B-NP	O
binding	binding	NN	I-NP	O
.	.	.	O	O

Second	Second	RB	B-ADVP	O
,	,	,	O	O
by	by	IN	B-PP	O
high	high	JJ	B-NP	O
stringency	stringency	NN	I-NP	O
Northern	Northern	NN	I-NP	O
blotting	blotting	NN	I-NP	O
and	and	CC	O	O
in	in	FW	B-NP	O
situ	situ	FW	I-NP	O
hybridization	hybridization	NN	I-NP	O
,	,	,	O	O
TCF-1	TCF-1	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
was	be	VBD	B-VP	O
shown	show	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
confined	confine	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
thymus	thymus	NN	I-NP	O
and	and	CC	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
T	T	NN	I-NP	O
cell	cell	NN	I-NP	O
areas	area	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
spleen	spleen	NN	I-NP	O
.	.	.	O	O

Third	Third	RB	B-ADVP	O
,	,	,	O	O
TCF-1	TCF-1	NN	B-NP	B-protein
bound	bind	VBD	B-VP	O
specifically	specifically	RB	B-ADVP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
functional	functional	JJ	I-NP	O
T	T	NN	I-NP	B-DNA
cell-specific	cell-specific	JJ	I-NP	I-DNA
element	element	NN	I-NP	I-DNA
in	in	IN	B-PP	O
the	the	DT	B-NP	O
T	T	NN	I-NP	B-DNA
cell	cell	NN	I-NP	I-DNA
receptor	receptor	NN	I-NP	I-DNA
alpha	alpha	NN	I-NP	I-DNA
(	(	(	O	I-DNA
TCR-alpha	TCR-alpha	NN	B-NP	I-DNA
)	)	)	O	I-DNA
enhancer	enhancer	NN	B-NP	I-DNA
.	.	.	O	O

The	The	DT	B-NP	O
T	T	NN	I-NP	O
lineage-specific	lineage-specific	JJ	I-NP	O
expression	expression	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
affinity	affinity	NN	I-NP	O
for	for	IN	B-PP	O
functional	functional	JJ	B-NP	O
motifs	motif	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	O	O
TCR-alpha	TCR-alpha	NN	B-NP	B-DNA
and	and	CC	O	I-DNA
CD3-epsilon	CD3-epsilon	NN	B-NP	I-DNA
enhancers	enhancer	NNS	B-NP	I-DNA
imply	imply	VBP	B-VP	O
an	an	DT	B-NP	O
important	important	JJ	I-NP	O
role	role	NN	I-NP	O
for	for	IN	B-PP	O
TCF-1	TCF-1	NN	B-NP	B-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
establishment	establishment	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mature	mature	JJ	I-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
cell	cell	NN	I-NP	I-cell_type
phenotype	phenotype	NN	I-NP	I-cell_type
.	.	.	O	O

=========a2006423.txt=========	=========a2006423.txt=========	LS	B-LST	O

Isolation	Isolation	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
rel-related	rel-related	JJ	I-NP	B-DNA
human	human	JJ	I-NP	I-DNA
cDNA	cDNA	NN	I-NP	I-DNA
that	that	WDT	B-NP	O
potentially	potentially	RB	B-ADVP	O
encodes	encode	VBZ	B-VP	O
the	the	DT	B-NP	O
65-kD	65-kD	JJ	I-NP	B-protein
subunit	subunit	NN	I-NP	I-protein
of	of	IN	B-PP	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
[	[	(	O	O
published	publish	VBN	B-NP	O
erratum	erratum	NN	I-NP	O
appears	appear	VBZ	B-VP	O
in	in	IN	B-PP	O
Science	Science	NNP	B-NP	O
1991	1991	CD	I-NP	O
Oct	Oct	NNP	I-NP	O
4	4	CD	I-NP	O
;	;	:	O	O
254	254	CD	B-NP	O
(	(	(	O	O
5028	5028	CD	B-NP	O
)	)	)	O	O
:	:	:	O	O
11	11	CD	B-NP	O
]	]	)	O	O

A	A	DT	B-NP	O
DNA	DNA	NN	I-NP	B-DNA
probe	probe	NN	I-NP	I-DNA
that	that	WDT	B-NP	O
spanned	span	VBD	B-VP	O
a	a	DT	B-NP	O
domain	domain	NN	I-NP	O
conserved	conserve	VBN	B-VP	O
among	among	IN	B-PP	O
the	the	DT	B-NP	O
proto-oncogene	proto-oncogene	NN	I-NP	B-DNA
c-rel	c-rel	NN	I-NP	I-DNA
,	,	,	O	O
the	the	DT	B-NP	O
Drosophila	Drosophila	NNP	I-NP	B-protein
morphogen	morphogen	NN	I-NP	I-protein
dorsal	dorsal	NN	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
p50	p50	NN	I-NP	B-protein
DNA	DNA	NN	I-NP	I-protein
binding	binding	NN	I-NP	I-protein
subunit	subunit	NN	I-NP	I-protein
of	of	IN	B-PP	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
was	be	VBD	B-VP	O
generated	generate	VBN	I-VP	O
from	from	IN	B-PP	O
Jurkat	Jurkat	NN	B-NP	B-DNA
T	T	NN	I-NP	I-DNA
cell	cell	NN	I-NP	I-DNA
complementary	complementary	JJ	I-NP	I-DNA
DNA	DNA	NN	I-NP	I-DNA
with	with	IN	B-PP	O
the	the	DT	B-NP	O
polymerase	polymerase	NN	I-NP	O
chain	chain	NN	I-NP	O
reaction	reaction	NN	I-NP	O
(	(	(	O	O
PCR	PCR	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
degenerate	degenerate	JJ	B-NP	O
oligonucleotides	oligonucleotide	NNS	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
probe	probe	NN	I-NP	O
was	be	VBD	B-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
identify	identify	VB	I-VP	O
a	a	DT	B-NP	O
rel-related	rel-related	JJ	I-NP	B-DNA
complementary	complementary	JJ	I-NP	I-DNA
DNA	DNA	NN	I-NP	I-DNA
that	that	WDT	B-NP	O
hybridized	hybridize	VBD	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
2.6-kilobase	2.6-kilobase	JJ	I-NP	B-RNA
messenger	messenger	NN	I-NP	I-RNA
RNA	RNA	NN	I-NP	I-RNA
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
and	and	CC	I-NP	I-cell_type
B	B	NN	I-NP	I-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
.	.	.	O	O

In	In	FW	B-NP	O
vitro	vitro	FW	I-NP	O
transcription	transcription	NN	B-NP	O
and	and	CC	O	O
translation	translation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
complementary	complementary	JJ	I-NP	B-DNA
DNA	DNA	NN	I-NP	I-DNA
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
synthesis	synthesis	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
protein	protein	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
apparent	apparent	JJ	I-NP	O
molecular	molecular	JJ	I-NP	O
size	size	NN	I-NP	O
of	of	IN	B-PP	O
65	65	CD	B-NP	B-protein
kilodaltons	kilodalton	NNS	B-NP	I-protein
(	(	(	O	O
kD	kD	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O

The	The	DT	B-NP	O
translated	translate	VBN	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
showed	show	VBD	B-VP	O
weak	weak	JJ	B-NP	O
DNA	DNA	NN	I-NP	O
binding	binding	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
specificity	specificity	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
kappa	kappa	NN	I-NP	B-DNA
B	B	NN	I-NP	I-DNA
binding	binding	NN	I-NP	I-DNA
motif	motif	NN	I-NP	I-DNA
.	.	.	O	O

This	This	DT	B-NP	O
protein-DNA	protein-DNA	JJ	I-NP	B-protein
complex	complex	NN	I-NP	I-protein
comigrated	comigrate	VBD	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
complex	complex	NN	I-NP	O
obtained	obtain	VBN	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
purified	purify	VBN	I-NP	B-protein
human	human	JJ	I-NP	I-protein
p65	p65	NN	I-NP	I-protein
NF-kappa	NF-kappa	NN	I-NP	I-protein
B	B	NN	I-NP	I-protein
subunit	subunit	NN	I-NP	I-protein
and	and	CC	O	O
binding	binding	NN	B-NP	O
was	be	VBD	B-VP	O
inhibited	inhibit	VBN	I-VP	O
by	by	IN	B-PP	O
I	I	NN	B-NP	B-protein
kappa	kappa	NN	I-NP	I-protein
B-alpha	B-alpha	NN	I-NP	I-protein
and	and	CC	O	O
-beta	-beta	NN	B-NP	O
proteins	protein	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
65-kD	65-kD	JJ	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
p50	p50	NN	I-NP	B-protein
subunit	subunit	NN	I-NP	I-protein
of	of	IN	B-PP	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
and	and	CC	O	O
the	the	DT	B-NP	O
kappa	kappa	NN	I-NP	B-DNA
B	B	NN	I-NP	I-DNA
probe	probe	NN	I-NP	I-DNA
to	to	TO	B-VP	O
form	form	VB	I-VP	O
a	a	DT	B-NP	O
complex	complex	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
electrophoretic	electrophoretic	JJ	I-NP	O
mobility	mobility	NN	I-NP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
NF-kappa	NF-kappa	NN	I-NP	B-protein
B-DNA	B-DNA	NN	I-NP	I-protein
complex	complex	NN	I-NP	I-protein
.	.	.	O	O

Therefore	Therefore	RB	B-ADVP	O
the	the	DT	B-NP	O
rel-related	rel-related	JJ	I-NP	B-protein
65-kD	65-kD	JJ	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
may	may	MD	B-VP	O
represent	represent	VB	I-VP	O
the	the	DT	B-NP	O
p65	p65	NN	I-NP	B-protein
subunit	subunit	NN	I-NP	I-protein
of	of	IN	B-PP	O
the	the	DT	B-NP	O
active	active	JJ	I-NP	O
NF-kappa	NF-kappa	NN	I-NP	B-protein
B	B	NN	I-NP	I-protein
transcription	transcription	NN	I-NP	O
factor	factor	NN	I-NP	O
complex	complex	NN	I-NP	O
.	.	.	O	O

=========a1987353.txt=========	=========a1987353.txt=========	LS	B-LST	O

The	The	DT	B-NP	O
NF	NF	NN	I-NP	B-DNA
kappa	kappa	NN	I-NP	I-DNA
B	B	NN	I-NP	I-DNA
independent	independent	JJ	I-NP	I-DNA
cis-acting	cis-acting	JJ	I-NP	I-DNA
sequences	sequence	NNS	I-NP	I-DNA
in	in	IN	B-PP	O
HIV-1	HIV-1	NN	B-NP	B-DNA
LTR	LTR	NN	I-NP	I-DNA
responsive	responsive	JJ	B-ADJP	O
to	to	TO	B-PP	O
T-cell	T-cell	NN	B-NP	O
activation	activation	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
transcription	transcription	NN	B-NP	O
initiation	initiation	NN	I-NP	O
directed	direct	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
long	long	JJ	I-NP	B-DNA
terminal	terminal	JJ	I-NP	I-DNA
repeat	repeat	NN	I-NP	I-DNA
(	(	(	O	O
LTR	LTR	NN	B-NP	B-DNA
)	)	)	O	O
of	of	IN	B-PP	O
HIV-1	HIV-1	NN	B-NP	O
increases	increase	NNS	I-NP	O
in	in	IN	B-PP	O
response	response	NN	I-PP	O
to	to	TO	I-PP	O
mitogenic	mitogenic	JJ	B-NP	O
stimuli	stimulus	NNS	I-NP	O
of	of	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Here	Here	RB	B-ADVP	O
we	we	PRP	B-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
response	response	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
HIV-1	HIV-1	NN	I-NP	B-DNA
LTR	LTR	NN	I-NP	I-DNA
may	may	MD	B-VP	O
be	be	VB	I-VP	O
governed	govern	VBN	I-VP	O
by	by	IN	B-PP	O
two	two	CD	B-NP	O
independent	independent	JJ	I-NP	O
sequences	sequence	NNS	I-NP	O
located	located	JJ	B-ADJP	O
5	5	CD	B-NP	O
'	'	SYM	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
site	site	NN	I-NP	O
of	of	IN	B-PP	O
transcription	transcription	NN	B-NP	B-DNA
initiation	initiation	NN	I-NP	I-DNA
sequences	sequence	NNS	I-NP	I-DNA
that	that	WDT	B-NP	O
bind	bind	VBP	B-VP	O
either	either	CC	O	O
NFAT-1	NFAT-1	NN	B-NP	B-protein
or	or	CC	O	O
NF	NF	NN	B-NP	B-protein
kappa	kappa	NN	I-NP	I-protein
B	B	NN	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
LTR-directed	LTR-directed	JJ	B-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
expression	expression	NN	I-NP	O
increased	increase	VBD	B-VP	O
in	in	IN	B-PP	O
response	response	NN	I-PP	O
to	to	TO	I-PP	O
treatment	treatment	NN	B-NP	O
with	with	IN	B-PP	O
either	either	CC	O	O
a	a	DT	B-NP	O
phorbol	phorbol	NN	I-NP	O
ester	ester	NN	I-NP	O
or	or	CC	O	O
tumor	tumor	NN	B-NP	B-protein
necrosis	necrosis	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
alpha	alpha	NN	I-NP	I-protein
if	if	IN	B-SBAR	O
either	either	CC	O	O
the	the	DT	O	O
NFAT-1	NFAT-1	NN	B-NP	B-protein
or	or	CC	O	O
NF	NF	NN	B-NP	B-DNA
kappa	kappa	NN	I-NP	I-DNA
B	B	NN	I-NP	I-DNA
binding	binding	NN	I-NP	I-DNA
sites	site	NNS	I-NP	I-DNA
were	be	VBD	B-VP	O
deleted	delete	VBN	I-VP	O
,	,	,	O	O
but	but	CC	O	O
failed	fail	VBD	B-VP	O
to	to	TO	I-VP	O
respond	respond	VB	I-VP	O
to	to	TO	B-PP	O
these	these	DT	B-NP	O
mitogenic	mitogenic	JJ	I-NP	O
stimuli	stimulus	NNS	I-NP	O
if	if	IN	B-SBAR	O
both	both	DT	B-NP	O
sequences	sequence	NNS	I-NP	O
were	be	VBD	B-VP	O
absent	absent	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
HIV-1	HIV-1	NN	I-NP	O
mutant	mutant	JJ	I-NP	O
virus	virus	NN	I-NP	O
containing	contain	VBG	B-VP	O
both	both	CC	O	O
NF	NF	NN	B-NP	B-protein
kappa	kappa	NN	I-NP	I-protein
B	B	NN	I-NP	I-protein
and	and	CC	O	O
NFAT-1	NFAT-1	NN	B-NP	B-protein
deletion	deletion	NN	B-NP	O
was	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
replicate	replicate	VB	I-VP	O
although	although	IN	B-SBAR	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
much	much	RB	I-NP	O
decreased	decrease	VBN	I-NP	O
growth	growth	NN	I-NP	O
rate	rate	NN	I-NP	O
,	,	,	O	O
while	while	IN	B-SBAR	O
the	the	DT	B-NP	O
deletion	deletion	NN	I-NP	O
of	of	IN	B-PP	O
NFAT-1	NFAT-1	NN	B-NP	B-protein
alone	alone	RB	B-ADVP	O
increased	increase	VBD	B-VP	O
the	the	DT	B-NP	O
viral	viral	JJ	I-NP	O
growth	growth	NN	I-NP	O
rate	rate	NN	I-NP	O
in	in	IN	B-PP	O
Jurkat	Jurkat	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
.	.	.	O	O

Neither	Neither	CC	O	O
deletion	deletion	NN	B-NP	O
of	of	IN	B-PP	O
NF	NF	NN	B-NP	B-protein
kappa	kappa	NN	I-NP	I-protein
B	B	NN	I-NP	I-protein
nor	nor	CC	O	O
deletion	deletion	NN	B-NP	O
of	of	IN	B-PP	O
NFAT-1	NFAT-1	NN	B-NP	B-protein
decreased	decrease	VBD	B-VP	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
viral	viral	JJ	B-NP	O
replication	replication	NN	I-NP	O
by	by	IN	B-PP	O
phorbol	phorbol	NN	B-NP	O
ester	ester	NN	I-NP	O
.	.	.	O	O

=========a1672442.txt=========	=========a1672442.txt=========	LS	B-LST	O

The	The	DT	B-NP	O
functional	functional	JJ	I-NP	B-protein
domains	domain	NNS	I-NP	I-protein
of	of	IN	B-PP	O
the	the	DT	B-NP	O
murine	murine	JJ	I-NP	B-DNA
Thy-1	Thy-1	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
promoter	promoter	NN	I-NP	I-DNA
.	.	.	O	O

The	The	DT	B-NP	O
Thy-1	Thy-1	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
promoter	promoter	NN	I-NP	I-DNA
resembles	resemble	VBZ	B-VP	O
a	a	DT	B-NP	O
``	``	``	I-NP	B-DNA
housekeeping	housekeeping	JJ	I-NP	I-DNA
``	``	``	I-NP	I-DNA
promoter	promoter	NN	I-NP	I-DNA
in	in	IN	B-PP	O
that	that	IN	B-NP	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
located	located	JJ	B-ADJP	O
within	within	IN	B-PP	O
a	a	DT	B-NP	O
methylation-free	methylation-free	JJ	I-NP	B-DNA
island	island	NN	I-NP	I-DNA
,	,	,	O	O
lacks	lack	VBZ	B-VP	O
a	a	DT	B-NP	O
canonical	canonical	JJ	I-NP	B-DNA
TATA	TATA	NN	I-NP	I-DNA
box	box	NN	I-NP	I-DNA
,	,	,	O	O
and	and	CC	O	O
displays	display	VBZ	B-VP	O
heterogeneity	heterogeneity	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
5'-end	5'-end	JJ	I-NP	B-RNA
termini	terminus	NNS	I-NP	I-RNA
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mRNA	mRNA	NN	I-NP	B-RNA
.	.	.	O	O

Using	Use	VBG	B-VP	O
transgenic	transgenic	JJ	B-NP	O
mice	mouse	NNS	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
promoter	promoter	NN	I-NP	B-DNA
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
confer	confer	VB	I-VP	O
any	any	DT	B-NP	O
tissue	tissue	NN	I-NP	O
specificity	specificity	NN	I-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
active	active	JJ	B-ADJP	O
only	only	RB	B-PP	O
in	in	IN	I-PP	O
a	a	DT	B-NP	O
position-dependent	position-dependent	JJ	I-NP	O
manner	manner	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
can	can	MD	B-VP	O
only	only	RB	I-VP	O
be	be	VB	I-VP	O
activated	activate	VBN	I-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
tissue-specific	tissue-specific	JJ	I-NP	O
manner	manner	NN	I-NP	O
by	by	IN	B-PP	O
elements	element	NNS	B-NP	O
that	that	WDT	B-NP	O
lie	lie	VBP	B-VP	O
downstream	downstream	RB	B-ADJP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
initiation	initiation	NN	I-NP	B-DNA
site	site	NN	I-NP	I-DNA
.	.	.	O	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
analyzed	analyze	VBN	I-VP	O
the	the	DT	B-NP	O
functional	functional	JJ	I-NP	B-protein
domains	domain	NNS	I-NP	I-protein
of	of	IN	B-PP	O
the	the	DT	B-NP	O
minimal	minimal	JJ	I-NP	B-DNA
Thy-1	Thy-1	NN	I-NP	I-DNA
promoter	promoter	NN	I-NP	I-DNA
and	and	CC	O	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
dominant	dominant	JJ	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
elements	element	NNS	I-NP	I-DNA
consist	consist	VBP	B-VP	O
of	of	IN	B-PP	O
multiple	multiple	JJ	B-NP	B-DNA
binding	bind	VBG	I-NP	I-DNA
sites	site	NNS	I-NP	I-DNA
for	for	IN	B-PP	O
the	the	DT	B-NP	O
transcription	transcription	NN	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
Sp1	Sp1	NN	I-NP	B-protein
,	,	,	O	O
an	an	DT	B-NP	O
inverted	invert	VBN	I-NP	O
CCAAT	CCAAT	NN	I-NP	B-DNA
box	box	NN	I-NP	I-DNA
,	,	,	O	O
and	and	CC	O	O
sequences	sequence	NNS	B-NP	O
proximal	proximal	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
transcription	transcription	NN	I-NP	B-DNA
start	start	NN	I-NP	I-DNA
site	site	NN	I-NP	I-DNA
.	.	.	O	O

DNase	DNase	NN	B-NP	B-protein
I	I	CD	I-NP	I-protein
and	and	CC	I-NP	O
gel	gel	NN	I-NP	O
mobility	mobility	NN	I-NP	O
shift	shift	NN	I-NP	O
assays	assay	NNS	I-NP	O
show	show	VBP	B-VP	O
the	the	DT	B-NP	O
binding	binding	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
nuclear	nuclear	JJ	B-NP	B-protein
factors	factor	NNS	I-NP	I-protein
to	to	TO	B-PP	O
these	these	DT	B-NP	O
elements	element	NNS	I-NP	B-DNA
,	,	,	O	O
including	include	VBG	B-PP	O
Sp1	Sp1	NN	B-NP	B-protein
and	and	CC	O	O
CP1	CP1	NN	B-NP	B-protein
.	.	.	O	O

Our	Our	PRP$	B-NP	O
results	result	NNS	I-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
structure	structure	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
promoter	promoter	NN	I-NP	B-DNA
only	only	RB	B-ADVP	O
permits	permit	VBZ	B-VP	O
productive	productive	JJ	B-NP	O
interactions	interaction	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
transcription	transcription	NN	I-NP	B-protein
factors	factor	NNS	I-NP	I-protein
Sp1	Sp1	NN	B-NP	B-protein
and	and	CC	O	O
CP1	CP1	NN	B-NP	B-protein
with	with	IN	B-PP	O
the	the	DT	B-NP	O
basal	basal	JJ	I-NP	O
transcription	transcription	NN	I-NP	O
machinery	machinery	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	I-PP	O
presence	presence	NN	I-PP	O
of	of	IN	I-PP	O
enhancer	enhancer	NN	B-NP	B-DNA
sequences	sequence	NNS	I-NP	I-DNA
.	.	.	O	O

=========a2006697.txt=========	=========a2006697.txt=========	LS	B-LST	O

Lymphocyte	Lymphocyte	NN	B-NP	O
glucocorticoid	glucocorticoid	NN	I-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
number	number	NN	I-NP	O
in	in	IN	B-PP	O
posttraumatic	posttraumatic	JJ	B-NP	O
stress	stress	NN	I-NP	O
disorder	disorder	NN	I-NP	O
.	.	.	O	O

OBJECTIVE	OBJECTIVE	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
authors	author	NNS	I-NP	O
'	'	POS	B-NP	O
objective	objective	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
investigate	investigate	VB	I-VP	O
the	the	DT	B-NP	O
possibility	possibility	NN	I-NP	O
that	that	IN	B-SBAR	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
changes	change	NNS	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
dysregulation	dysregulation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
hypothalamic-pituitary-adrenal	hypothalamic-pituitary-adrenal	JJ	I-NP	O
(	(	(	O	O
HPA	HPA	JJ	B-ADJP	O
)	)	)	O	O
axis	axis	NN	B-NP	O
in	in	IN	B-PP	O
posttraumatic	posttraumatic	JJ	B-NP	O
stress	stress	NN	I-NP	O
disorder	disorder	NN	I-NP	O
(	(	(	O	O
PTSD	PTSD	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O

METHOD	METHOD	NN	B-NP	O
:	:	:	O	O
They	They	PRP	B-NP	O
measured	measure	VBD	B-VP	O
the	the	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
lymphocyte	lymphocyte	NN	B-NP	B-protein
cytosolic	cytosolic	JJ	I-NP	I-protein
glucocorticoid	glucocorticoid	NN	I-NP	I-protein
receptors	receptor	NNS	I-NP	I-protein
and	and	CC	O	O
plasma	plasma	NN	B-NP	O
cortisol	cortisol	NN	I-NP	O
concentrations	concentration	NNS	I-NP	O
in	in	IN	B-PP	O
15	15	CD	B-NP	O
consecutively	consecutively	RB	I-NP	O
admitted	admit	VBN	I-NP	O
male	male	JJ	I-NP	O
combat	combat	NN	I-NP	O
Vietnam	Vietnam	NNP	I-NP	O
veterans	veteran	NNS	I-NP	O
with	with	IN	B-PP	O
PTSD	PTSD	NN	B-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
normal	normal	JJ	I-NP	O
comparison	comparison	NN	I-NP	O
group	group	NN	I-NP	O
of	of	IN	B-PP	O
11	11	CD	B-NP	O
subjects	subject	NNS	I-NP	O
.	.	.	O	O

RESULTS	RESULTS	NNS	B-NP	O
:	:	:	O	O
Both	Both	CC	O	O
the	the	DT	B-NP	O
patients	patient	NNS	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
normal	normal	JJ	I-NP	O
comparison	comparison	NN	I-NP	O
subjects	subject	NNS	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
morning-to-afternoon	morning-to-afternoon	JJ	I-NP	O
decline	decline	NN	I-NP	O
in	in	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
concentrations	concentration	NNS	I-NP	O
,	,	,	O	O
paralleling	parallel	VBG	B-VP	O
the	the	DT	B-NP	O
normal	normal	JJ	I-NP	O
diurnal	diurnal	JJ	I-NP	O
decline	decline	NN	I-NP	O
in	in	IN	B-PP	O
cortisol	cortisol	NN	B-NP	O
levels	level	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
was	be	VBD	B-VP	O
63	63	CD	B-NP	O
%	%	NN	I-NP	O
greater	great	JJR	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
and	and	CC	O	O
26	26	CD	B-NP	O
%	%	NN	I-NP	O
greater	great	JJR	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
afternoon	afternoon	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
PTSD	PTSD	NN	B-NP	O
than	than	IN	B-PP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
normal	normal	JJ	I-NP	O
subjects	subject	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
group	group	NN	I-NP	O
differences	difference	NNS	I-NP	O
in	in	IN	B-PP	O
cortisol	cortisol	NN	B-NP	O
levels	level	NNS	I-NP	O
were	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
,	,	,	O	O
nor	nor	CC	O	O
were	be	VBD	O	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
number	number	NN	I-NP	O
and	and	CC	O	O
cortisol	cortisol	NN	B-NP	O
levels	level	NNS	I-NP	O
correlated	correlate	VBD	B-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
morning	morning	NN	B-NP	B-protein
glucocorticoid	glucocorticoid	NN	I-NP	I-protein
receptors	receptor	NNS	I-NP	I-protein
was	be	VBD	B-VP	O
positively	positively	RB	B-ADJP	O
correlated	correlate	VBN	I-ADJP	O
with	with	IN	B-PP	O
symptoms	symptom	NNS	B-NP	O
of	of	IN	B-PP	O
PTSD	PTSD	NN	B-NP	O
and	and	CC	I-NP	O
anxiety	anxiety	NN	I-NP	O
.	.	.	O	O

CONCLUSIONS	CONCLUSIONS	NNS	B-NP	O
:	:	:	O	O
These	These	DT	B-NP	O
results	result	NNS	I-NP	O
provide	provide	VBP	B-VP	O
further	further	JJ	B-NP	O
evidence	evidence	NN	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
dysregulation	dysregulation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
HPA	HPA	JJ	I-NP	O
axis	axis	NN	I-NP	O
in	in	IN	B-PP	O
PTSD	PTSD	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
finding	finding	NN	I-NP	O
that	that	IN	B-SBAR	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
PTSD	PTSD	NN	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
substantially	substantially	RB	I-NP	O
greater	great	JJR	I-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
lymphocyte	lymphocyte	NN	B-NP	B-protein
glucocorticoid	glucocorticoid	NN	I-NP	I-protein
receptors	receptor	NNS	I-NP	I-protein
than	than	IN	B-PP	O
normal	normal	JJ	B-NP	O
comparison	comparison	NN	I-NP	O
subjects	subject	NNS	I-NP	O
is	be	VBZ	B-VP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
authors	author	NNS	I-NP	O
'	'	POS	B-NP	O
previous	previous	JJ	I-NP	O
observations	observation	NNS	I-NP	O
of	of	IN	B-PP	O
low	low	JJ	B-NP	O
24-hour	24-hour	JJ	I-NP	O
urinary	urinary	JJ	I-NP	O
cortisol	cortisol	NN	I-NP	O
excretion	excretion	NN	I-NP	O
in	in	IN	B-PP	O
subjects	subject	NNS	B-NP	O
with	with	IN	B-PP	O
PTSD	PTSD	NN	B-NP	O
.	.	.	O	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
receptor	receptor	NN	I-NP	O
changes	change	NNS	I-NP	O
observed	observe	VBN	B-VP	O
are	be	VBP	B-VP	O
opposite	opposite	JJ	B-ADJP	O
of	of	IN	B-PP	O
those	those	DT	B-NP	O
reported	report	VBN	B-VP	O
in	in	IN	B-PP	O
major	major	JJ	B-NP	O
depressive	depressive	JJ	I-NP	O
disorder	disorder	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
present	present	JJ	I-NP	O
data	datum	NNS	I-NP	O
,	,	,	O	O
along	along	IN	B-ADVP	O
with	with	IN	B-PP	O
other	other	JJ	B-NP	O
findings	finding	NNS	I-NP	O
of	of	IN	B-PP	O
HPA	HPA	JJ	B-NP	O
abnormalities	abnormality	NNS	I-NP	O
in	in	IN	B-PP	O
PTSD	PTSD	NN	B-NP	O
,	,	,	O	O
support	support	VBP	B-VP	O
the	the	DT	B-NP	O
possibility	possibility	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
greater	great	JJR	I-NP	O
negative	negative	JJ	I-NP	O
feedback	feedback	NN	I-NP	O
sensitivity	sensitivity	NN	I-NP	O
at	at	IN	B-PP	O
one	one	CD	B-NP	O
or	or	CC	I-NP	O
more	more	JJR	I-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
HPA	HPA	JJ	I-NP	O
axis	axis	NN	I-NP	O
.	.	.	O	O

=========a1984449.txt=========	=========a1984449.txt=========	LS	B-LST	O

Induction	Induction	NN	B-NP	O
of	of	IN	B-PP	O
NF-KB	NF-KB	NN	B-NP	B-protein
during	during	IN	B-PP	O
monocyte	monocyte	NN	B-NP	O
differentiation	differentiation	NN	I-NP	O
by	by	IN	B-PP	O
HIV	HIV	NN	B-NP	O
type	type	NN	I-NP	O
1	1	CD	I-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
production	production	NN	I-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	O
immunodeficiency	immunodeficiency	NN	I-NP	O
virus	virus	NN	I-NP	O
type	type	NN	I-NP	O
1	1	CD	I-NP	O
(	(	(	O	O
HIV-1	HIV-1	NN	B-NP	O
)	)	)	O	O
progeny	progeny	NN	B-NP	O
was	be	VBD	B-VP	O
followed	follow	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
U937	U937	NN	I-NP	B-cell_line
promonocytic	promonocytic	JJ	I-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
after	after	IN	B-PP	O
stimulation	stimulation	NN	B-NP	O
either	either	CC	B-PP	O
with	with	IN	I-PP	O
retinoic	retinoic	JJ	B-NP	O
acid	acid	NN	I-NP	O
or	or	CC	O	O
PMA	PMA	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
in	in	IN	B-PP	O
purified	purify	VBN	B-NP	O
human	human	JJ	I-NP	B-cell_type
monocytes	monocyte	NNS	B-NP	I-cell_type
and	and	CC	O	O
macrophages	macrophage	NNS	B-NP	B-cell_type
.	.	.	O	O

Electrophoretic	Electrophoretic	JJ	B-NP	O
mobility	mobility	NN	I-NP	O
shift	shift	NN	I-NP	O
assays	assay	NNS	I-NP	O
and	and	CC	O	O
Southwestern	Southwestern	NN	B-NP	O
blotting	blotting	NN	I-NP	O
experiments	experiment	NNS	I-NP	O
were	be	VBD	B-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
detect	detect	VB	I-VP	O
the	the	DT	B-NP	O
binding	binding	NN	I-NP	O
of	of	IN	B-PP	O
cellular	cellular	JJ	B-NP	B-protein
transactivation	transactivation	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
NF-KB	NF-KB	NN	I-NP	B-protein
to	to	TO	B-PP	O
the	the	DT	B-NP	O
double	double	JJ	I-NP	B-DNA
repeat-KB	repeat-KB	NN	I-NP	I-DNA
enhancer	enhancer	NN	I-NP	I-DNA
sequence	sequence	NN	I-NP	I-DNA
located	located	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
long	long	JJ	I-NP	B-DNA
terminal	terminal	JJ	I-NP	I-DNA
repeat	repeat	NN	I-NP	I-DNA
.	.	.	O	O

PMA	PMA	NN	B-NP	O
treatment	treatment	NN	I-NP	O
,	,	,	O	O
and	and	CC	B-CONJP	O
not	not	RB	I-CONJP	O
retinoic	retinoic	JJ	B-NP	O
acid	acid	NN	I-NP	O
treatment	treatment	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
U937	U937	NN	I-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
acts	act	VBZ	B-VP	O
in	in	IN	B-PP	O
inducing	induce	VBG	B-VP	O
NF-KB	NF-KB	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
nuclei	nucleus	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
nuclear	nuclear	JJ	B-NP	O
extracts	extract	NNS	I-NP	O
from	from	IN	B-PP	O
monocytes	monocyte	NNS	B-NP	B-cell_type
or	or	CC	O	O
macrophages	macrophage	NNS	B-NP	B-cell_type
,	,	,	O	O
induction	induction	NN	B-NP	O
of	of	IN	B-PP	O
NF-KB	NF-KB	NN	B-NP	B-protein
occurred	occur	VBD	B-VP	O
only	only	RB	B-SBAR	O
if	if	IN	I-SBAR	O
the	the	DT	B-NP	O
cells	cell	NNS	I-NP	O
were	be	VBD	B-VP	O
previously	previously	RB	I-VP	O
infected	infect	VBN	I-VP	O
with	with	IN	B-PP	O
HIV-1	HIV-1	NN	B-NP	O
.	.	.	O	O

When	When	WRB	B-ADVP	O
U937	U937	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
were	be	VBD	B-VP	O
infected	infect	VBN	I-VP	O
with	with	IN	B-PP	O
HIV-1	HIV-1	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
NF-KB	NF-KB	NN	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
was	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
,	,	,	O	O
whereas	whereas	IN	O	O
high	high	JJ	B-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
progeny	progeny	NN	B-NP	O
virions	virion	NNS	I-NP	O
was	be	VBD	B-VP	O
produced	produce	VBN	I-VP	O
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
factor	factor	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
required	require	VBN	I-VP	O
for	for	IN	B-PP	O
viral	viral	JJ	B-NP	O
replication	replication	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
in	in	IN	B-PP	O
monocytic	monocytic	JJ	B-NP	B-cell_type
cell	cell	NN	I-NP	I-cell_type
lineage	lineage	NN	I-NP	I-cell_type
,	,	,	O	O
HIV-1	HIV-1	NN	B-NP	O
could	could	MD	B-VP	O
mimic	mimic	VB	I-VP	O
some	some	DT	B-NP	O
differentiation/activation	differentiation/activation	NN	I-NP	O
stimuli	stimulus	NNS	B-NP	O
allowing	allow	VBG	B-VP	O
nuclear	nuclear	JJ	B-NP	O
NF-KB	NF-KB	NN	I-NP	B-protein
expression	expression	NN	I-NP	O
.	.	.	O	O

=========a1986254.txt=========	=========a1986254.txt=========	LS	B-LST	O

Positive	Positive	JJ	B-NP	O
and	and	CC	I-NP	O
negative	negative	JJ	I-NP	O
regulation	regulation	NN	I-NP	O
of	of	IN	B-PP	O
immunoglobulin	immunoglobulin	NN	B-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
expression	expression	NN	I-NP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
B-cell-specific	B-cell-specific	JJ	I-NP	B-DNA
enhancer	enhancer	NN	I-NP	I-DNA
element	element	NN	I-NP	I-DNA
.	.	.	O	O

A	A	DT	B-NP	O
new	new	JJ	I-NP	O
B-cell-specific	B-cell-specific	JJ	I-NP	B-DNA
enhancer	enhancer	NN	I-NP	I-DNA
element	element	NN	I-NP	I-DNA
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
identified	identify	VBN	I-VP	O
3	3	CD	B-NP	O
'	'	SYM	B-NP	O
of	of	IN	B-PP	O
E4	E4	NN	B-NP	B-protein
and	and	CC	O	O
the	the	DT	B-NP	O
octamerlike	octamerlike	JJ	I-NP	B-DNA
motifs	motif	NNS	I-NP	I-DNA
in	in	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	B-DNA
immunoglobulin	immunoglobulin	NN	I-NP	I-DNA
heavy-chain	heavy-chain	JJ	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
enhancer	enhancer	NN	I-NP	I-DNA
.	.	.	O	O

Tandem	Tandem	JJ	B-NP	O
copies	copy	NNS	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
67-bp	67-bp	JJ	I-NP	B-DNA
MnlI-AluI	MnlI-AluI	NN	I-NP	I-DNA
fragment	fragment	NN	I-NP	I-DNA
,	,	,	O	O
when	when	WRB	B-ADVP	O
fused	fuse	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
chloramphenicol	chloramphenicol	NN	I-NP	B-DNA
acetyltransferase	acetyltransferase	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
driven	drive	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
conalbumin	conalbumin	NN	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
,	,	,	O	O
stimulated	stimulate	VBD	B-VP	O
transcription	transcription	NN	B-NP	O
in	in	IN	B-PP	O
B	B	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
but	but	CC	B-PP	O
not	not	RB	B-PP	O
in	in	IN	I-PP	O
Jurkat	Jurkat	NN	B-NP	B-cell_line
T	T	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
or	or	CC	O	O
HeLa	HeLa	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
.	.	.	O	O

Footprinting	Footprinting	NN	B-NP	O
analysis	analysis	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
identical	identical	JJ	I-NP	O
sequence	sequence	NN	I-NP	O
CCGAAACTGAAAAGG	CCGAAACTGAAAAGG	NN	I-NP	O
,	,	,	O	O
designated	designate	VBN	B-VP	O
E6	E6	NN	B-NP	B-DNA
,	,	,	O	O
was	be	VBD	B-VP	O
protected	protect	VBN	I-VP	O
by	by	IN	B-PP	O
nuclear	nuclear	JJ	B-NP	O
extracts	extract	NNS	I-NP	O
from	from	IN	B-PP	O
B	B	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
or	or	CC	O	O
HeLa	HeLa	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
.	.	.	O	O

Gel	Gel	NN	B-NP	O
mobility	mobility	NN	I-NP	O
shift	shift	NN	I-NP	O
assays	assay	NNS	I-NP	O
using	use	VBG	B-VP	O
a	a	DT	B-NP	O
synthetic	synthetic	JJ	I-NP	B-DNA
E6	E6	NN	I-NP	I-DNA
motif	motif	NN	I-NP	I-DNA
detected	detect	VBD	B-VP	O
a	a	DT	B-NP	O
B-cell-specific	B-cell-specific	JJ	I-NP	B-protein
complex	complex	NN	I-NP	I-protein
in	in	IN	B-PP	O
addition	addition	NN	B-NP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
ubiquitous	ubiquitous	JJ	I-NP	O
band	band	NN	I-NP	O
found	find	VBN	B-VP	O
also	also	RB	B-ADVP	O
in	in	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	O	O
HeLa	HeLa	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
.	.	.	O	O

In	In	IN	B-PP	O
agreement	agreement	NN	I-PP	O
with	with	IN	I-PP	O
the	the	DT	B-NP	O
results	result	NNS	I-NP	O
of	of	IN	B-PP	O
gel	gel	NN	B-NP	O
retardation	retardation	NN	I-NP	O
assays	assay	NNS	I-NP	O
,	,	,	O	O
tandem	tandem	JJ	B-NP	O
copies	copy	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
E6	E6	NN	I-NP	B-DNA
motif	motif	NN	I-NP	I-DNA
stimulated	stimulate	VBD	B-VP	O
transcription	transcription	NN	B-NP	O
in	in	IN	B-PP	O
ARH77	ARH77	NN	B-NP	B-cell_line
and	and	CC	O	O
Raji	Raji	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
but	but	CC	B-PP	O
not	not	RB	B-PP	O
in	in	IN	I-PP	O
Jurkat	Jurkat	NN	B-NP	B-cell_line
or	or	CC	O	O
HeLa	HeLa	NN	B-NP	B-cell_line
cells	cell	NNS	B-NP	I-cell_line
.	.	.	O	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
a	a	DT	B-NP	O
mutant	mutant	JJ	I-NP	B-DNA
E6	E6	NN	I-NP	I-DNA
motif	motif	NN	I-NP	I-DNA
lost	lose	VBD	B-VP	O
both	both	CC	O	O
in	in	FW	B-NP	O
vitro	vitro	FW	I-NP	O
binding	binding	NN	I-NP	O
activity	activity	NN	I-NP	O
and	and	CC	B-PP	O
in	in	FW	B-NP	O
vivo	vivo	FW	I-NP	O
enhancer	enhancer	NN	I-NP	O
activity	activity	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
striking	striking	JJ	B-NP	O
contrast	contrast	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
mouse	mouse	NN	I-NP	B-DNA
Ig	Ig	NN	I-NP	I-DNA
heavy-chain	heavy-chain	JJ	I-NP	I-DNA
enhancer	enhancer	NN	I-NP	I-DNA
,	,	,	O	O
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
the	the	DT	B-NP	O
octamer	octamer	NN	I-NP	B-DNA
motif	motif	NN	I-NP	I-DNA
acts	act	VBZ	B-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
B-cell-specific	B-cell-specific	JJ	I-NP	B-DNA
enhancer	enhancer	NN	I-NP	I-DNA
element	element	NN	I-NP	I-DNA
,	,	,	O	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	B-DNA
enhancer	enhancer	NN	I-NP	I-DNA
contains	contain	VBZ	B-VP	O
an	an	DT	B-NP	O
octamerlike	octamerlike	JJ	I-NP	B-DNA
sequence	sequence	NN	I-NP	I-DNA
with	with	IN	B-PP	O
one	one	CD	B-NP	O
base	base	NN	I-NP	O
substitution	substitution	NN	I-NP	O
which	which	WDT	B-NP	O
bound	bind	VBD	B-VP	O
octamer-binding	octamer-binding	JJ	B-NP	B-protein
proteins	protein	NNS	I-NP	I-protein
with	with	IN	B-PP	O
only	only	RB	B-NP	O
very	very	RB	I-NP	O
low	low	JJ	I-NP	O
affinity	affinity	NN	I-NP	O
and	and	CC	O	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
enhancer	enhancer	NN	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
its	its	PRP$	B-NP	O
own	own	JJ	I-NP	O
.	.	.	O	O

Interestingly	Interestingly	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
MnlI-AluI	MnlI-AluI	NN	I-NP	B-DNA
fragment	fragment	NN	I-NP	I-DNA
could	could	MD	B-VP	O
suppress	suppress	VB	I-VP	O
the	the	DT	B-NP	O
basal-level	basal-level	JJ	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
conalbumin	conalbumin	NN	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
in	in	IN	B-PP	O
both	both	CC	O	O
Jurkat	Jurkat	NN	B-NP	B-cell_line
and	and	CC	O	O
HeLa	HeLa	NN	B-NP	B-cell_line
cells	cell	NNS	B-NP	I-cell_line
.	.	.	O	O

Moreover	Moreover	RB	B-ADVP	O
,	,	,	O	O
simian	simian	JJ	B-NP	O
virus	virus	NN	I-NP	O
40	40	CD	I-NP	O
enhancer	enhancer	NN	I-NP	O
activity	activity	NN	I-NP	O
was	be	VBD	B-VP	O
blocked	block	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
MnlI-AluI	MnlI-AluI	NN	I-NP	B-DNA
fragment	fragment	NN	I-NP	I-DNA
in	in	IN	B-PP	O
HeLa	HeLa	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
but	but	CC	B-PP	O
not	not	RB	B-PP	O
in	in	IN	I-PP	O
B	B	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
novel	novel	JJ	I-NP	O
enhancer	enhancer	NN	I-NP	B-DNA
element	element	NN	I-NP	I-DNA
identified	identify	VBN	B-VP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
is	be	VBZ	B-VP	O
probably	probably	RB	B-ADVP	O
a	a	DT	B-NP	O
target	target	NN	I-NP	B-DNA
site	site	NN	I-NP	I-DNA
for	for	IN	B-PP	O
both	both	CC	B-NP	O
positive	positive	JJ	I-NP	B-protein
and	and	CC	I-NP	I-protein
negative	negative	JJ	I-NP	I-protein
factors	factor	NNS	I-NP	I-protein
.	.	.	O	O

=========a1899335.txt=========	=========a1899335.txt=========	LS	B-LST	O

Expression	Expression	NN	B-NP	O
of	of	IN	B-PP	O
c-jun	c-jun	NN	B-NP	B-DNA
,	,	,	O	O
jun	jun	NN	B-NP	B-DNA
B	B	NN	I-NP	I-DNA
and	and	CC	O	O
jun	jun	NN	B-NP	B-DNA
D	D	NN	I-NP	I-DNA
proto-oncogenes	proto-oncogene	NNS	B-NP	I-DNA
in	in	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
peripheral-blood	peripheral-blood	JJ	I-NP	I-cell_type
granulocytes	granulocyte	NNS	I-NP	I-cell_type
.	.	.	O	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
found	find	VBN	I-VP	O
that	that	IN	B-SBAR	O
purified	purify	VBN	B-NP	B-cell_type
human	human	JJ	I-NP	I-cell_type
peripheral-blood	peripheral-blood	JJ	I-NP	I-cell_type
granulocytes	granulocyte	NNS	I-NP	I-cell_type
express	express	VBP	B-VP	O
constitutively	constitutively	RB	B-NP	O
significant	significant	JJ	I-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
proto-oncogenes	proto-oncogene	NNS	B-NP	B-DNA
c-jun	c-jun	NN	B-NP	B-RNA
,	,	,	O	I-RNA
jun	jun	NN	B-NP	I-RNA
B	B	NN	I-NP	I-RNA
and	and	CC	O	I-RNA
jun	jun	NN	B-NP	I-RNA
D	D	NN	I-NP	I-RNA
mRNA	mRNA	NN	B-NP	I-RNA
.	.	.	O	O

Upon	Upon	IN	B-PP	O
functional	functional	JJ	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
granulocytes	granulocyte	NNS	B-NP	B-cell_type
by	by	IN	B-PP	O
4	4	CD	B-NP	O
beta-phorbol	beta-phorbol	NN	I-NP	O
12-myristate	12-myristate	NN	I-NP	O
13-acetate	13-acetate	NN	I-NP	O
(	(	(	O	O
PMA	PMA	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
the	the	DT	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
c-jun	c-jun	NN	B-NP	B-RNA
,	,	,	O	I-RNA
jun	jun	NN	B-NP	I-RNA
B	B	NN	I-NP	I-RNA
and	and	CC	O	I-RNA
jun	jun	NN	B-NP	I-RNA
D	D	NN	I-NP	I-RNA
transcripts	transcript	NNS	B-NP	I-RNA
were	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
three	three	CD	I-NP	O
jun	jun	NN	I-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
similar	similar	JJ	I-NP	O
time	time	NN	I-NP	O
course	course	NN	I-NP	O
in	in	IN	B-PP	O
their	their	PRP$	B-NP	O
induction	induction	NN	I-NP	O
by	by	IN	B-PP	O
PMA	PMA	NN	B-NP	O
,	,	,	O	O
maximal	maximal	JJ	B-NP	O
mRNA	mRNA	NN	I-NP	O
levels	level	NNS	I-NP	O
being	be	VBG	B-VP	O
reached	reach	VBN	I-VP	O
after	after	IN	B-PP	O
60	60	CD	B-NP	O
min	min	NN	I-NP	O
of	of	IN	B-PP	O
induction	induction	NN	B-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
c-jun	c-jun	NN	B-NP	B-DNA
,	,	,	O	O
jun	jun	NN	B-NP	B-DNA
B	B	NN	I-NP	I-DNA
and	and	CC	O	O
jun	jun	NN	B-NP	B-DNA
D	D	NN	I-NP	I-DNA
genes	gene	NNS	B-NP	I-DNA
might	might	MD	B-VP	O
be	be	VB	I-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
terminal	terminal	JJ	B-NP	B-cell_type
granulocyte	granulocyte	NN	I-NP	I-cell_type
differentiation	differentiation	NN	I-NP	O
or	or	CC	B-PP	O
in	in	IN	B-PP	O
regulating	regulate	VBG	B-VP	O
granulocyte	granulocyte	NN	B-NP	B-cell_type
functionality	functionality	NN	I-NP	O
.	.	.	O	O

=========a2006151.txt=========	=========a2006151.txt=========	LS	B-LST	O

Comparison	Comparison	NN	B-NP	O
of	of	IN	B-PP	O
constitutive	constitutive	JJ	B-NP	O
and	and	CC	I-NP	O
inducible	inducible	JJ	I-NP	O
transcriptional	transcriptional	JJ	I-NP	O
enhancement	enhancement	NN	I-NP	O
mediated	mediate	VBN	B-VP	O
by	by	IN	B-PP	O
kappa	kappa	NN	B-NP	B-DNA
B-related	B-related	JJ	I-NP	I-DNA
sequences	sequence	NNS	I-NP	I-DNA
:	:	:	O	O
modulation	modulation	NN	B-NP	O
of	of	IN	B-PP	O
activity	activity	NN	B-NP	O
in	in	IN	B-PP	O
B	B	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
by	by	IN	B-PP	O
human	human	JJ	B-NP	B-DNA
T-cell	T-cell	NN	I-NP	I-DNA
leukemia	leukemia	NN	I-NP	I-DNA
virus	virus	NN	I-NP	I-DNA
type	type	NN	I-NP	I-DNA
I	I	CD	I-NP	I-DNA
tax	tax	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
.	.	.	O	O

The	The	DT	B-NP	O
kappa	kappa	NN	I-NP	B-DNA
B	B	NN	I-NP	I-DNA
sequence	sequence	NN	I-NP	I-DNA
(	(	(	O	O
GGGACTTTCC	GGGACTTTCC	NN	B-NP	O
)	)	)	O	O
binds	bind	VBZ	B-VP	O
a	a	DT	B-NP	O
factor	factor	NN	I-NP	O
,	,	,	O	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
,	,	,	O	O
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
constitutively	constitutively	RB	I-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
its	its	PRP$	B-NP	O
functional	functional	JJ	I-NP	O
,	,	,	I-NP	O
DNA	DNA	NN	I-NP	B-protein
binding	binding	NN	I-NP	I-protein
form	form	NN	I-NP	I-protein
only	only	RB	B-PP	O
in	in	IN	I-PP	O
B	B	NN	B-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
.	.	.	O	O

A	A	DT	B-NP	O
factor	factor	NN	I-NP	O
with	with	IN	B-PP	O
apparently	apparently	RB	B-NP	O
indistinguishable	indistinguishable	JJ	I-NP	O
sequence	sequence	NN	I-NP	O
specificity	specificity	NN	I-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
induced	induce	VBN	I-VP	O
in	in	IN	B-PP	O
many	many	JJ	B-NP	O
other	other	JJ	I-NP	O
cell	cell	NN	I-NP	O
types	type	NNS	I-NP	O
,	,	,	O	O
where	where	WRB	B-ADVP	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
regulate	regulate	VB	I-VP	O
inducible	inducible	JJ	B-NP	O
gene	gene	NN	I-NP	O
expression	expression	NN	I-NP	O
.	.	.	O	O

For	For	IN	B-PP	O
example	example	NN	B-NP	O
,	,	,	O	O
kappa	kappa	NN	B-NP	B-DNA
B-related	B-related	JJ	I-NP	I-DNA
sequences	sequence	NNS	I-NP	I-DNA
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
shown	show	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
important	important	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
transcription	transcription	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
few	few	JJ	I-NP	O
inducible	inducible	JJ	I-NP	O
genes	gene	NNS	I-NP	O
,	,	,	O	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
the	the	DT	B-NP	O
interleukin	interleukin	NN	I-NP	B-DNA
2	2	CD	I-NP	I-DNA
receptor	receptor	NN	I-NP	I-DNA
alpha-chain	alpha-chain	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
and	and	CC	O	O
the	the	DT	B-NP	O
beta-interferon	beta-interferon	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
these	these	DT	B-NP	O
genes	gene	NNS	I-NP	O
are	be	VBP	B-VP	O
not	not	RB	O	O
constitutively	constitutively	RB	B-ADJP	O
active	active	JJ	I-ADJP	O
in	in	IN	B-PP	O
B	B	NN	B-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
that	that	IN	B-SBAR	O
other	other	JJ	B-NP	O
regulatory	regulatory	JJ	I-NP	O
mechanisms	mechanism	NNS	I-NP	O
must	must	MD	B-VP	O
play	play	VB	I-VP	O
a	a	DT	B-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
determining	determine	VBG	B-VP	O
the	the	DT	B-NP	O
patterns	pattern	NNS	I-NP	O
of	of	IN	B-PP	O
expression	expression	NN	B-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
investigated	investigate	VBN	I-VP	O
the	the	DT	B-NP	O
constitutive	constitutive	JJ	I-NP	O
and	and	CC	I-NP	O
inducible	inducible	JJ	I-NP	O
transcriptional	transcriptional	JJ	I-NP	O
activity	activity	NN	I-NP	O
mediated	mediate	VBN	B-VP	O
by	by	IN	B-PP	O
five	five	CD	B-NP	O
kappa	kappa	NN	I-NP	B-DNA
B-related	B-related	JJ	I-NP	I-DNA
sequence	sequence	NN	I-NP	I-DNA
elements	element	NNS	I-NP	I-DNA
in	in	IN	B-PP	O
two	two	CD	B-NP	O
different	different	JJ	I-NP	O
cell	cell	NN	I-NP	O
types	type	NNS	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
in	in	IN	B-PP	O
S194	S194	NN	B-NP	B-cell_line
plasma	plasma	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
the	the	DT	B-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
each	each	DT	B-NP	O
element	element	NN	I-NP	O
correlates	correlate	VBZ	B-VP	O
well	well	RB	B-ADVP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
relative	relative	JJ	I-NP	O
affinity	affinity	NN	I-NP	O
of	of	IN	B-PP	O
B-cell-derived	B-cell-derived	JJ	B-NP	O
NF-kappa	NF-kappa	NN	I-NP	B-protein
B	B	NN	I-NP	I-protein
for	for	IN	B-PP	O
that	that	DT	B-NP	O
element	element	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
leads	lead	VBZ	B-VP	O
to	to	TO	B-PP	O
significantly	significantly	RB	B-NP	O
lower	low	JJR	I-NP	O
transcription	transcription	NN	I-NP	O
enhancement	enhancement	NN	I-NP	O
by	by	IN	B-PP	O
sites	site	NNS	B-NP	O
derived	derive	VBN	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
interleukin	interleukin	NN	I-NP	B-protein
2	2	CD	I-NP	I-protein
receptor	receptor	NN	I-NP	I-protein
or	or	CC	O	O
T-cell	T-cell	NN	B-NP	B-DNA
receptor	receptor	NN	I-NP	I-DNA
genes	gene	NNS	B-NP	I-DNA
in	in	IN	B-PP	O
S194	S194	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
in	in	IN	B-PP	O
either	either	CC	O	O
EL-4	EL-4	NN	B-NP	B-cell_line
(	(	(	I-NP	I-cell_line
T	T	NN	I-NP	I-cell_line
)	)	)	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
or	or	CC	O	O
S194	S194	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
,	,	,	O	O
both	both	DT	B-NP	O
lower-affinity	lower-affinity	JJ	I-NP	B-DNA
sites	site	NNS	I-NP	I-DNA
can	can	MD	B-VP	O
be	be	VB	I-VP	O
significantly	significantly	RB	I-VP	O
induced	induce	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
tax	tax	NN	I-NP	B-protein
gene	gene	NN	I-NP	I-protein
product	product	NN	I-NP	I-protein
of	of	IN	B-PP	O
human	human	JJ	B-NP	O
T-cell	T-cell	NN	I-NP	O
leukemia	leukemia	NN	I-NP	O
virus	virus	NN	I-NP	O
type	type	NN	I-NP	O
I	I	CD	I-NP	O
,	,	,	O	O
showing	show	VBG	B-VP	O
that	that	IN	B-SBAR	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
activity	activity	NN	I-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
modulated	modulate	VBN	I-VP	O
even	even	RB	B-PP	O
in	in	IN	I-PP	O
a	a	DT	B-NP	O
B-cell	B-cell	NN	I-NP	B-cell_line
line	line	NN	I-NP	I-cell_line
that	that	WDT	B-NP	O
constitutively	constitutively	RB	B-ADVP	O
expresses	express	VBZ	B-VP	O
this	this	DT	B-NP	O
factor	factor	NN	I-NP	O
.	.	.	O	O

=========a1707027.txt=========	=========a1707027.txt=========	LS	B-LST	O

Immune	Immune	JJ	B-NP	O
response	response	NN	I-NP	O
of	of	IN	B-PP	O
peripheral	peripheral	JJ	B-NP	B-cell_type
blood	blood	NN	I-NP	I-cell_type
mononuclear	mononuclear	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
to	to	TO	B-PP	O
HBx-antigen	HBx-antigen	NN	B-NP	B-protein
of	of	IN	B-PP	O
hepatitis	hepatitis	NN	B-NP	O
B	B	NN	I-NP	O
virus	virus	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
hepatitis	hepatitis	NN	I-NP	B-DNA
B	B	NN	I-NP	I-DNA
virus	virus	NN	I-NP	I-DNA
genome	genome	NN	I-NP	I-DNA
encodes	encode	VBZ	B-VP	O
a	a	DT	B-NP	O
transcriptional	transcriptional	JJ	I-NP	B-protein
transactivator	transactivator	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
designated	designate	VBN	B-VP	O
HBxAg	HBxAg	NN	B-NP	B-protein
.	.	.	O	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
investigated	investigate	VBN	I-VP	O
whether	whether	IN	B-SBAR	O
this	this	DT	B-NP	O
antigen	antigen	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
target	target	NN	I-NP	O
structure	structure	NN	I-NP	O
for	for	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
T-lymphocytes	T-lymphocyte	NNS	I-NP	I-cell_type
.	.	.	O	O

Using	Use	VBG	B-VP	O
recombinant	recombinant	JJ	B-NP	B-protein
HBxAg	HBxAg	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
,	,	,	O	O
we	we	PRP	B-NP	O
found	find	VBD	B-VP	O
HBxAg-specific	HBxAg-specific	JJ	B-NP	O
stimulation	stimulation	NN	I-NP	O
of	of	IN	B-PP	O
peripheral	peripheral	JJ	B-NP	B-cell_type
blood	blood	NN	I-NP	I-cell_type
mononuclear	mononuclear	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
acute	acute	JJ	B-NP	O
hepatitis	hepatitis	NN	I-NP	O
B	B	NN	I-NP	O
virus	virus	NN	I-NP	O
infection	infection	NN	I-NP	O
(	(	(	O	O
6	6	CD	B-NP	O
of	of	IN	B-PP	O
6	6	CD	B-NP	O
)	)	)	O	O
and	and	CC	O	O
chronic	chronic	JJ	B-NP	O
hepatitis	hepatitis	NN	I-NP	O
B	B	NN	I-NP	O
virus	virus	NN	I-NP	O
infection	infection	NN	I-NP	O
(	(	(	O	O
6	6	CD	B-NP	O
of	of	IN	B-PP	O
17	17	CD	B-NP	O
)	)	)	O	O
but	but	CC	B-PP	O
not	not	RB	B-PP	O
in	in	IN	I-PP	O
healthy	healthy	JJ	B-NP	O
individuals	individual	NNS	I-NP	O
.	.	.	O	O

With	With	IN	B-PP	O
HBxAg-specific	HBxAg-specific	JJ	B-NP	B-protein
synthetic	synthetic	JJ	I-NP	I-protein
polypeptides	polypeptide	NNS	I-NP	I-protein
,	,	,	O	O
several	several	JJ	B-NP	O
T-cell	T-cell	NN	I-NP	B-protein
epitopes	epitope	NNS	I-NP	I-protein
were	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
.	.	.	O	O

Most	Most	JJS	B-NP	O
were	be	VBD	B-VP	O
located	locate	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
carboxyterminal	carboxyterminal	JJ	I-NP	B-protein
half	half	NN	I-NP	I-protein
of	of	IN	B-PP	O
the	the	DT	B-NP	O
HBxAg	HBxAg	NN	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
.	.	.	O	O

Five	Five	CD	B-NP	O
T-cell	T-cell	NN	I-NP	B-cell_line
clones	clone	NNS	I-NP	I-cell_line
specific	specific	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
T-cell	T-cell	NN	I-NP	B-protein
epitope	epitope	NN	I-NP	I-protein
located	located	JJ	B-ADJP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
carboxyterminal	carboxyterminal	JJ	I-NP	B-protein
region	region	NN	I-NP	I-protein
of	of	IN	B-PP	O
HBxAg	HBxAg	NN	B-NP	B-protein
were	be	VBD	B-VP	O
established	establish	VBN	I-VP	O
and	and	CC	O	O
found	find	VBN	B-VP	O
to	to	TO	I-VP	O
belong	belong	VB	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
CD2/CD4-positive	CD2/CD4-positive	JJ	I-NP	B-cell_line
,	,	,	I-NP	I-cell_line
CD8-negative	CD8-negative	JJ	I-NP	I-cell_line
subtype	subtype	NN	I-NP	I-cell_line
.	.	.	O	O

These	These	DT	B-NP	O
data	datum	NNS	I-NP	O
establish	establish	VBP	B-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
time	time	NN	I-NP	O
HBxAg	HBxAg	NN	B-NP	B-protein
as	as	IN	B-PP	O
an	an	DT	B-NP	O
antigen	antigen	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
cellular	cellular	JJ	I-NP	O
immune	immune	JJ	I-NP	O
response	response	NN	I-NP	O
.	.	.	O	O

=========a1847170.txt=========	=========a1847170.txt=========	LS	B-LST	O

Platelet-activating	Platelet-activating	JJ	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
induces	induce	VBZ	B-VP	O
phospholipid	phospholipid	JJ	B-NP	O
turnover	turnover	NN	I-NP	O
,	,	,	O	O
calcium	calcium	NN	B-NP	O
flux	flux	NN	I-NP	O
,	,	,	O	O
arachidonic	arachidonic	JJ	B-NP	O
acid	acid	NN	I-NP	O
liberation	liberation	NN	I-NP	O
,	,	,	O	O
eicosanoid	eicosanoid	NN	B-NP	O
generation	generation	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
oncogene	oncogene	NN	B-NP	B-DNA
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
human	human	JJ	I-NP	B-cell_line
B	B	NN	I-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
.	.	.	O	O

Platelet-activating	Platelet-activating	JJ	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
potent	potent	JJ	I-NP	O
mediator	mediator	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
inflammatory	inflammatory	JJ	I-NP	O
response	response	NN	I-NP	O
.	.	.	O	O

Studies	Study	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
actions	action	NNS	I-NP	O
of	of	IN	B-PP	O
platelet-activating	platelet-activating	JJ	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
have	have	VBP	B-VP	O
centered	center	VBN	I-VP	O
mainly	mainly	RB	B-ADVP	O
around	around	IN	B-PP	O
neutrophils	neutrophil	NNS	B-NP	B-cell_type
,	,	,	O	O
monocytes	monocyte	NNS	B-NP	B-cell_type
,	,	,	O	O
and	and	CC	O	O
platelets	platelet	NNS	B-NP	B-cell_type
.	.	.	O	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
report	report	NN	I-NP	O
we	we	PRP	B-NP	O
begin	begin	VBP	B-VP	O
to	to	TO	I-VP	O
uncover	uncover	VB	I-VP	O
the	the	DT	B-NP	O
influence	influence	NN	I-NP	O
of	of	IN	B-PP	O
platelet-activating	platelet-activating	JJ	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
on	on	IN	B-PP	O
B	B	NN	B-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
.	.	.	O	O

Employing	Employ	VBG	B-VP	O
the	the	DT	B-NP	O
EBV-transformed	EBV-transformed	JJ	I-NP	B-cell_line
human	human	JJ	I-NP	I-cell_line
B	B	NN	I-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
SKW6.4	SKW6.4	NN	I-NP	B-cell_line
,	,	,	O	O
we	we	PRP	B-NP	O
demonstrate	demonstrate	VBP	B-VP	O
that	that	IN	B-SBAR	O
platelet-activating	platelet-activating	JJ	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
significantly	significantly	RB	B-ADVP	O
alters	alter	VBZ	B-VP	O
membrane	membrane	NN	B-NP	O
phospholipid	phospholipid	NN	I-NP	O
metabolism	metabolism	NN	I-NP	O
indicated	indicate	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
incorporation	incorporation	NN	I-NP	O
of	of	IN	B-PP	O
32P	32P	NN	B-NP	O
into	into	IN	B-PP	O
phosphatidylcholine	phosphatidylcholine	NN	B-NP	O
,	,	,	O	O
phosphatidylinositol	phosphatidylinositol	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
phosphatidic	phosphatidic	JJ	B-NP	O
acid	acid	NN	I-NP	O
but	but	CC	B-PP	O
not	not	RB	B-ADVP	O
significantly	significantly	RB	I-ADVP	O
into	into	IN	B-PP	O
phosphatidylethanolamine	phosphatidylethanolamine	NN	B-NP	O
at	at	IN	B-PP	O
concentrations	concentration	NNS	B-NP	O
ranging	range	VBG	B-VP	O
from	from	IN	B-PP	O
10	10	CD	B-NP	O
(	(	(	O	O
-9	-9	CD	B-NP	O
)	)	)	O	O
to	to	TO	B-PP	O
10	10	CD	B-NP	O
(	(	(	O	O
-6	-6	CD	B-NP	O
)	)	)	O	O
M	M	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
inactive	inactive	JJ	I-NP	O
precursor	precursor	NN	I-NP	O
,	,	,	O	O
lyso-platelet-activating	lyso-platelet-activating	JJ	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
,	,	,	O	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
concentration	concentration	NN	I-NP	O
as	as	RB	B-ADJP	O
high	high	JJ	I-ADJP	O
as	as	IN	B-PP	O
10	10	CD	B-NP	O
(	(	(	O	O
-7	-7	CD	B-NP	O
)	)	)	O	O
M	M	NN	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
effect	effect	NN	I-NP	O
on	on	IN	B-PP	O
any	any	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
membrane	membrane	NN	I-NP	O
phospholipids	phospholipid	NNS	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
also	also	RB	B-ADVP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
platelet-activating	platelet-activating	JJ	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
from	from	IN	B-PP	O
10	10	CD	B-NP	O
(	(	(	O	O
-12	-12	CD	B-NP	O
)	)	)	O	O
to	to	TO	B-PP	O
10	10	CD	B-NP	O
(	(	(	O	O
-6	-6	CD	B-NP	O
)	)	)	O	O
M	M	NN	B-NP	O
induced	induce	VBD	B-VP	O
rapid	rapid	JJ	B-NP	O
and	and	CC	I-NP	O
significant	significant	JJ	I-NP	O
elevation	elevation	NN	I-NP	O
in	in	IN	B-PP	O
intracellular	intracellular	JJ	B-NP	O
calcium	calcium	NN	I-NP	O
levels	level	NNS	I-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
lyso-platelet-activating	lyso-platelet-activating	JJ	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
was	be	VBD	B-VP	O
again	again	RB	B-ADJP	O
ineffective	ineffective	JJ	I-ADJP	O
.	.	.	O	O

We	We	PRP	B-NP	O
further	further	RB	B-ADVP	O
demonstrate	demonstrate	VBP	B-VP	O
the	the	DT	B-NP	O
impact	impact	NN	I-NP	O
of	of	IN	B-PP	O
platelet-activating	platelet-activating	JJ	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
binding	bind	VBG	B-VP	O
to	to	TO	B-PP	O
B	B	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
by	by	IN	B-PP	O
measuring	measure	VBG	B-VP	O
platelet-activating	platelet-activating	JJ	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
induced	induced	JJ	B-NP	O
arachidonic	arachidonic	JJ	I-NP	O
acid	acid	NN	I-NP	O
release	release	NN	I-NP	O
and	and	CC	O	O
5-hydroxyeicosatetraenoic	5-hydroxyeicosatetraenoic	JJ	B-NP	O
acid	acid	NN	I-NP	O
production	production	NN	I-NP	O
.	.	.	O	O

Moreover	Moreover	RB	B-ADVP	O
,	,	,	O	O
platelet-activating	platelet-activating	JJ	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
was	be	VBD	B-VP	O
capable	capable	JJ	B-ADJP	O
of	of	IN	B-PP	O
inducing	induce	VBG	B-VP	O
transcription	transcription	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
nuclear	nuclear	JJ	I-NP	B-DNA
proto-oncogenes	proto-oncogene	NNS	I-NP	I-DNA
c-fos	c-fos	NN	B-NP	B-DNA
and	and	CC	O	O
c-jun	c-jun	NN	B-NP	B-DNA
.	.	.	O	O

Finally	Finally	RB	B-ADVP	O
we	we	PRP	B-NP	O
explored	explore	VBD	B-VP	O
the	the	DT	B-NP	O
possible	possible	JJ	I-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
5-hydroxyeicosatetraenoic	5-hydroxyeicosatetraenoic	JJ	B-NP	O
acid	acid	NN	I-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
regulator	regulator	NN	I-NP	O
of	of	IN	B-PP	O
arachidonic	arachidonic	JJ	B-NP	O
acid	acid	NN	I-NP	O
liberation	liberation	NN	I-NP	O
demonstrating	demonstrate	VBG	B-VP	O
that	that	IN	B-SBAR	O
endogenous	endogenous	JJ	B-NP	B-protein
5-lipoxygenase	5-lipoxygenase	NN	I-NP	I-protein
activity	activity	NN	I-NP	O
modulates	modulate	VBZ	B-VP	O
platelet-activating	platelet-activating	JJ	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
induced	induced	JJ	B-NP	O
arachidonic	arachidonic	JJ	I-NP	O
acid	acid	NN	I-NP	O
release	release	NN	I-NP	O
perhaps	perhaps	RB	B-ADVP	O
acting	act	VBG	B-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
phospholipase	phospholipase	NN	B-NP	B-protein
A2	A2	NN	I-NP	I-protein
.	.	.	O	O

In	In	IN	B-PP	O
summary	summary	NN	B-NP	O
,	,	,	O	O
platelet-activating	platelet-activating	JJ	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
is	be	VBZ	B-VP	O
shown	show	VBN	I-VP	O
here	here	RB	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
direct	direct	JJ	I-NP	O
and	and	CC	I-NP	O
profound	profound	JJ	I-NP	O
effect	effect	NN	I-NP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
pure	pure	JJ	I-NP	B-cell_line
B	B	NN	I-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
.	.	.	O	O

=========a2017177.txt=========	=========a2017177.txt=========	LS	B-LST	O

Murine	Murine	JJ	B-NP	B-protein
and	and	CC	I-NP	I-protein
human	human	JJ	I-NP	I-protein
T-lymphocyte	T-lymphocyte	NN	I-NP	I-protein
GATA-3	GATA-3	NN	I-NP	I-protein
factors	factor	NNS	I-NP	I-protein
mediate	mediate	VBP	B-VP	O
transcription	transcription	NN	B-NP	O
through	through	IN	B-PP	O
a	a	DT	B-NP	O
cis-regulatory	cis-regulatory	JJ	I-NP	B-DNA
element	element	NN	I-NP	I-DNA
within	within	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	B-DNA
T-cell	T-cell	NN	I-NP	I-DNA
receptor	receptor	NN	I-NP	I-DNA
delta	delta	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
enhancer	enhancer	NN	I-NP	I-DNA
.	.	.	O	O

A	A	DT	B-NP	O
family	family	NN	I-NP	O
of	of	IN	B-PP	O
transcriptional	transcriptional	JJ	B-NP	B-protein
activators	activator	NNS	I-NP	I-protein
has	have	VBZ	B-VP	O
recently	recently	RB	I-VP	O
been	be	VBN	I-VP	O
identified	identify	VBN	I-VP	O
in	in	IN	B-PP	O
chickens	chicken	NNS	B-NP	O
;	;	:	O	O

these	these	DT	B-NP	O
transcriptional	transcriptional	JJ	I-NP	B-protein
activators	activator	NNS	I-NP	I-protein
recognize	recognize	VBP	B-VP	O
a	a	DT	B-NP	O
common	common	JJ	I-NP	O
consensus	consensus	NN	I-NP	B-DNA
motif	motif	NN	I-NP	I-DNA
(	(	(	O	O
WGATAR	WGATAR	NN	B-NP	B-DNA
)	)	)	O	O
through	through	IN	B-PP	O
a	a	DT	B-NP	O
conserved	conserve	VBN	I-NP	O
C4	C4	NN	I-NP	B-protein
zinc	zinc	NN	I-NP	I-protein
finger	finger	NN	I-NP	I-protein
DNA-binding	DNA-binding	JJ	I-NP	I-protein
domain	domain	NN	I-NP	I-protein
.	.	.	O	O

One	One	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
members	member	NNS	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
multigene	multigene	JJ	I-NP	O
family	family	NN	I-NP	O
,	,	,	O	O
cGATA-3	cGATA-3	NN	B-NP	B-protein
,	,	,	O	O
is	be	VBZ	B-VP	O
most	most	RBS	I-VP	O
abundantly	abundantly	RB	I-VP	O
expressed	express	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
T-lymphocyte	T-lymphocyte	NN	I-NP	B-cell_type
cell	cell	NN	I-NP	I-cell_type
lineage	lineage	NN	I-NP	I-cell_type
.	.	.	O	O

Analysis	Analysis	NN	B-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	B-protein
and	and	CC	I-NP	I-protein
murine	murine	JJ	I-NP	I-protein
GATA-3	GATA-3	NN	I-NP	I-protein
factors	factor	NNS	I-NP	I-protein
shows	show	VBZ	B-VP	O
a	a	DT	B-NP	O
striking	striking	JJ	I-NP	O
degree	degree	NN	I-NP	O
of	of	IN	B-PP	O
amino	amino	JJ	B-NP	O
acid	acid	NN	I-NP	O
sequence	sequence	NN	I-NP	O
identity	identity	NN	I-NP	O
and	and	CC	O	O
similar	similar	JJ	B-NP	O
patterns	pattern	NNS	I-NP	O
of	of	IN	B-PP	O
tissue	tissue	NN	B-NP	O
specificity	specificity	NN	I-NP	O
of	of	IN	B-PP	O
expression	expression	NN	B-NP	O
in	in	IN	B-PP	O
these	these	DT	B-NP	O
three	three	CD	I-NP	O
organisms	organism	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
murine	murine	JJ	I-NP	B-protein
and	and	CC	I-NP	I-protein
human	human	JJ	I-NP	I-protein
factors	factor	NNS	I-NP	I-protein
are	be	VBP	B-VP	O
abundantly	abundantly	RB	I-VP	O
expressed	express	VBN	I-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
variety	variety	NN	I-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	B-cell_line
and	and	CC	I-NP	I-cell_line
murine	murine	JJ	I-NP	I-cell_line
T-cell	T-cell	NN	I-NP	I-cell_line
lines	line	NNS	I-NP	I-cell_line
and	and	CC	O	O
can	can	MD	B-VP	O
activate	activate	VB	I-VP	O
transcription	transcription	NN	B-NP	O
through	through	IN	B-PP	O
a	a	DT	B-NP	O
tissue-specific	tissue-specific	JJ	I-NP	B-DNA
GATA-binding	GATA-binding	JJ	I-NP	I-DNA
site	site	NN	I-NP	I-DNA
identified	identify	VBN	B-VP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	B-DNA
T-cell	T-cell	NN	I-NP	I-DNA
receptor	receptor	NN	I-NP	I-DNA
delta	delta	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
enhancer	enhancer	NN	I-NP	I-DNA
.	.	.	O	O

We	We	PRP	B-NP	O
infer	infer	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
murine	murine	JJ	I-NP	B-protein
and	and	CC	I-NP	I-protein
human	human	JJ	I-NP	I-protein
GATA-3	GATA-3	NN	B-NP	I-protein
proteins	protein	NNS	I-NP	I-protein
play	play	VBP	B-VP	O
a	a	DT	B-NP	O
central	central	JJ	I-NP	O
and	and	CC	I-NP	O
highly	highly	RB	I-NP	O
conserved	conserve	VBN	I-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
vertebrate	vertebrate	NN	B-NP	O
T-cell-specific	T-cell-specific	JJ	I-NP	O
transcriptional	transcriptional	JJ	I-NP	O
regulation	regulation	NN	I-NP	O
.	.	.	O	O

=========a2010090.txt=========	=========a2010090.txt=========	LS	B-LST	O

A	A	DT	B-NP	O
thymus-specific	thymus-specific	JJ	I-NP	B-protein
member	member	NN	I-NP	I-protein
of	of	IN	B-PP	O
the	the	DT	B-NP	O
HMG	HMG	NN	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
family	family	NN	I-NP	I-protein
regulates	regulate	VBZ	B-VP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	B-DNA
T	T	NN	I-NP	I-DNA
cell	cell	NN	I-NP	I-DNA
receptor	receptor	NN	I-NP	I-DNA
C	C	NN	I-NP	I-DNA
alpha	alpha	NN	I-NP	I-DNA
enhancer	enhancer	NN	I-NP	I-DNA
.	.	.	O	O

The	The	DT	B-NP	O
human	human	JJ	I-NP	B-protein
T	T	NN	I-NP	I-protein
cell-specific	cell-specific	JJ	I-NP	I-protein
transcription	transcription	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
TCF-1	TCF-1	NN	I-NP	B-protein
alpha	alpha	NN	I-NP	I-protein
plays	play	VBZ	B-VP	O
a	a	DT	B-NP	O
key	key	JJ	I-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
tissue-specific	tissue-specific	JJ	I-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
T	T	NN	I-NP	B-protein
cell	cell	NN	I-NP	I-protein
receptor	receptor	NN	I-NP	I-protein
(	(	(	I-NP	O
TCR	TCR	NN	I-NP	B-protein
)	)	)	I-NP	O
C	C	NN	I-NP	O
alpha	alpha	NN	I-NP	O
enhancer	enhancer	NN	I-NP	O
and	and	CC	O	O
binds	bind	VBZ	B-VP	O
to	to	TO	B-PP	O
pyrimidine-rich	pyrimidine-rich	JJ	B-NP	B-DNA
elements	element	NNS	I-NP	I-DNA
(	(	(	O	O
5'-PyCTTTG-3	5'-PyCTTTG-3	NN	B-NP	O
'	'	''	O	O
)	)	)	O	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
variety	variety	NN	I-NP	O
of	of	IN	B-PP	O
other	other	JJ	B-NP	O
T	T	NN	I-NP	B-DNA
cell-specific	cell-specific	JJ	I-NP	I-DNA
control	control	NN	I-NP	I-DNA
regions	region	NNS	I-NP	I-DNA
.	.	.	O	O

Using	Use	VBG	B-VP	O
amino	amino	JJ	B-NP	O
acid	acid	NN	I-NP	O
sequence	sequence	NN	I-NP	O
information	information	NN	I-NP	O
derived	derive	VBN	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
DNA	DNA	NN	I-NP	B-protein
affinity-purified	affinity-purified	JJ	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
,	,	,	O	O
we	we	PRP	B-NP	O
have	have	VBP	B-VP	O
now	now	RB	I-VP	O
isolated	isolate	VBN	I-VP	O
cDNA	cDNA	NN	B-NP	B-DNA
clones	clone	NNS	I-NP	I-DNA
encoding	encode	VBG	B-VP	O
TCF-1	TCF-1	NN	B-NP	B-protein
alpha	alpha	NN	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
TCF-1	TCF-1	NN	I-NP	B-DNA
alpha	alpha	NN	I-NP	I-DNA
cDNA	cDNA	NN	I-NP	I-DNA
contains	contain	VBZ	B-VP	O
a	a	DT	B-NP	O
single	single	JJ	I-NP	O
68-amino-acid	68-amino-acid	JJ	I-NP	B-protein
domain	domain	NN	I-NP	I-protein
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
homologous	homologous	JJ	B-ADJP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
region	region	NN	I-NP	O
conserved	conserve	VBN	B-VP	O
among	among	IN	B-PP	O
high-mobility	high-mobility	JJ	B-NP	B-protein
group	group	NN	I-NP	I-protein
(	(	(	O	O
HMG	HMG	NN	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
nonhistone	nonhistone	JJ	B-NP	B-protein
chromosomal	chromosomal	JJ	I-NP	I-protein
proteins	protein	NNS	I-NP	I-protein
.	.	.	O	O

Expression	Expression	NN	B-NP	O
of	of	IN	B-PP	O
full-length	full-length	JJ	B-NP	O
and	and	CC	I-NP	O
mutant	mutant	JJ	I-NP	B-DNA
cDNA	cDNA	NN	I-NP	I-DNA
clones	clone	NNS	I-NP	I-DNA
in	in	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
reveal	reveal	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
single	single	JJ	I-NP	B-protein
HMG	HMG	NN	I-NP	I-protein
motif	motif	NN	I-NP	I-protein
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
predicted	predict	VBN	I-VP	O
to	to	TO	I-VP	O
contain	contain	VB	I-VP	O
two	two	CD	B-NP	O
extended	extended	JJ	I-NP	O
alpha-helical	alpha-helical	JJ	I-NP	B-protein
segments	segment	NNS	I-NP	I-protein
,	,	,	O	O
is	be	VBZ	B-VP	O
sufficient	sufficient	JJ	B-ADJP	O
to	to	TO	B-VP	O
direct	direct	VB	I-VP	O
the	the	DT	B-NP	O
sequence-specific	sequence-specific	JJ	I-NP	O
binding	binding	NN	I-NP	O
of	of	IN	B-PP	O
TCF-1	TCF-1	NN	B-NP	B-protein
alpha	alpha	NN	I-NP	I-protein
to	to	TO	B-PP	O
DNA	DNA	NN	B-NP	O
.	.	.	O	O

Northern	Northern	NN	B-NP	O
blot	blot	NN	I-NP	O
experiments	experiment	NNS	I-NP	O
demonstrate	demonstrate	VBP	B-VP	O
further	further	RBR	B-ADVP	O
that	that	IN	B-SBAR	O
TCF-1	TCF-1	NN	B-NP	B-RNA
alpha	alpha	NN	I-NP	I-RNA
mRNA	mRNA	NN	I-NP	I-RNA
is	be	VBZ	B-VP	O
highly	highly	RB	B-ADJP	O
tissue	tissue	NN	I-ADJP	O
specific	specific	JJ	I-ADJP	O
,	,	,	O	O
found	find	VBN	B-VP	O
primarily	primarily	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
thymus	thymus	NN	B-NP	B-cell_line
or	or	CC	O	I-cell_line
T	T	NN	B-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
lines	line	NNS	I-NP	I-cell_line
.	.	.	O	O

The	The	DT	B-NP	O
immature	immature	JJ	I-NP	B-cell_line
CEM	CEM	NN	I-NP	I-cell_line
T	T	NN	I-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
expresses	express	VBZ	B-VP	O
relatively	relatively	RB	B-NP	O
low	low	JJ	I-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
TCF-1	TCF-1	NN	B-NP	B-RNA
alpha	alpha	NN	I-NP	I-RNA
mRNA	mRNA	NN	I-NP	I-RNA
,	,	,	O	O
which	which	WDT	B-NP	O
are	be	VBP	B-VP	O
increased	increase	VBN	I-VP	O
upon	upon	IN	B-PP	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
cells	cell	NNS	I-NP	O
by	by	IN	B-PP	O
phorbol	phorbol	NN	B-NP	O
esters	ester	NNS	I-NP	O
.	.	.	O	O

Interestingly	Interestingly	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
cloned	clone	VBN	I-NP	O
TCF-1	TCF-1	NN	I-NP	B-protein
alpha	alpha	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
potent	potent	JJ	I-NP	O
transcriptional	transcriptional	JJ	I-NP	B-protein
activator	activator	NN	I-NP	I-protein
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	B-DNA
TCR	TCR	NN	I-NP	I-DNA
alpha	alpha	NN	I-NP	I-DNA
enhancer	enhancer	NN	I-NP	I-DNA
in	in	IN	B-PP	O
nonlymphoid	nonlymphoid	JJ	B-NP	B-cell_line
cell	cell	NN	I-NP	I-cell_line
lines	line	NNS	I-NP	I-cell_line
,	,	,	O	O
whereas	whereas	IN	O	O
the	the	DT	B-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
endogenous	endogenous	JJ	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
in	in	IN	B-PP	O
T	T	NN	B-NP	B-cell_line
cell	cell	NN	I-NP	I-cell_line
lines	line	NNS	I-NP	I-cell_line
is	be	VBZ	B-VP	O
strongly	strongly	RB	B-ADJP	O
dependent	dependent	JJ	I-ADJP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
additional	additional	JJ	I-NP	O
T	T	NN	I-NP	B-protein
cell-specific	cell-specific	JJ	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
that	that	WDT	B-NP	O
interacts	interact	VBZ	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
core	core	NN	I-NP	B-DNA
enhancer	enhancer	NN	I-NP	I-DNA
.	.	.	O	O

TCF-1	TCF-1	NN	B-NP	B-protein
alpha	alpha	NN	I-NP	I-protein
is	be	VBZ	B-VP	O
currently	currently	RB	B-ADJP	O
unique	unique	JJ	I-ADJP	O
among	among	IN	B-PP	O
the	the	DT	B-NP	O
newly	newly	RB	I-NP	O
emerging	emerge	VBG	I-NP	O
family	family	NN	I-NP	O
of	of	IN	B-PP	O
DNA-binding	DNA-binding	JJ	B-NP	B-protein
regulatory	regulatory	JJ	I-NP	I-protein
proteins	protein	NNS	I-NP	I-protein
that	that	WDT	B-NP	O
share	share	VBP	B-VP	O
the	the	DT	B-NP	O
HMG	HMG	NN	I-NP	B-protein
motif	motif	NN	I-NP	I-protein
in	in	IN	B-PP	O
that	that	IN	B-NP	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
highly	highly	RB	I-NP	B-protein
tissue-specific	tissue-specific	JJ	I-NP	I-protein
RNA	RNA	NN	I-NP	I-protein
polymerase	polymerase	NN	I-NP	I-protein
II	II	CD	I-NP	I-protein
transcription	transcription	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
.	.	.	O	O

=========a2033090.txt=========	=========a2033090.txt=========	LS	B-LST	O

Demonstration	Demonstration	NN	B-NP	O
of	of	IN	B-PP	O
estrogen	estrogen	NN	B-NP	B-protein
and	and	CC	O	O
progesterone	progesterone	NN	B-NP	B-protein
receptors	receptor	NNS	B-NP	I-protein
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
Ki-67	Ki-67	NN	B-NP	B-protein
and	and	CC	O	I-protein
p-145	p-145	NN	B-NP	I-protein
antigens	antigen	NNS	I-NP	I-protein
in	in	IN	B-PP	O
single	single	JJ	B-NP	B-cell_type
tumor	tumor	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
from	from	IN	B-PP	O
blood	blood	NN	B-NP	O
and	and	CC	O	O
pleural	pleural	JJ	B-ADJP	O
effusions	effusion	NNS	B-NP	O
using	use	VBG	B-VP	O
a	a	DT	B-NP	O
slide	slide	NN	I-NP	O
assay	assay	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
describe	describe	VBP	B-VP	O
a	a	DT	B-NP	O
slide	slide	NN	I-NP	O
assay	assay	NN	I-NP	O
that	that	WDT	B-NP	O
allows	allow	VBZ	B-VP	O
the	the	DT	B-NP	O
demonstration	demonstration	NN	I-NP	O
of	of	IN	B-PP	O
antigens	antigen	NNS	B-NP	B-protein
localized	localize	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
nucleus	nucleus	NN	I-NP	O
from	from	IN	B-PP	O
isolated	isolate	VBN	B-NP	B-cell_type
white	white	JJ	I-NP	I-cell_type
blood	blood	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
from	from	IN	B-PP	O
single	single	JJ	B-NP	B-cell_type
tumor	tumor	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
derived	derive	VBN	B-VP	O
from	from	IN	B-PP	O
malignant	malignant	JJ	B-NP	O
effusions	effusion	NNS	I-NP	O
.	.	.	O	O

With	With	IN	B-PP	O
the	the	DT	B-NP	O
antibodies	antibody	NNS	I-NP	O
Ki-67	Ki-67	NN	I-NP	B-protein
and	and	CC	O	O
anti-p-145	anti-p-145	NN	B-NP	B-protein
an	an	DT	B-NP	O
increased	increase	VBN	I-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
nuclear	nuclear	JJ	B-NP	O
and	and	CC	I-NP	O
nucleolar	nucleolar	JJ	I-NP	O
staining	staining	NN	I-NP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
cells	cell	NNS	B-NP	O
from	from	IN	B-PP	O
highly	highly	RB	B-NP	O
malignant	malignant	JJ	I-NP	O
lymphomas	lymphoma	NNS	I-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
almost	almost	RB	I-NP	O
identical	identical	JJ	I-NP	O
reaction	reaction	NN	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
when	when	WRB	B-ADVP	O
tumor	tumor	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
from	from	IN	B-PP	O
malignant	malignant	JJ	B-NP	O
effusions	effusion	NNS	I-NP	O
were	be	VBD	B-VP	O
tested	test	VBN	I-VP	O
.	.	.	O	O

Cells	Cell	NNS	B-NP	O
isolated	isolate	VBN	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
blood	blood	NN	I-NP	O
of	of	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
leukemic	leukemic	JJ	B-NP	O
spread	spread	NN	I-NP	O
of	of	IN	B-PP	O
lymphomas	lymphoma	NNS	B-NP	O
of	of	IN	B-PP	O
low	low	JJ	B-NP	O
malignancy	malignancy	NN	I-NP	O
yielded	yield	VBD	B-VP	O
a	a	DT	B-NP	O
weak	weak	JJ	I-NP	O
staining	staining	NN	I-NP	O
comparable	comparable	JJ	B-ADJP	O
to	to	TO	B-PP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
normal	normal	JJ	B-NP	B-cell_type
mesothelial	mesothelial	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
from	from	IN	B-PP	O
non-tumorous	non-tumorous	JJ	B-NP	O
cavity	cavity	NN	I-NP	O
fluids	fluid	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
detection	detection	NN	I-NP	O
of	of	IN	B-PP	O
estrogen	estrogen	NN	B-NP	B-protein
and	and	CC	O	O
progesterone	progesterone	NN	B-NP	B-protein
receptors	receptor	NNS	B-NP	I-protein
(	(	(	O	O
ER	ER	NN	B-NP	B-protein
and	and	CC	O	O
PR	PR	NN	B-NP	B-protein
)	)	)	O	O
localized	localize	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
cell	cell	NN	I-NP	O
nucleus	nucleus	NN	I-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
achieved	achieve	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
assay	assay	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
reaction	reaction	NN	I-NP	O
is	be	VBZ	B-VP	O
enhanced	enhance	VBN	I-VP	O
by	by	IN	B-PP	O
incubation	incubation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
tumor	tumor	NN	I-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
for	for	IN	B-PP	O
30	30	CD	B-NP	O
min	min	NN	I-NP	O
at	at	IN	B-PP	O
37	37	CD	B-NP	O
degrees	degree	NNS	I-NP	O
C	C	JJ	B-ADJP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
fixation	fixation	NN	B-NP	O
.	.	.	O	O

Pleural	Pleural	JJ	B-NP	O
effusions	effusion	NNS	I-NP	O
from	from	IN	B-PP	O
20	20	CD	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
breast	breast	NN	B-NP	O
cancer	cancer	NN	I-NP	O
were	be	VBD	B-VP	O
tested	test	VBN	I-VP	O
.	.	.	O	O

ER	ER	NN	B-NP	B-protein
was	be	VBD	B-VP	O
positive	positive	JJ	B-ADJP	O
in	in	IN	B-PP	O
13	13	CD	B-NP	O
and	and	CC	O	O
PR	PR	NN	B-NP	B-protein
was	be	VBD	B-VP	O
positive	positive	JJ	B-ADJP	O
in	in	IN	B-PP	O
12	12	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
20	20	CD	I-NP	O
samples	sample	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
5	5	CD	B-NP	O
cases	case	NNS	I-NP	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
divergent	divergent	JJ	I-NP	O
reaction	reaction	NN	I-NP	O
with	with	IN	B-PP	O
ER	ER	NN	B-NP	B-protein
and	and	CC	O	O
PR	PR	NN	B-NP	B-protein
antibody	antibody	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
hormone	hormone	NN	I-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
of	of	IN	B-PP	O
the	the	DT	B-NP	O
primary	primary	JJ	I-NP	O
tumor	tumor	NN	I-NP	O
were	be	VBD	B-VP	O
known	know	VBN	I-VP	O
in	in	IN	B-PP	O
15	15	CD	B-NP	O
(	(	(	O	O
ER	ER	NN	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
14	14	CD	B-NP	O
(	(	(	O	O
PR	PR	NN	B-NP	B-protein
)	)	)	O	O
patients	patient	NNS	B-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
.	.	.	O	O

In	In	IN	B-PP	O
each	each	DT	B-NP	O
cohort	cohort	JJ	I-NP	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
only	only	RB	B-NP	O
one	one	CD	I-NP	O
case	case	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
negative	negative	JJ	I-NP	O
reaction	reaction	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
primary	primary	JJ	I-NP	O
tumor	tumor	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
positive	positive	JJ	I-NP	O
reaction	reaction	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
isolated	isolate	VBN	I-NP	O
tumor	tumor	NN	I-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
from	from	IN	B-PP	O
the	the	DT	B-NP	O
pleural	pleural	JJ	I-NP	O
effusions	effusion	NNS	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
demonstration	demonstration	NN	I-NP	O
of	of	IN	B-PP	O
hormone	hormone	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
proteins	protein	NNS	I-NP	I-protein
in	in	IN	B-PP	O
cells	cell	NNS	B-NP	O
from	from	IN	B-PP	O
malignant	malignant	JJ	B-NP	O
effusions	effusion	NNS	I-NP	O
is	be	VBZ	B-VP	O
possible	possible	JJ	B-ADJP	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
there	there	EX	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
correlation	correlation	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
status	status	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
primary	primary	JJ	I-NP	O
site	site	NN	I-NP	O
of	of	IN	B-PP	O
cancer	cancer	NN	B-NP	O
.	.	.	O	O

=========a2024810.txt=========	=========a2024810.txt=========	LS	B-LST	O

Glucocorticoid	Glucocorticoid	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
characteristics	characteristic	NNS	I-NP	O
in	in	IN	B-PP	O
monocytes	monocyte	NNS	B-NP	B-cell_type
of	of	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
corticosteroid-resistant	corticosteroid-resistant	JJ	B-NP	O
bronchial	bronchial	JJ	I-NP	O
asthma	asthma	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
mechanism	mechanism	NN	I-NP	O
of	of	IN	B-PP	O
corticosteroid	corticosteroid	NN	B-NP	O
resistance	resistance	NN	I-NP	O
in	in	IN	B-PP	O
bronchial	bronchial	JJ	B-NP	O
asthma	asthma	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
studied	study	VBN	I-VP	O
by	by	IN	B-PP	O
determining	determine	VBG	B-VP	O
the	the	DT	B-NP	O
rank	rank	NN	I-NP	O
order	order	NN	I-NP	O
of	of	IN	B-PP	O
potency	potency	NN	B-NP	O
for	for	IN	B-PP	O
different	different	JJ	B-NP	O
corticosteroids	corticosteroid	NNS	I-NP	O
in	in	IN	B-PP	O
inhibiting	inhibit	VBG	B-VP	O
the	the	DT	B-NP	O
generation	generation	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
3	3	CD	I-NP	O
kD	kD	NN	I-NP	O
molecule	molecule	NN	I-NP	O
from	from	IN	B-PP	O
peripheral	peripheral	JJ	B-NP	B-cell_type
blood	blood	NN	I-NP	I-cell_type
monocytes	monocyte	NNS	I-NP	I-cell_type
isolated	isolate	VBN	B-VP	O
from	from	IN	B-PP	O
corticosteroid-sensitive	corticosteroid-sensitive	JJ	O	O
(	(	(	O	O
CS	CS	JJ	B-ADJP	O
)	)	)	O	O
and	and	CC	O	O
corticosteroid-resistant	corticosteroid-resistant	JJ	O	O
(	(	(	O	O
CR	CR	JJ	B-ADJP	O
)	)	)	O	O
asthmatic	asthmatic	JJ	B-NP	O
subjects	subject	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
augments	augment	VBZ	B-VP	O
leukotriene	leukotriene	NN	B-NP	O
B4	B4	NN	I-NP	O
(	(	(	O	O
LTB4	LTB4	NN	B-NP	O
)	)	)	O	O
generation	generation	NN	B-NP	O
by	by	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
neutrophils	neutrophil	NNS	I-NP	I-cell_type
(	(	(	O	O
PMN	PMN	NN	B-NP	B-cell_type
)	)	)	O	O
stimulated	stimulate	VBN	B-VP	O
by	by	IN	B-PP	O
calcium	calcium	NN	B-NP	O
ionophore	ionophore	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
binding	bind	VBG	B-NP	O
studies	study	NNS	I-NP	O
with	with	IN	B-PP	O
(	(	(	B-NP	O
3H	3H	NN	I-NP	O
)	)	)	I-NP	O
dexamethasone	dexamethasone	NN	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
performed	perform	VBN	I-VP	O
to	to	TO	B-VP	O
determine	determine	VB	I-VP	O
the	the	DT	B-NP	O
dissociation	dissociation	NN	I-NP	O
constant	constant	NN	I-NP	O
(	(	(	O	O
Kd	Kd	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
receptor	receptor	NN	B-NP	O
numbers	number	NNS	I-NP	O
(	(	(	O	O
Ro	Ro	NN	B-NP	O
)	)	)	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
monocytes	monocyte	NNS	I-NP	B-cell_type
of	of	IN	B-PP	O
these	these	DT	B-NP	O
two	two	CD	I-NP	O
groups	group	NNS	I-NP	O
of	of	IN	B-PP	O
subjects	subject	NNS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
concentration	concentration	NN	I-NP	O
of	of	IN	B-PP	O
corticosteroid	corticosteroid	NN	B-NP	O
producing	produce	VBG	B-VP	O
50	50	CD	B-NP	O
%	%	NN	I-NP	O
inhibition	inhibition	NN	I-NP	O
(	(	(	O	O
IC50	IC50	NN	B-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
600	600	CD	B-NP	O
nM	nM	NN	I-NP	O
,	,	,	O	O
70	70	CD	B-NP	O
nM	nM	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
0.5	0.5	CD	B-NP	O
nM	nM	NN	I-NP	O
for	for	IN	B-PP	O
hydrocortisone	hydrocortisone	NN	B-NP	O
,	,	,	O	O
methylprednisolone	methylprednisolone	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
dexamethasone	dexamethasone	NN	B-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
,	,	,	O	O
in	in	IN	B-PP	O
monocytes	monocyte	NNS	B-NP	B-cell_type
from	from	IN	B-PP	O
CS	CS	JJ	B-NP	O
individuals	individual	NNS	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
only	only	RB	B-NP	O
weak	weak	JJ	I-NP	O
inhibition	inhibition	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
generation	generation	NN	I-NP	O
of	of	IN	B-PP	O
enhancing	enhancing	NN	B-NP	O
activity	activity	NN	I-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
corticosteroids	corticosteroid	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
CR	CR	JJ	I-NP	O
asthmatic	asthmatic	JJ	I-NP	O
individuals	individual	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
dexamethasone	dexamethasone	NN	I-NP	O
Kd	Kd	NN	I-NP	O
was	be	VBD	B-VP	O
2.45	2.45	CD	B-NP	O
		SYM	O	O
0.58	0.58	CD	B-NP	O
nM	nM	NN	I-NP	O
(	(	(	O	O
mean	mean	NN	B-NP	O
		NN	I-NP	O
SEM	SEM	NN	I-NP	O
,	,	,	O	O
n	n	NN	B-NP	O
=	=	JJ	B-VP	O
6	6	CD	B-NP	O
)	)	)	O	O
in	in	IN	B-PP	O
the	the	DT	O	O
CS	CS	JJ	B-NP	O
group	group	NN	B-NP	O
and	and	CC	O	O
1.6	1.6	CD	B-NP	O
		HYPH	I-NP	O
0.35	0.35	CD	I-NP	O
nM	nM	NN	I-NP	O
(	(	(	O	O
mean	mean	NN	B-NP	O
		NN	I-NP	O
SEM	SEM	NN	I-NP	O
,	,	,	O	O
n	n	NN	B-NP	O
=	=	JJ	B-VP	O
6	6	CD	B-NP	O
)	)	)	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
CR	CR	JJ	I-NP	O
group	group	NN	I-NP	O
of	of	IN	B-PP	O
patients	patient	NNS	B-NP	O
(	(	(	O	O
p	p	NN	B-NP	O
=	=	SYM	B-VP	O
0.14	0.14	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O

The	The	DT	B-NP	O
Ro	Ro	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
CS	CS	NN	I-NP	O
group	group	NN	I-NP	O
was	be	VBD	B-VP	O
3	3	CD	B-NP	O
,	,	,	I-NP	O
605	605	CD	I-NP	O
		CC	I-NP	B-DNA
984	984	CD	I-NP	I-DNA
binding	bind	VBG	I-NP	I-DNA
sites	site	NNS	I-NP	I-DNA
per	per	IN	B-PP	O
nucleus	nucleus	NN	B-NP	O
(	(	(	O	O
mean	mean	NN	B-NP	O
		NN	I-NP	O
SEM	SEM	NN	I-NP	O
,	,	,	O	O
n	n	NN	B-NP	O
=	=	JJ	B-VP	O
6	6	CD	B-NP	O
)	)	)	O	O
and	and	CC	O	O
4	4	CD	B-NP	O
,	,	,	I-NP	O
757	757	CD	I-NP	O
		CC	I-NP	B-DNA
692	692	CD	I-NP	I-DNA
binding	bind	VBG	I-NP	I-DNA
sites	site	NNS	I-NP	I-DNA
per	per	IN	B-PP	O
nucleus	nucleus	NN	B-NP	O
(	(	(	O	O
mean	mean	NN	B-NP	O
		NN	I-NP	O
SEM	SEM	NN	I-NP	O
,	,	,	O	O
n	n	NN	B-NP	O
=	=	JJ	B-VP	O
6	6	CD	B-NP	O
)	)	)	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
CR	CR	JJ	I-NP	O
group	group	NN	I-NP	O
(	(	(	O	O
p	p	NN	B-NP	O
=	=	SYM	B-VP	O
0.23	0.23	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O

These	These	DT	B-NP	O
findings	finding	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
corticosteroid	corticosteroid	NN	B-NP	O
resistance	resistance	NN	I-NP	O
in	in	IN	B-PP	O
bronchial	bronchial	JJ	B-NP	O
asthma	asthma	NN	I-NP	O
can	can	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
explained	explain	VBN	I-VP	O
by	by	IN	B-PP	O
abnormalities	abnormality	NNS	B-NP	O
in	in	IN	B-PP	O
corticosteroid	corticosteroid	NN	B-NP	O
receptor	receptor	NN	I-NP	O
characteristics	characteristic	NNS	I-NP	O
.	.	.	O	O

=========a1851743.txt=========	=========a1851743.txt=========	LS	B-LST	O

Inhibition	Inhibition	NN	B-NP	O
of	of	IN	B-PP	O
protein	protein	NN	B-NP	B-protein
phosphatases	phosphatas	NNS	I-NP	I-protein
by	by	IN	B-PP	O
okadaic	okadaic	JJ	B-NP	O
acid	acid	NN	I-NP	O
induces	induce	VBZ	B-VP	O
AP1	AP1	NN	B-NP	B-protein
in	in	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

To	To	TO	B-VP	O
examine	examine	VB	I-VP	O
the	the	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
protein	protein	NN	B-NP	B-protein
phosphatases	phosphatas	NNS	I-NP	I-protein
in	in	IN	B-PP	O
T	T	NN	B-NP	O
cell	cell	NN	I-NP	O
activation	activation	NN	I-NP	O
,	,	,	O	O
Jurkat	Jurkat	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
were	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
okadaic	okadaic	JJ	B-NP	O
acid	acid	NN	I-NP	O
,	,	,	O	O
an	an	DT	B-NP	O
inhibitor	inhibitor	NN	I-NP	O
of	of	IN	B-PP	O
type	type	NN	B-NP	B-protein
1	1	CD	I-NP	I-protein
and	and	CC	I-NP	I-protein
2A	2A	NN	I-NP	I-protein
phosphatases	phosphatas	NNS	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
nuclear	nuclear	JJ	B-NP	O
extracts	extract	NNS	I-NP	O
were	be	VBD	B-VP	O
examined	examine	VBN	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
AP1	AP1	NN	B-NP	B-protein
as	as	IN	B-PP	O
a	a	DT	B-NP	O
measure	measure	NN	I-NP	O
of	of	IN	B-PP	O
early	early	JJ	B-NP	O
T	T	NN	I-NP	O
cell	cell	NN	I-NP	O
activation	activation	NN	I-NP	O
.	.	.	O	O

Okadaic	Okadaic	JJ	B-NP	O
acid	acid	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
potent	potent	JJ	I-NP	O
inducer	inducer	NN	I-NP	O
of	of	IN	B-PP	O
AP1	AP1	NN	B-NP	B-protein
.	.	.	O	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
to	to	TO	B-PP	O
phorbol	phorbol	NN	B-NP	O
esters	ester	NNS	I-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
phorbol	phorbol	NN	B-NP	O
myristate	myristate	NN	I-NP	O
acetate	acetate	NN	I-NP	O
(	(	(	O	O
PMA	PMA	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
the	the	DT	B-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
AP1	AP1	NN	B-NP	B-protein
by	by	IN	B-PP	O
okadaic	okadaic	JJ	B-NP	O
acid	acid	NN	I-NP	O
occurs	occur	VBZ	B-VP	O
predominantly	predominantly	RB	B-PP	O
by	by	IN	I-PP	O
transcriptional	transcriptional	JJ	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	O	O
jun	jun	NN	B-NP	B-DNA
and	and	CC	O	I-DNA
fos	fos	NN	B-NP	I-DNA
family	family	NN	B-NP	I-DNA
of	of	IN	B-PP	O
proto-oncogenes	proto-oncogene	NNS	B-NP	B-DNA
.	.	.	O	O

Surprisingly	Surprisingly	RB	B-ADVP	O
,	,	,	O	O
while	while	IN	B-SBAR	O
the	the	DT	B-NP	O
addition	addition	NN	I-NP	O
of	of	IN	B-PP	O
phytohemagglutinin	phytohemagglutinin	NN	B-NP	B-protein
further	further	RBR	B-ADVP	O
enhanced	enhance	VBD	B-VP	O
the	the	DT	B-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
AP1	AP1	NN	B-NP	B-protein
,	,	,	O	O
the	the	DT	B-NP	O
addition	addition	NN	I-NP	O
of	of	IN	B-PP	O
PMA	PMA	NN	B-NP	O
inhibited	inhibit	VBD	B-VP	O
it	it	PRP	B-NP	O
.	.	.	O	O

Okadaic	Okadaic	JJ	B-NP	O
acid	acid	NN	I-NP	O
treatment	treatment	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
dramatically	dramatically	RB	I-VP	O
increase	increase	VB	I-VP	O
mRNA	mRNA	NN	B-NP	B-RNA
transcripts	transcript	NNS	I-NP	I-RNA
of	of	IN	B-PP	O
the	the	DT	B-NP	O
jun	jun	NN	I-NP	B-protein
family	family	NN	I-NP	I-protein
of	of	IN	B-PP	O
proto-oncogenes	proto-oncogene	NNS	B-NP	B-DNA
including	include	VBG	B-PP	O
c-jun	c-jun	NN	B-NP	B-DNA
,	,	,	O	O
junD	junD	NN	B-NP	B-DNA
,	,	,	O	O
and	and	CC	O	O
junB	junB	NN	B-NP	B-DNA
and	and	CC	O	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
lesser	less	JJR	I-NP	O
extent	extent	NN	I-NP	O
the	the	DT	B-NP	O
fos	fos	NN	I-NP	B-DNA
family	family	NN	I-NP	I-DNA
including	include	VBG	B-PP	O
c-fos	c-fos	NN	B-NP	B-DNA
and	and	CC	O	O
fra-1	fra-1	NN	B-NP	B-DNA
.	.	.	O	O

By	By	IN	B-PP	O
comparison	comparison	NN	B-NP	O
,	,	,	O	O
PMA	PMA	NN	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
very	very	RB	I-NP	O
inefficient	inefficient	JJ	I-NP	O
inducer	inducer	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
jun	jun	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
family	family	NN	I-NP	I-DNA
in	in	IN	B-PP	O
Jurkat	Jurkat	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
.	.	.	O	O

Similar	Similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
its	its	PRP$	B-NP	O
effect	effect	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
AP1	AP1	NN	B-NP	B-protein
by	by	IN	B-PP	O
okadaic	okadaic	JJ	B-NP	O
acid	acid	NN	I-NP	O
,	,	,	O	O
PMA	PMA	NN	B-NP	O
inhibits	inhibit	VBZ	B-VP	O
the	the	DT	B-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
c-jun	c-jun	NN	B-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
by	by	IN	B-PP	O
okadaic	okadaic	JJ	B-NP	O
acid	acid	NN	I-NP	O
.	.	.	O	O

Transfection	Transfection	NN	B-NP	O
of	of	IN	B-PP	O
c-jun	c-jun	NN	B-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
constructs	construct	NNS	I-NP	I-DNA
confirmed	confirm	VBD	B-VP	O
the	the	DT	B-NP	O
marked	marked	JJ	I-NP	O
difference	difference	NN	I-NP	O
between	between	IN	B-PP	O
PMA	PMA	NN	B-NP	O
and	and	CC	O	O
okadaic	okadaic	JJ	B-NP	O
acid	acid	NN	I-NP	O
in	in	IN	B-PP	O
inducing	induce	VBG	B-VP	O
c-jun	c-jun	NN	B-NP	B-DNA
transcription	transcription	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
AP1	AP1	NN	B-NP	B-protein
by	by	IN	B-PP	O
okadaic	okadaic	JJ	B-NP	O
acid	acid	NN	I-NP	O
suggests	suggest	VBZ	B-VP	O
that	that	IN	B-SBAR	O
protein	protein	NN	B-NP	B-protein
phosphatases	phosphatas	NNS	I-NP	I-protein
1	1	CD	B-NP	I-protein
and	and	CC	O	I-protein
2A	2A	NN	B-NP	I-protein
(	(	(	O	O
PP1	PP1	NN	B-NP	B-protein
and	and	CC	O	O
PP2A	PP2A	NN	B-NP	B-protein
)	)	)	O	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
T	T	NN	B-NP	O
cell	cell	NN	I-NP	O
activation	activation	NN	I-NP	O
as	as	IN	B-PP	O
important	important	JJ	B-NP	O
negative	negative	JJ	I-NP	O
regulators	regulator	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
transcription	transcription	NN	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
AP1	AP1	NN	I-NP	B-protein
.	.	.	O	O

=========a2023633.txt=========	=========a2023633.txt=========	LS	B-LST	O

HIV	HIV	NN	B-NP	B-DNA
enhancer	enhancer	NN	I-NP	I-DNA
activity	activity	NN	I-NP	O
perpetuated	perpetuate	VBN	B-VP	O
by	by	IN	B-PP	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
induction	induction	NN	I-NP	O
on	on	IN	B-PP	O
infection	infection	NN	B-NP	O
of	of	IN	B-PP	O
monocytes	monocyte	NNS	B-NP	B-cell_type
[	[	(	O	O
see	see	VB	B-VP	O
comments	comment	NNS	B-NP	O
]	]	)	O	O

Permissiveness	Permissiveness	NN	B-NP	O
to	to	TO	B-PP	O
replication	replication	NN	B-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	O
immunodeficiency	immunodeficiency	NN	I-NP	O
virus	virus	NN	I-NP	O
(	(	(	O	O
HIV	HIV	NN	B-NP	O
)	)	)	O	O
differs	differ	VBZ	B-VP	O
in	in	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
and	and	CC	O	O
macrophages	macrophage	NNS	B-NP	B-cell_type
.	.	.	O	O

In	In	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
HIV	HIV	NN	B-NP	O
transcription	transcription	NN	I-NP	O
is	be	VBZ	B-VP	O
poorly	poorly	RB	I-VP	O
detected	detect	VBN	I-VP	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
.	.	.	O	O

Cloned	Clone	VBN	B-NP	O
,	,	,	I-NP	O
normal	normal	JJ	I-NP	O
T	T	NN	I-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
show	show	VBP	B-VP	O
very	very	RB	O	O
little	little	JJ	O	O
,	,	,	O	O
if	if	IN	B-SBAR	O
any	any	DT	O	O
,	,	,	O	O
basal	basal	JJ	B-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
HIV	HIV	NN	I-NP	B-DNA
enhancer	enhancer	NN	I-NP	I-DNA
and	and	CC	O	O
low	low	JJ	B-NP	O
nuclear	nuclear	JJ	I-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
,	,	,	O	O
a	a	DT	B-NP	O
potent	potent	JJ	I-NP	O
transcriptional	transcriptional	JJ	I-NP	B-protein
activator	activator	NN	I-NP	I-protein
of	of	IN	B-PP	O
the	the	DT	B-NP	O
HIV	HIV	NN	I-NP	B-DNA
enhancer	enhancer	NN	I-NP	I-DNA
.	.	.	O	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
,	,	,	O	O
fixed	fixed	JJ	B-NP	O
tissue	tissue	NN	I-NP	O
macrophages	macrophage	NNS	I-NP	B-cell_type
express	express	VBP	B-VP	O
detectable	detectable	JJ	B-NP	O
HIV	HIV	NN	I-NP	B-protein
proteins	protein	NNS	I-NP	I-protein
,	,	,	O	O
indicating	indicate	VBG	B-VP	O
permanent	permanent	JJ	B-NP	O
virus	virus	NN	I-NP	O
transcription	transcription	NN	I-NP	O
.	.	.	O	O

One	One	CD	B-NP	O
explanation	explanation	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
perpetuation	perpetuation	NN	I-NP	O
of	of	IN	B-PP	O
virus	virus	NN	B-NP	O
infection	infection	NN	I-NP	O
in	in	IN	B-PP	O
macrophages	macrophage	NNS	B-NP	B-cell_type
could	could	MD	B-VP	O
be	be	VB	I-VP	O
sustained	sustain	VBN	I-VP	O
nuclear	nuclear	JJ	B-NP	O
NF-kappa	NF-kappa	NN	I-NP	B-protein
B	B	NN	I-NP	I-protein
expression	expression	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
U937	U937	NN	I-NP	B-cell_line
monocytic	monocytic	JJ	I-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
fully	fully	RB	B-ADJP	O
permissive	permissive	JJ	I-ADJP	O
to	to	TO	B-PP	O
HIV	HIV	NN	B-NP	O
replication	replication	NN	I-NP	O
,	,	,	O	O
is	be	VBZ	B-VP	O
known	know	VBN	I-VP	O
to	to	TO	I-VP	O
express	express	VB	I-VP	O
only	only	RB	B-NP	O
low	low	JJ	I-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
nuclear	nuclear	JJ	B-NP	B-protein
NF-kappa	NF-kappa	NN	I-NP	I-protein
B	B	NN	I-NP	I-protein
.	.	.	O	O

We	We	PRP	B-NP	O
show	show	VBP	B-VP	O
here	here	RB	B-ADVP	O
that	that	IN	B-SBAR	O
chronic	chronic	JJ	B-NP	O
HIV	HIV	NN	I-NP	O
infection	infection	NN	I-NP	O
results	result	VBZ	B-VP	O
in	in	IN	B-PP	O
both	both	CC	O	O
induction	induction	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
nuclear	nuclear	JJ	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
with	with	IN	B-PP	O
antigenic	antigenic	JJ	B-NP	O
properties	property	NNS	I-NP	O
indistinguishable	indistinguishable	JJ	B-ADJP	O
from	from	IN	B-PP	O
those	those	DT	B-NP	O
of	of	IN	B-PP	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
and	and	CC	O	O
permanently	permanently	RB	B-NP	O
increased	increase	VBN	I-NP	O
HIV	HIV	NN	I-NP	B-DNA
enhancer	enhancer	NN	I-NP	I-DNA
activity	activity	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
phenomenon	phenomenon	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
independent	independent	JJ	B-ADJP	O
of	of	IN	B-PP	O
tumour	tumour	NN	B-NP	B-protein
necrosis	necrosis	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
,	,	,	O	O
is	be	VBZ	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
HIV	HIV	NN	B-NP	O
replication	replication	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
thus	thus	RB	B-ADVP	O
likely	likely	JJ	B-ADJP	O
to	to	TO	B-VP	O
explain	explain	VB	I-VP	O
at	at	IN	B-ADVP	O
least	least	JJS	I-ADVP	O
in	in	IN	B-PP	O
part	part	NN	B-NP	O
the	the	DT	B-NP	O
perpetuation	perpetuation	NN	I-NP	O
of	of	IN	B-PP	O
HIV	HIV	NN	B-NP	O
infection	infection	NN	I-NP	O
in	in	IN	B-PP	O
monocytes	monocyte	NNS	B-NP	B-cell_type
.	.	.	O	O

=========a2026605.txt=========	=========a2026605.txt=========	LS	B-LST	O

Tissue-specific	Tissue-specific	JJ	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
platelet	platelet	NN	I-NP	B-DNA
GPIIb	GPIIb	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
.	.	.	O	O

One	One	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
major	major	JJ	I-NP	O
objectives	objective	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
study	study	NN	I-NP	O
of	of	IN	B-PP	O
thrombogenesis	thrombogenesis	NN	B-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
determine	determine	VB	I-VP	O
the	the	DT	B-NP	O
mechanisms	mechanism	NNS	I-NP	O
by	by	IN	B-PP	O
which	which	WDT	B-NP	O
a	a	DT	B-NP	O
hematopoietic	hematopoietic	JJ	I-NP	B-cell_type
progenitor	progenitor	NN	I-NP	I-cell_type
is	be	VBZ	B-VP	O
activated	activate	VBN	I-VP	O
and	and	CC	O	O
committed	commit	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
megakaryocytic	megakaryocytic	JJ	I-NP	B-cell_type
lineage	lineage	NN	I-NP	I-cell_type
.	.	.	O	O

Recent	Recent	JJ	B-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
primary	primary	JJ	B-NP	B-cell_line
cultures	culture	NNS	I-NP	I-cell_line
of	of	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
megakaryocytes	megakaryocyte	NNS	I-NP	I-cell_type
and	and	CC	O	O
the	the	DT	B-NP	O
molecular	molecular	JJ	I-NP	O
cloning	cloning	NN	I-NP	O
of	of	IN	B-PP	O
genes	gene	NNS	B-NP	O
that	that	WDT	B-NP	O
are	be	VBP	B-VP	O
specific	specific	JJ	B-ADJP	O
to	to	TO	B-PP	O
this	this	DT	B-NP	O
lineage	lineage	NN	I-NP	O
offer	offer	VBP	B-VP	O
the	the	DT	B-NP	O
possibility	possibility	NN	I-NP	O
of	of	IN	B-PP	O
getting	get	VBG	B-VP	O
some	some	DT	B-NP	O
insights	insight	NNS	I-NP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
genetic	genetic	JJ	I-NP	O
mechanisms	mechanism	NNS	I-NP	O
that	that	WDT	B-NP	O
control	control	VBP	B-VP	O
megakaryocytopoiesis	megakaryocytopoiesis	NN	B-NP	O
.	.	.	O	O

One	One	CD	B-NP	O
gene	gene	NN	I-NP	O
of	of	IN	B-PP	O
interest	interest	NN	B-NP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
glycoprotein	glycoprotein	NN	I-NP	B-DNA
IIb	IIb	NN	I-NP	I-DNA
(	(	(	O	I-DNA
GPIIb	GPIIb	NN	B-NP	I-DNA
)	)	)	O	I-DNA
gene	gene	NN	B-NP	I-DNA
;	;	:	O	O

GPIIb	GPIIb	NN	B-NP	B-protein
,	,	,	O	O
the	the	DT	B-NP	O
alpha	alpha	NN	I-NP	B-protein
subunit	subunit	NN	I-NP	I-protein
of	of	IN	B-PP	O
the	the	DT	B-NP	O
platelet	platelet	NN	I-NP	B-protein
cytoadhesin	cytoadhesin	NN	I-NP	I-protein
GPIIb-IIIa	GPIIb-IIIa	NN	I-NP	I-protein
,	,	,	O	O
is	be	VBZ	B-VP	O
produced	produce	VBN	I-VP	O
in	in	IN	B-PP	O
megakaryocytes	megakaryocyte	NNS	B-NP	B-cell_type
at	at	IN	B-PP	O
an	an	DT	B-NP	O
early	early	JJ	I-NP	O
stage	stage	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
differentiation	differentiation	NN	I-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
the	the	DT	B-NP	O
other	other	JJ	I-NP	O
subunit	subunit	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
complex	complex	NN	I-NP	O
,	,	,	O	O
GPIIIa	GPIIIa	NN	B-NP	B-protein
,	,	,	O	O
is	be	VBZ	B-VP	O
expressed	express	VBN	I-VP	O
in	in	IN	B-PP	O
other	other	JJ	B-NP	O
cells	cell	NNS	I-NP	O
.	.	.	O	O

For	For	IN	B-PP	O
these	these	DT	B-NP	O
reasons	reason	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
5'-flanking	5'-flanking	JJ	I-NP	B-DNA
region	region	NN	I-NP	I-DNA
of	of	IN	B-PP	O
the	the	DT	B-NP	O
GPIIb	GPIIb	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
was	be	VBD	B-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
identify	identify	VB	I-VP	O
the	the	DT	B-NP	O
regions	region	NNS	I-NP	O
that	that	WDT	B-NP	O
interact	interact	VBP	B-VP	O
with	with	IN	B-PP	O
DNA-binding	DNA-binding	JJ	B-NP	B-protein
nuclear	nuclear	JJ	I-NP	I-protein
factors	factor	NNS	I-NP	I-protein
.	.	.	O	O

A	A	DT	B-NP	O
fragment	fragment	NN	I-NP	O
extending	extend	VBG	B-VP	O
from	from	IN	B-PP	O
-643	-643	CD	B-NP	B-DNA
to	to	TO	B-PP	I-DNA
+33	+33	CD	B-NP	I-DNA
is	be	VBZ	B-VP	O
capable	capable	JJ	B-ADJP	O
of	of	IN	B-PP	O
controlling	control	VBG	B-VP	O
the	the	DT	B-NP	O
tissue-specific	tissue-specific	JJ	I-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
CAT	CAT	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
in	in	IN	B-PP	O
transfection	transfection	NN	B-NP	O
experiments	experiment	NNS	I-NP	O
.	.	.	O	O

Within	Within	IN	B-PP	O
this	this	DT	B-NP	O
region	region	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
have	have	VBP	B-VP	O
identified	identify	VBN	I-VP	O
several	several	JJ	B-NP	O
sequences	sequence	NNS	I-NP	O
that	that	WDT	B-NP	O
are	be	VBP	B-VP	O
implicated	implicate	VBN	I-VP	O
in	in	IN	B-PP	O
DNA	DNA	NN	B-NP	O
protein	protein	NN	I-NP	O
interactions	interaction	NNS	I-NP	O
as	as	IN	B-SBAR	O
shown	show	VBN	B-VP	O
in	in	IN	B-PP	O
DNAse	DNAse	NN	B-NP	B-protein
I	I	NN	I-NP	I-protein
footprints	footprint	NNS	I-NP	O
and	and	CC	O	O
gel	gel	NN	B-NP	O
mobility	mobility	NN	I-NP	O
shift	shift	NN	I-NP	O
assays	assay	NNS	I-NP	O
.	.	.	O	O

One	One	CD	B-NP	O
region	region	NN	I-NP	O
,	,	,	O	O
centered	center	VBN	B-ADJP	O
at	at	IN	B-PP	O
-54	-54	CD	B-NP	O
,	,	,	O	O
is	be	VBZ	B-VP	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
nuclear	nuclear	JJ	I-NP	B-DNA
factor	factor	NN	I-NP	I-DNA
E1-binding	E1-binding	JJ	I-NP	I-DNA
site	site	NN	I-NP	I-DNA
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
region	region	NN	I-NP	O
located	located	JJ	B-ADJP	O
at	at	IN	B-PP	O
position	position	NN	B-NP	B-DNA
-233	-233	CD	I-NP	I-DNA
contains	contain	VBZ	B-VP	O
a	a	DT	B-NP	O
CCAAT	CCAAT	NN	I-NP	B-DNA
motif	motif	NN	I-NP	I-DNA
.	.	.	O	O

Two	Two	CD	B-NP	O
domains	domain	NNS	I-NP	O
centered	center	VBN	B-ADJP	O
at	at	IN	B-PP	O
positions	position	NNS	B-NP	B-DNA
-345	-345	CD	B-NP	I-DNA
and	and	CC	O	I-DNA
-540	-540	CD	B-NP	I-DNA
,	,	,	B-ADJP	O
respectively	respectively	RB	I-ADJP	O
,	,	,	O	O
bind	bind	VBP	B-VP	O
proteins	protein	NNS	B-NP	O
that	that	WDT	B-NP	O
are	be	VBP	B-VP	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
megakaryocytic	megakaryocytic	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	O	O
nonrelated	nonrelated	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O
.	.	.	O	O

Finally	Finally	RB	B-ADVP	O
,	,	,	O	O
two	two	CD	B-NP	O
other	other	JJ	I-NP	O
domains	domain	NNS	I-NP	O
,	,	,	O	O
located	located	JJ	B-ADJP	O
at	at	IN	B-PP	O
positions	position	NNS	B-NP	B-DNA
-460	-460	CD	B-NP	I-DNA
and	and	CC	O	I-DNA
-510	-510	CD	B-NP	I-DNA
,	,	,	O	O
interact	interact	VBP	B-VP	O
with	with	IN	B-PP	O
proteins	protein	NNS	B-NP	O
that	that	WDT	B-NP	O
are	be	VBP	B-VP	O
only	only	RB	B-ADJP	O
present	present	JJ	I-ADJP	O
in	in	IN	B-PP	O
megakaryocytic	megakaryocytic	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
deletion	deletion	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
region	region	NN	I-NP	O
containing	contain	VBG	B-VP	O
these	these	DT	B-NP	O
two	two	CD	I-NP	O
domains	domain	NNS	I-NP	O
results	result	VBZ	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
significant	significant	JJ	I-NP	O
decrease	decrease	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
promoter	promoter	NN	I-NP	O
activity	activity	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
very	very	RB	B-ADJP	O
likely	likely	JJ	I-ADJP	O
that	that	IN	B-SBAR	O
these	these	DT	B-NP	O
domains	domain	NNS	I-NP	O
bind	bind	VBP	B-VP	O
megakaryocyte-specific	megakaryocyte-specific	JJ	B-NP	B-protein
nuclear	nuclear	JJ	I-NP	I-protein
proteins	protein	NNS	I-NP	I-protein
acting	act	VBG	B-VP	O
as	as	IN	B-PP	O
positive	positive	JJ	B-NP	B-protein
transcription	transcription	NN	I-NP	I-protein
factors	factor	NNS	I-NP	I-protein
.	.	.	O	O

=========a1989880.txt=========	=========a1989880.txt=========	LS	B-LST	O

Identification	Identification	NN	B-NP	O
and	and	CC	I-NP	O
cloning	cloning	NN	I-NP	O
of	of	IN	B-PP	O
TCF-1	TCF-1	NN	B-NP	B-protein
,	,	,	O	O
a	a	DT	B-NP	O
T	T	NN	I-NP	B-protein
lymphocyte-specific	lymphocyte-specific	JJ	I-NP	I-protein
transcription	transcription	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
containing	contain	VBG	B-VP	O
a	a	DT	B-NP	O
sequence-specific	sequence-specific	JJ	I-NP	B-protein
HMG	HMG	NN	I-NP	I-protein
box	box	NN	I-NP	I-protein
.	.	.	O	O

CD3-epsilon	CD3-epsilon	NN	B-NP	O
expression	expression	NN	I-NP	O
is	be	VBZ	B-VP	O
controlled	control	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
downstream	downstream	JJ	I-NP	B-DNA
T	T	NN	I-NP	I-DNA
lymphocyte-specific	lymphocyte-specific	JJ	I-NP	I-DNA
enhancer	enhancer	NN	I-NP	I-DNA
element	element	NN	I-NP	I-DNA
.	.	.	O	O

We	We	PRP	B-NP	O
report	report	VBP	B-VP	O
the	the	DT	B-NP	O
identification	identification	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
T	T	NN	I-NP	B-protein
cell-specific	cell-specific	JJ	I-NP	I-protein
transcription	transcription	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
,	,	,	O	O
TCF-1	TCF-1	NN	B-NP	B-protein
,	,	,	O	O
binding	bind	VBG	B-VP	O
to	to	TO	B-PP	O
this	this	DT	B-NP	O
element	element	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
multimerized	multimerized	JJ	I-NP	B-protein
recognition	recognition	NN	I-NP	I-protein
motif	motif	NN	I-NP	I-protein
of	of	IN	B-PP	O
TCF-1	TCF-1	NN	B-NP	B-protein
constituted	constitute	VBD	B-VP	O
a	a	DT	B-NP	O
T	T	NN	I-NP	B-DNA
cell-specific	cell-specific	JJ	I-NP	I-DNA
enhancer	enhancer	NN	I-NP	I-DNA
.	.	.	O	O

Subsequent	Subsequent	JJ	B-NP	O
cloning	cloning	NN	I-NP	O
of	of	IN	B-PP	O
TCF-1	TCF-1	NN	B-NP	B-protein
identified	identify	VBD	B-VP	O
three	three	CD	B-NP	O
splice	splice	NN	I-NP	B-protein
alternatives	alternative	NNS	I-NP	I-protein
.	.	.	O	O

TCF-1	TCF-1	NN	B-NP	B-protein
contained	contain	VBD	B-VP	O
a	a	DT	B-NP	O
single	single	JJ	I-NP	O
DNA-binding	DNA-binding	JJ	I-NP	B-protein
HMG	HMG	NN	I-NP	I-protein
box	box	NN	I-NP	I-protein
most	most	RBS	B-ADJP	O
closely	closely	RB	I-ADJP	O
related	related	JJ	I-ADJP	O
to	to	TO	B-PP	O
similar	similar	JJ	B-NP	O
boxes	box	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
putative	putative	JJ	I-NP	B-DNA
mammalian	mammalian	JJ	I-NP	I-DNA
sex-determining	sex-determining	JJ	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
SRY	SRY	NN	I-NP	B-DNA
and	and	CC	B-PP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Schizosaccharomyces	Schizosaccharomyces	FW	I-NP	B-DNA
pombe	pombe	FW	I-NP	I-DNA
Mc	Mc	NN	I-NP	I-DNA
mating	mating	NN	I-NP	I-DNA
type	type	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
.	.	.	O	O

TCF-1	TCF-1	NN	B-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
was	be	VBD	B-VP	O
expressed	express	VBN	I-VP	O
uniquely	uniquely	RB	B-ADVP	O
in	in	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
.	.	.	O	O

Upon	Upon	IN	B-PP	O
cotransfection	cotransfection	NN	B-NP	O
into	into	IN	B-PP	O
non-T	non-T	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
TCF-1	TCF-1	NN	B-NP	B-protein
could	could	MD	B-VP	O
transactivate	transactivate	VB	I-VP	O
through	through	IN	B-PP	O
its	its	PRP$	B-NP	O
cognate	cognate	JJ	I-NP	O
motif	motif	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
identify	identify	VBP	B-VP	O
TCF-1	TCF-1	NN	B-NP	B-protein
as	as	IN	B-PP	O
a	a	DT	B-NP	O
T	T	NN	I-NP	B-protein
cell-specific	cell-specific	JJ	I-NP	I-protein
transcription	transcription	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
,	,	,	O	O
which	which	WDT	B-NP	O
might	might	MD	B-VP	O
play	play	VB	I-VP	O
a	a	DT	B-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
establishment	establishment	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mature	mature	JJ	I-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
cell	cell	NN	I-NP	I-cell_type
phenotype	phenotype	NN	I-NP	I-cell_type
.	.	.	O	O

=========a1994572.txt=========	=========a1994572.txt=========	LS	B-LST	O

A	A	DT	B-NP	O
novel	novel	JJ	I-NP	O
HIV-1	HIV-1	NN	I-NP	O
isolate	isolate	NN	I-NP	O
containing	contain	VBG	B-VP	O
alterations	alteration	NNS	B-NP	O
affecting	affect	VBG	B-VP	O
the	the	DT	B-NP	O
NF-kappa	NF-kappa	NN	I-NP	B-DNA
B	B	NN	I-NP	I-DNA
element	element	NN	I-NP	I-DNA
.	.	.	O	O

Three	Three	CD	B-NP	O
molecular	molecular	JJ	I-NP	O
clones	clone	NNS	I-NP	O
of	of	IN	B-PP	O
HIV-1	HIV-1	NN	B-NP	O
,	,	,	O	O
derived	derive	VBN	B-VP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
single	single	JJ	I-NP	O
isolate	isolate	NN	I-NP	O
(	(	(	O	O
AL1	AL1	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
exhibited	exhibit	VBD	B-VP	O
distinct	distinct	JJ	B-NP	O
replicative	replicative	JJ	I-NP	O
and	and	CC	I-NP	O
cytopathic	cytopathic	JJ	I-NP	O
properties	property	NNS	I-NP	O
during	during	IN	B-PP	O
propagation	propagation	NN	B-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
human	human	JJ	I-NP	B-cell_line
T	T	NN	I-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
.	.	.	O	O

The	The	DT	B-NP	O
phenotypic	phenotypic	JJ	I-NP	O
differences	difference	NNS	I-NP	O
observed	observe	VBN	B-VP	O
were	be	VBD	B-VP	O
attributable	attributable	JJ	B-ADJP	O
,	,	,	O	O
in	in	IN	B-PP	O
large	large	JJ	B-NP	O
part	part	NN	I-NP	O
,	,	,	O	O
to	to	TO	B-PP	O
changes	change	NNS	B-NP	O
affecting	affect	VBG	B-VP	O
the	the	DT	B-NP	O
viral	viral	JJ	I-NP	B-DNA
LTR	LTR	NN	I-NP	I-DNA
.	.	.	O	O

Nucleotide	Nucleotide	NN	B-NP	B-DNA
sequence	sequence	NN	I-NP	I-DNA
and	and	CC	O	O
PCR	PCR	NN	B-NP	O
analyses	analysis	NNS	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
novel	novel	JJ	B-NP	O
duplications	duplication	NNS	I-NP	O
or	or	CC	O	O
deletions	deletion	NNS	B-NP	O
involving	involve	VBG	B-VP	O
the	the	DT	B-NP	O
NF-kappa	NF-kappa	NN	I-NP	B-DNA
B	B	NN	I-NP	I-DNA
motif	motif	NN	I-NP	I-DNA
.	.	.	O	O

These	These	DT	B-NP	O
changes	change	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
enhancer	enhancer	NN	I-NP	B-DNA
element	element	NN	I-NP	I-DNA
were	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
original	original	JJ	I-NP	O
AL1	AL1	NN	I-NP	O
virus	virus	NN	I-NP	O
stock	stock	NN	I-NP	O
.	.	.	O	O

Subcloning	Subcloning	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
variant	variant	JJ	I-NP	B-DNA
NF-kappa	NF-kappa	NN	I-NP	I-DNA
B	B	NN	I-NP	I-DNA
segments	segment	NNS	I-NP	I-DNA
into	into	IN	B-PP	O
LTR-driven	LTR-driven	JJ	B-NP	B-DNA
CAT	CAT	NN	I-NP	I-DNA
expression	expression	NN	I-NP	I-DNA
vectors	vector	NNS	I-NP	I-DNA
confirmed	confirm	VBD	B-VP	O
a	a	DT	B-NP	O
correlation	correlation	NN	I-NP	O
between	between	IN	B-PP	O
promoter	promoter	NN	B-NP	O
activity	activity	NN	I-NP	O
and	and	CC	O	O
replicative/cytopathic	replicative/cytopathic	JJ	B-NP	O
capacity	capacity	NN	I-NP	O
.	.	.	O	O

=========a1850412.txt=========	=========a1850412.txt=========	LS	B-LST	O

Vitamin	Vitamin	NN	B-NP	B-protein
D	D	NN	I-NP	I-protein
receptor	receptor	NN	I-NP	I-protein
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
.	.	.	O	O

Signal	Signal	NN	B-NP	O
requirements	requirement	NNS	I-NP	O
and	and	CC	O	O
characterization	characterization	NN	B-NP	O
by	by	IN	B-PP	O
western	western	JJ	B-NP	O
blots	blot	NNS	I-NP	O
and	and	CC	O	O
DNA	DNA	NN	B-NP	O
sequencing	sequencing	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
signals	signal	NNS	I-NP	O
controlling	control	VBG	B-VP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
receptor	receptor	NN	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
for	for	IN	B-PP	O
1	1	CD	B-NP	O
alpha	alpha	SYM	B-NP	O
,	,	,	O	O
25-dihydroxyvitamin	25-dihydroxyvitamin	NN	B-NP	O
D3	D3	NN	I-NP	O
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	B-cell_type
human	human	JJ	I-NP	I-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
and	and	CC	O	O
the	the	DT	B-NP	O
relationship	relationship	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
protein	protein	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
classical	classical	JJ	I-NP	B-protein
vitamin	vitamin	NN	I-NP	I-protein
D	D	NN	I-NP	I-protein
receptor	receptor	NN	I-NP	I-protein
were	be	VBD	B-VP	O
examined	examine	VBN	I-VP	O
.	.	.	O	O

Lymphocytes	Lymphocyte	NNS	B-NP	B-cell_type
activated	activate	VBN	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
OKT3	OKT3	NN	I-NP	B-protein
antibody	antibody	NN	I-NP	I-protein
to	to	TO	B-PP	O
the	the	DT	B-NP	O
T-cell	T-cell	NN	I-NP	B-protein
antigen	antigen	NN	I-NP	I-protein
receptor	receptor	NN	I-NP	I-protein
expressed	express	VBD	B-VP	O
fewer	few	JJR	B-NP	O
binding	bind	VBG	I-NP	O
sites	site	NNS	I-NP	O
as	as	IN	B-SBAR	O
compared	compare	VBN	B-VP	O
to	to	TO	B-PP	O
lymphocytes	lymphocyte	NNS	B-NP	B-cell_type
that	that	WDT	B-NP	O
were	be	VBD	B-VP	O
activated	activate	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
polyclonal	polyclonal	JJ	I-NP	O
activator	activator	NN	I-NP	O
phytohemagglutinin	phytohemagglutinin	NN	I-NP	B-protein
(	(	(	O	O
PHA	PHA	NN	B-NP	B-protein
)	)	)	O	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
combination	combination	NN	B-NP	O
of	of	IN	B-PP	O
OKT3	OKT3	NN	B-NP	B-protein
and	and	CC	O	O
phorbol	phorbol	NN	B-NP	O
myristate	myristate	NN	I-NP	O
acetate	acetate	NN	I-NP	O
produced	produce	VBD	B-VP	O
a	a	DT	B-NP	O
concentration	concentration	NN	I-NP	O
of	of	IN	B-PP	O
binding	bind	VBG	B-NP	O
sites	site	NNS	I-NP	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
PHA-activated	PHA-activated	JJ	I-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
.	.	.	O	O

The	The	DT	B-NP	O
receptor	receptor	NN	I-NP	O
from	from	IN	B-PP	O
OKT3	OKT3	NN	B-NP	B-protein
and	and	CC	I-NP	O
OKT3	OKT3	NN	I-NP	B-protein
+	+	SYM	O	O
phorbol	phorbol	NN	B-NP	O
myristate	myristate	NN	I-NP	O
acetate-activated	acetate-activated	JJ	B-VP	O
lymphocytes	lymphocyte	NNS	B-NP	O
exhibited	exhibit	VBD	B-VP	O
decreased	decrease	VBN	B-NP	O
binding	binding	NN	I-NP	O
to	to	TO	B-PP	O
DNA-cellulose	DNA-cellulose	NN	B-NP	O
compared	compare	VBN	B-VP	O
to	to	TO	B-PP	O
PHA-activated	PHA-activated	JJ	B-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
.	.	.	O	O

In	In	IN	B-PP	O
lymphocytes	lymphocyte	NNS	B-NP	B-cell_type
activated	activate	VBN	B-VP	O
either	either	CC	B-PP	O
by	by	IN	I-PP	O
PHA	PHA	NN	B-NP	B-protein
or	or	CC	O	O
OKT3	OKT3	NN	B-NP	B-protein
(	(	(	B-PP	O
but	but	CC	I-PP	O
not	not	RB	B-PP	O
in	in	IN	I-PP	O
resting	rest	VBG	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
)	)	)	O	O
,	,	,	O	O
a	a	DT	B-NP	O
50-kDa	50-kDa	JJ	I-NP	B-protein
species	specie	NNS	I-NP	I-protein
cross-reacting	cross-reacte	VBG	B-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
monoclonal	monoclonal	JJ	I-NP	B-protein
antibody	antibody	NN	I-NP	I-protein
against	against	IN	B-PP	O
the	the	DT	B-NP	O
intestinal	intestinal	JJ	I-NP	B-protein
vitamin	vitamin	NN	I-NP	I-protein
D	D	NN	I-NP	I-protein
receptor	receptor	NN	I-NP	I-protein
was	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
.	.	.	O	O

Finally	Finally	RB	B-ADVP	O
,	,	,	O	O
RNA	RNA	NN	B-NP	O
from	from	IN	B-PP	O
activated	activate	VBN	B-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
was	be	VBD	B-VP	O
amplified	amplify	VBN	I-VP	O
by	by	IN	B-PP	O
polymerase	polymerase	NN	B-NP	O
chain	chain	NN	I-NP	O
reaction	reaction	NN	I-NP	O
using	use	VBG	B-VP	O
oligonucleotide	oligonucleotide	NN	B-NP	O
primers	primer	NNS	I-NP	O
flanking	flank	VBG	B-VP	O
the	the	DT	B-NP	O
196	196	CD	I-NP	B-DNA
base	base	NN	I-NP	I-DNA
pair	pair	NN	I-NP	I-DNA
long	long	JJ	I-NP	I-DNA
region	region	NN	I-NP	I-DNA
encoding	encode	VBG	B-VP	O
the	the	DT	B-NP	O
DNA-binding	DNA-binding	JJ	I-NP	B-protein
domain	domain	NN	I-NP	I-protein
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	B-protein
intestinal	intestinal	JJ	I-NP	I-protein
receptor	receptor	NN	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
amplified	amplify	VBN	I-NP	O
product	product	NN	I-NP	O
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
identical	identical	JJ	I-NP	B-DNA
nucleotide	nucleotide	NN	I-NP	I-DNA
sequence	sequence	NN	I-NP	I-DNA
to	to	TO	B-PP	O
the	the	DT	B-NP	O
DNA-binding	DNA-binding	JJ	I-NP	B-protein
domain	domain	NN	I-NP	I-protein
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	B-protein
intestinal	intestinal	JJ	I-NP	I-protein
receptor	receptor	NN	I-NP	I-protein
.	.	.	O	O

These	These	DT	B-NP	O
findings	finding	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	B-protein
,	,	,	I-NP	I-protein
25-	25-	CD	I-NP	I-protein
(	(	(	O	I-protein
OH	OH	NN	B-NP	I-protein
)	)	)	O	I-protein
2D3	2D3	NN	B-NP	I-protein
receptor	receptor	NN	I-NP	I-protein
in	in	IN	B-PP	O
lymphocytes	lymphocyte	NNS	B-NP	B-cell_type
is	be	VBZ	B-VP	O
triggered	trigger	VBN	I-VP	O
by	by	IN	B-PP	O
distinct	distinct	JJ	B-NP	O
and	and	CC	I-NP	O
contingent	contingent	JJ	I-NP	O
signals	signal	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
protein	protein	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
mRNA	mRNA	NN	I-NP	B-RNA
encoding	encode	VBG	B-VP	O
it	it	PRP	B-NP	O
are	be	VBP	B-VP	O
identical	identical	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
classical	classical	JJ	I-NP	B-protein
vitamin	vitamin	NN	I-NP	I-protein
D	D	NN	I-NP	I-protein
receptor	receptor	NN	I-NP	I-protein
.	.	.	O	O

=========a1705836.txt=========	=========a1705836.txt=========	LS	B-LST	O

1	1	CD	B-NP	B-RNA
,	,	,	O	I-RNA
25-Dihydroxyvitamin	25-Dihydroxyvitamin	NN	B-NP	I-RNA
D3	D3	NN	I-NP	I-RNA
receptor	receptor	NN	I-NP	I-RNA
RNA	RNA	NN	I-NP	I-RNA
:	:	:	O	O
expression	expression	NN	B-NP	O
in	in	IN	B-PP	O
hematopoietic	hematopoietic	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

1	1	CD	B-NP	O
,	,	,	O	O
25-Dihydroxyvitamin	25-Dihydroxyvitamin	NN	B-NP	O
D3	D3	NN	I-NP	O
[	[	(	B-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
25	25	CD	I-NP	O
(	(	(	O	O
OH	OH	NN	B-NP	O
)	)	)	O	O
2D3	2D3	NN	B-NP	O
]	]	)	O	O
induces	induce	VBZ	B-VP	O
differentiation	differentiation	NN	B-NP	O
and	and	CC	O	O
inhibits	inhibit	VBZ	B-VP	O
proliferation	proliferation	NN	B-NP	O
of	of	IN	B-PP	O
myeloid	myeloid	JJ	B-NP	B-cell_type
leukemic	leukemic	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
from	from	IN	B-PP	O
various	various	JJ	B-NP	O
lines	line	NNS	B-NP	O
and	and	CC	O	O
patients	patient	NNS	B-NP	O
;	;	:	O	O

these	these	DT	B-NP	O
effects	effect	NNS	I-NP	O
are	be	VBP	B-VP	O
probably	probably	RB	I-VP	O
mediated	mediate	VBN	I-VP	O
through	through	IN	B-PP	O
the	the	DT	B-NP	O
1	1	CD	I-NP	B-protein
,	,	,	I-NP	I-protein
25	25	CD	I-NP	I-protein
(	(	(	O	I-protein
OH	OH	NN	B-NP	I-protein
)	)	)	O	I-protein
2D3	2D3	NN	B-NP	I-protein
receptor	receptor	NN	I-NP	I-protein
.	.	.	O	O

Little	Little	JJ	B-NP	O
is	be	VBZ	B-VP	O
known	know	VBN	I-VP	O
of	of	IN	B-PP	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	B-RNA
,	,	,	I-NP	I-RNA
25	25	CD	I-NP	I-RNA
(	(	(	O	I-RNA
OH	OH	NN	B-NP	I-RNA
)	)	)	O	I-RNA
2D3	2D3	NN	B-NP	I-RNA
receptor	receptor	NN	I-NP	I-RNA
RNA	RNA	NN	I-NP	I-RNA
in	in	IN	B-PP	O
hematopoietic	hematopoietic	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

We	We	PRP	B-NP	O
examined	examine	VBD	B-VP	O
the	the	DT	B-NP	O
expression	expression	NN	B-NP	O
and	and	CC	O	O
modulation	modulation	NN	B-NP	O
of	of	IN	B-PP	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	B-RNA
,	,	,	I-NP	I-RNA
25	25	CD	I-NP	I-RNA
(	(	(	O	I-RNA
OH	OH	NN	B-NP	I-RNA
)	)	)	O	I-RNA
2D3	2D3	NN	B-NP	I-RNA
receptor	receptor	NN	I-NP	I-RNA
RNA	RNA	NN	I-NP	I-RNA
in	in	IN	B-PP	O
various	various	JJ	B-NP	O
proliferating	proliferate	VBG	I-NP	O
and	and	CC	I-NP	O
nonproliferating	nonproliferating	JJ	I-NP	B-cell_type
hematopoietic	hematopoietic	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Constitutive	Constitutive	JJ	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	B-RNA
,	,	,	I-NP	I-RNA
25	25	CD	I-NP	I-RNA
(	(	(	O	I-RNA
OH	OH	NN	B-NP	I-RNA
)	)	)	O	I-RNA
2D3	2D3	NN	B-NP	I-RNA
receptor	receptor	NN	I-NP	I-RNA
RNA	RNA	NN	I-NP	I-RNA
was	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
various	various	JJ	B-NP	O
kinds	kind	NNS	I-NP	O
of	of	IN	B-PP	O
hematopoietic	hematopoietic	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
including	include	VBG	B-PP	O
macrophages	macrophage	NNS	B-NP	B-cell_type
and	and	CC	O	O
activated	activate	VBN	B-NP	O
T	T	NN	I-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
in	in	IN	B-PP	O
cell	cell	NN	B-NP	O
lines	line	NNS	I-NP	O
KG-1	KG-1	NN	B-NP	B-cell_line
(	(	(	O	O
myeloblasts	myeloblast	NNS	B-NP	B-cell_type
)	)	)	O	O
,	,	,	O	O
HL-60	HL-60	NN	B-NP	B-cell_line
(	(	(	O	O
promyelocytes	promyelocyte	NNS	B-NP	B-cell_line
)	)	)	O	O
,	,	,	O	O
ML-3	ML-3	NN	B-NP	B-cell_line
(	(	(	O	O
myelomonoblasts	myelomonoblast	NNS	B-NP	B-cell_line
)	)	)	O	O
,	,	,	O	O
U937	U937	NN	B-NP	B-cell_line
,	,	,	O	O
THP-1	THP-1	NN	B-NP	B-cell_line
(	(	(	O	O
monoblasts	monoblast	NNS	B-NP	B-cell_line
)	)	)	O	O
,	,	,	O	O
K562	K562	NN	B-NP	B-cell_line
(	(	(	O	O
erythroblasts	erythroblast	NNS	B-NP	B-cell_type
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
S-LB1	S-LB1	NN	B-NP	B-cell_line
(	(	(	O	O
HTLV-1-transfected	HTLV-1-transfected	JJ	B-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
)	)	)	O	O
.	.	.	O	O

Receptor	Receptor	NN	B-NP	B-RNA
transcripts	transcript	NNS	I-NP	I-RNA
were	be	VBD	B-VP	O
4.6	4.6	CD	B-NP	O
kilobases	kilobas	NNS	B-NP	O
(	(	(	O	O
kb	kb	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
no	no	DT	B-NP	O
variant	variant	JJ	I-NP	O
sizes	size	NNS	I-NP	O
were	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
.	.	.	O	O

All	All	DT	B-NP	O
cell	cell	NN	I-NP	B-cell_line
lines	line	NNS	I-NP	I-cell_line
examined	examine	VBN	B-VP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
group	group	NN	I-NP	O
also	also	RB	B-ADVP	O
expressed	express	VBD	B-VP	O
1	1	CD	B-NP	B-protein
,	,	,	I-NP	I-protein
25	25	CD	I-NP	I-protein
(	(	(	O	I-protein
OH	OH	NN	B-NP	I-protein
)	)	)	O	I-protein
2D3	2D3	NN	B-NP	I-protein
receptors	receptor	NNS	I-NP	I-protein
.	.	.	O	O

Most	Most	JJS	B-NP	O
B	B	NN	I-NP	B-cell_line
lymphocyte	lymphocyte	NN	I-NP	I-cell_line
lines	line	NNS	I-NP	I-cell_line
expressed	express	VBD	B-VP	O
negligible	negligible	JJ	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	B-RNA
,	,	,	I-NP	I-RNA
25	25	CD	I-NP	I-RNA
(	(	(	O	I-RNA
OH	OH	NN	B-NP	I-RNA
)	)	)	O	I-RNA
2D3	2D3	NN	B-NP	I-RNA
receptor	receptor	NN	I-NP	I-RNA
RNA	RNA	NN	I-NP	I-RNA
and	and	CC	I-NP	O
protein	protein	NN	I-NP	O
;	;	:	O	O
however	however	RB	O	O
;	;	:	O	O
analysis	analysis	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
lymphoid/myeloid	lymphoid/myeloid	JJ	I-NP	B-cell_line
somatic	somatic	JJ	I-NP	I-cell_line
hybrid	hybrid	NN	I-NP	I-cell_line
suggested	suggest	VBD	B-VP	O
that	that	IN	B-SBAR	O
suppression	suppression	NN	B-NP	O
of	of	IN	B-PP	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	B-RNA
,	,	,	I-NP	I-RNA
25	25	CD	I-NP	I-RNA
(	(	(	O	I-RNA
OH	OH	NN	B-NP	I-RNA
)	)	)	O	I-RNA
2D3	2D3	NN	B-NP	I-RNA
receptor	receptor	NN	I-NP	I-RNA
RNA	RNA	NN	I-NP	I-RNA
in	in	IN	B-PP	O
B	B	NN	B-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
may	may	MD	B-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
dominant	dominant	JJ	I-NP	O
characteristic	characteristic	NN	I-NP	O
.	.	.	O	O

HL-60	HL-60	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
were	be	VBD	B-VP	O
cultured	culture	VBN	I-VP	O
with	with	IN	B-PP	O
10	10	CD	B-NP	O
(	(	(	O	O
-7	-7	CD	B-NP	O
)	)	)	O	O
mol/L	mol/L	NN	B-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
25	25	CD	I-NP	O
(	(	(	O	O
OH	OH	NN	B-NP	O
)	)	)	O	O
2D3	2D3	NN	B-NP	O
for	for	IN	B-PP	O
24	24	CD	B-NP	O
to	to	TO	I-NP	O
72	72	CD	I-NP	O
hours	hour	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
levels	level	NNS	B-NP	O
of	of	IN	B-PP	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	B-protein
,	,	,	I-NP	I-protein
25	25	CD	I-NP	I-protein
(	(	(	O	I-protein
OH	OH	NN	B-NP	I-protein
)	)	)	O	I-protein
2D3	2D3	NN	B-NP	I-protein
receptor	receptor	NN	I-NP	I-protein
and	and	CC	O	O
its	its	PRP$	B-NP	O
RNA	RNA	NN	I-NP	O
were	be	VBD	B-VP	O
examined	examine	VBN	I-VP	O
.	.	.	O	O

Levels	Level	NNS	B-NP	O
of	of	IN	B-PP	O
RNA	RNA	NN	B-NP	O
coding	coding	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
receptor	receptor	NN	I-NP	O
were	be	VBD	B-VP	O
not	not	RB	I-VP	O
modulated	modulate	VBN	I-VP	O
by	by	IN	B-PP	O
exposure	exposure	NN	B-NP	O
to	to	TO	B-PP	O
high	high	JJ	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
ligand	ligand	NN	B-NP	O
.	.	.	O	O

Levels	Level	NNS	B-NP	O
of	of	IN	B-PP	O
occupied	occupy	VBN	B-NP	O
1	1	CD	I-NP	B-protein
,	,	,	I-NP	I-protein
25	25	CD	I-NP	I-protein
(	(	(	O	I-protein
OH	OH	NN	B-NP	I-protein
)	)	)	O	I-protein
2D3	2D3	NN	B-NP	I-protein
receptor	receptor	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
increased	increase	VBD	B-VP	O
in	in	IN	B-PP	O
these	these	DT	B-NP	O
HL-60	HL-60	NN	I-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
;	;	:	O	O
but	but	CC	O	O
the	the	DT	B-NP	O
total	total	JJ	I-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	B-protein
,	,	,	I-NP	I-protein
25	25	CD	I-NP	I-protein
(	(	(	O	I-protein
OH	OH	NN	B-NP	I-protein
)	)	)	O	I-protein
2D3	2D3	NN	B-NP	I-protein
receptors	receptor	NNS	I-NP	I-protein
decreased	decrease	VBD	B-VP	O
about	about	RB	B-NP	O
50	50	CD	I-NP	O
%	%	NN	I-NP	O
at	at	IN	B-PP	O
24	24	CD	B-NP	O
hours	hour	NNS	I-NP	O
and	and	CC	O	O
returned	return	VBD	B-VP	O
toward	toward	IN	B-PP	O
normal	normal	JJ	B-NP	O
at	at	IN	B-PP	O
72	72	CD	B-NP	O
hours	hour	NNS	I-NP	O
.	.	.	O	O

Steady-state	Steady-state	JJ	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	B-RNA
,	,	,	I-NP	I-RNA
25	25	CD	I-NP	I-RNA
(	(	(	O	I-RNA
OH	OH	NN	B-NP	I-RNA
)	)	)	O	I-RNA
2D3	2D3	NN	B-NP	I-RNA
receptor	receptor	NN	I-NP	I-RNA
RNA	RNA	NN	I-NP	I-RNA
were	be	VBD	B-VP	O
not	not	RB	I-VP	O
affected	affect	VBN	I-VP	O
by	by	IN	B-PP	O
terminal	terminal	JJ	B-NP	O
differentiation	differentiation	NN	I-NP	O
of	of	IN	B-PP	O
HL-60	HL-60	NN	B-NP	B-cell_line
toward	toward	IN	B-PP	O
either	either	CC	O	O
granulocytes	granulocyte	NNS	B-NP	B-cell_type
or	or	CC	O	O
macrophages	macrophage	NNS	B-NP	B-cell_type
.	.	.	O	O

Nondividing	Nondivide	VBG	B-VP	O
macrophages	macrophage	NNS	B-NP	B-cell_type
from	from	IN	B-PP	O
normal	normal	JJ	B-NP	O
individuals	individual	NNS	I-NP	O
also	also	RB	B-ADVP	O
expressed	express	VBD	B-VP	O
1	1	CD	B-NP	B-RNA
,	,	,	I-NP	I-RNA
25	25	CD	I-NP	I-RNA
(	(	(	O	I-RNA
OH	OH	NN	B-NP	I-RNA
)	)	)	O	I-RNA
2D3	2D3	NN	B-NP	I-RNA
receptor	receptor	NN	I-NP	I-RNA
RNA	RNA	NN	I-NP	I-RNA
.	.	.	O	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
,	,	,	O	O
nondividing	nondividing	JJ	B-NP	B-cell_type
peripheral	peripheral	JJ	I-NP	I-cell_type
blood	blood	NN	I-NP	I-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
from	from	IN	B-PP	O
normal	normal	JJ	B-NP	O
individuals	individual	NNS	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
express	express	VB	I-VP	O
1	1	CD	B-NP	B-RNA
,	,	,	I-NP	I-RNA
25	25	CD	I-NP	I-RNA
(	(	(	O	I-RNA
OH	OH	NN	B-NP	I-RNA
)	)	)	O	I-RNA
2D3	2D3	NN	B-NP	I-RNA
receptor	receptor	NN	I-NP	I-RNA
RNA	RNA	NN	I-NP	I-RNA
;	;	:	O	O

with	with	IN	B-PP	O
stimulation	stimulation	NN	B-NP	O
of	of	IN	B-PP	O
proliferation	proliferation	NN	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
cells	cell	NNS	I-NP	O
,	,	,	O	O
accumulation	accumulation	NN	B-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	B-RNA
,	,	,	I-NP	I-RNA
25	25	CD	I-NP	I-RNA
(	(	(	O	I-RNA
OH	OH	NN	B-NP	I-RNA
)	)	)	O	I-RNA
2D3	2D3	NN	B-NP	I-RNA
receptor	receptor	NN	I-NP	I-RNA
RNA	RNA	NN	I-NP	I-RNA
increased	increase	VBD	B-VP	O
markedly	markedly	RB	B-ADVP	O
.	.	.	O	O

Half-life	Half-life	NN	B-NP	O
(	(	(	O	O
t1/2	t1/2	NN	B-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
1	1	CD	B-NP	B-RNA
,	,	,	I-NP	I-RNA
25	25	CD	I-NP	I-RNA
(	(	(	O	I-RNA
OH	OH	NN	B-NP	I-RNA
)	)	)	O	I-RNA
2D3	2D3	NN	B-NP	I-RNA
receptor	receptor	NN	I-NP	I-RNA
RNA	RNA	NN	I-NP	I-RNA
in	in	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
was	be	VBD	B-VP	O
short	short	JJ	B-ADJP	O
(	(	(	O	O
1	1	CD	B-NP	O
hour	hour	NN	I-NP	O
)	)	)	O	O
as	as	IN	B-SBAR	O
determined	determine	VBN	B-VP	O
by	by	IN	B-PP	O
measuring	measure	VBG	B-VP	O
decay	decay	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
message	message	NN	I-NP	O
after	after	IN	B-PP	O
addition	addition	NN	B-NP	O
of	of	IN	B-PP	O
actinomycin	actinomycin	NN	B-NP	O
D	D	NN	I-NP	O
.	.	.	O	O

Consistent	Consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
this	this	DT	B-NP	O
short	short	JJ	I-NP	O
t1/2	t1/2	NN	I-NP	O
,	,	,	O	O
accumulation	accumulation	NN	B-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	B-RNA
,	,	,	I-NP	I-RNA
25	25	CD	I-NP	I-RNA
(	(	(	O	I-RNA
OH	OH	NN	B-NP	I-RNA
)	)	)	O	I-RNA
2D3	2D3	NN	B-NP	I-RNA
receptor	receptor	NN	I-NP	I-RNA
RNA	RNA	NN	I-NP	I-RNA
increased	increase	VBD	B-VP	O
in	in	IN	B-PP	O
cells	cell	NNS	B-NP	O
as	as	IN	B-SBAR	O
their	their	PRP$	B-NP	O
protein	protein	NN	I-NP	O
synthesis	synthesis	NN	I-NP	O
was	be	VBD	B-VP	O
inhibited	inhibit	VBN	I-VP	O
.	.	.	O	O

Further	Further	JJ	B-NP	O
studies	study	NNS	I-NP	O
are	be	VBP	B-VP	O
required	require	VBN	I-VP	O
to	to	TO	B-VP	O
understand	understand	VB	I-VP	O
the	the	DT	B-NP	O
physiologic	physiologic	JJ	I-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	B-protein
,	,	,	I-NP	I-protein
25	25	CD	I-NP	I-protein
(	(	(	O	I-protein
OH	OH	NN	B-NP	I-protein
)	)	)	O	I-protein
2D3	2D3	NN	B-NP	I-protein
receptors	receptor	NNS	I-NP	I-protein
in	in	IN	B-PP	O
myeloid	myeloid	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	O	O
proliferating	proliferate	VBG	B-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
.	.	.	O	O

=========a1850841.txt=========	=========a1850841.txt=========	LS	B-LST	O

Role	Role	NN	B-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
Epstein-Barr	Epstein-Barr	JJ	I-NP	B-protein
virus	virus	NN	I-NP	I-protein
nuclear	nuclear	JJ	I-NP	I-protein
antigen	antigen	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
in	in	IN	B-PP	O
viral	viral	JJ	B-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
switching	switching	NN	I-NP	O
during	during	IN	B-PP	O
initial	initial	JJ	B-NP	O
stages	stage	NNS	I-NP	O
of	of	IN	B-PP	O
infection	infection	NN	B-NP	O
.	.	.	O	O

During	During	IN	B-PP	O
latent	latent	JJ	O	O
Epstein-Barr	Epstein-Barr	JJ	B-NP	O
virus	virus	NN	I-NP	O
(	(	(	O	O
EBV	EBV	NN	B-NP	O
)	)	)	O	O
infection	infection	NN	B-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
B	B	NN	I-NP	I-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
,	,	,	O	O
six	six	CD	B-NP	O
viral	viral	JJ	I-NP	B-protein
nuclear	nuclear	JJ	I-NP	I-protein
antigen	antigen	NN	I-NP	I-protein
(	(	(	O	O
EBNAs	EBNA	NNS	B-NP	B-protein
)	)	)	O	O
are	be	VBP	B-VP	O
expressed	express	VBN	I-VP	O
from	from	IN	B-PP	O
long	long	JJ	B-NP	B-RNA
primary	primary	JJ	I-NP	I-RNA
transcripts	transcript	NNS	I-NP	I-RNA
by	by	IN	B-PP	O
means	mean	NNS	I-PP	O
of	of	IN	I-PP	O
alternative	alternative	JJ	B-NP	O
splicing	splicing	NN	I-NP	O
and	and	CC	O	O
alternative	alternative	JJ	B-NP	B-DNA
polyadenylylation	polyadenylylation	NN	I-NP	I-DNA
sites	site	NNS	I-NP	I-DNA
.	.	.	O	O

These	These	DT	B-NP	O
transcripts	transcript	NNS	I-NP	O
initiate	initiate	VBP	B-VP	O
from	from	IN	B-PP	O
one	one	CD	B-NP	O
of	of	IN	B-PP	O
two	two	CD	B-NP	O
promoters	promoter	NNS	I-NP	B-DNA
,	,	,	O	O
Cp	Cp	NN	B-NP	B-DNA
or	or	CC	O	O
Wp	Wp	NN	B-NP	B-DNA
,	,	,	O	O
that	that	WDT	B-NP	O
function	function	VBP	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
mutually	mutually	RB	I-NP	O
exclusive	exclusive	JJ	I-NP	O
fashion	fashion	NN	I-NP	O
.	.	.	O	O

Wp	Wp	NN	B-NP	B-DNA
is	be	VBZ	B-VP	O
exclusively	exclusively	RB	I-VP	O
utilized	utilize	VBN	I-VP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
initial	initial	JJ	I-NP	O
stages	stage	NNS	I-NP	O
of	of	IN	B-PP	O
infection	infection	NN	B-NP	O
of	of	IN	B-PP	O
primary	primary	JJ	B-NP	B-cell_type
B	B	NN	I-NP	I-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
,	,	,	O	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
switch	switch	NN	I-NP	O
to	to	TO	B-PP	O
Cp	Cp	NN	B-NP	B-DNA
usage	usage	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
studies	study	NNS	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
extended	extend	VBN	I-VP	O
to	to	TO	I-VP	O
show	show	VB	I-VP	O
that	that	IN	B-SBAR	O
(	(	(	B-LST	O
i	i	LS	I-LST	O
)	)	)	O	O
a	a	DT	B-NP	O
mutant	mutant	JJ	I-NP	O
EBV	EBV	NN	I-NP	O
strain	strain	NN	I-NP	O
lacking	lack	VBG	B-VP	O
the	the	DT	B-NP	O
gene	gene	NN	I-NP	O
encoding	encode	VBG	B-VP	O
EBNA	EBNA	NN	B-NP	B-protein
2	2	CD	I-NP	I-protein
fails	fail	VBZ	B-VP	O
to	to	TO	I-VP	O
switch	switch	VB	I-VP	O
from	from	IN	B-PP	O
Wp	Wp	NN	B-NP	B-DNA
to	to	TO	B-PP	O
Cp	Cp	NN	B-NP	B-DNA
usage	usage	NN	I-NP	O
in	in	IN	B-PP	O
primary	primary	JJ	B-NP	B-cell_type
B	B	NN	I-NP	I-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
,	,	,	O	O
although	although	IN	B-SBAR	O
the	the	DT	B-NP	O
virus	virus	NN	I-NP	O
contains	contain	VBZ	B-VP	O
a	a	DT	B-NP	O
functional	functional	JJ	I-NP	O
Cp	Cp	NN	I-NP	B-DNA
;	;	:	O	O
(	(	(	B-LST	O
ii	ii	LS	I-LST	O
)	)	)	O	O
a	a	DT	B-NP	O
region	region	NN	I-NP	O
from	from	IN	B-PP	O
-429	-429	CD	B-NP	B-DNA
to	to	TO	I-NP	I-DNA
-245	-245	CD	I-NP	I-DNA
base	base	NN	I-NP	I-DNA
pairs	pair	NNS	I-NP	I-DNA
upstream	upstream	JJ	B-ADJP	O
of	of	IN	B-PP	O
Cp	Cp	NN	B-NP	B-DNA
is	be	VBZ	B-VP	O
essential	essential	JJ	B-ADJP	O
for	for	IN	B-PP	O
Cp	Cp	NN	B-NP	B-DNA
activity	activity	NN	I-NP	O
in	in	IN	B-PP	O
B	B	NN	B-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
,	,	,	O	O
but	but	CC	O	O
only	only	RB	B-PP	O
in	in	IN	I-PP	O
the	the	DT	B-NP	O
context	context	NN	I-NP	O
of	of	IN	B-PP	O
upstream	upstream	JJ	B-NP	B-DNA
and	and	CC	I-NP	I-DNA
downstream	downstream	JJ	I-NP	I-DNA
sequences	sequence	NNS	I-NP	I-DNA
;	;	:	O	O
(	(	(	B-LST	O
iii	iii	LS	I-LST	O
)	)	)	O	O
this	this	DT	B-NP	O
region	region	NN	I-NP	O
contains	contain	VBZ	B-VP	O
an	an	DT	B-NP	O
EBNA	EBNA	NN	I-NP	B-DNA
2-dependent	2-dependent	JJ	I-NP	I-DNA
enhancer	enhancer	NN	I-NP	I-DNA
;	;	:	O	O
and	and	CC	O	O
(	(	(	B-LST	O
iv	iv	LS	I-LST	O
)	)	)	O	O
DNase	DNase	NN	B-NP	B-protein
I	I	CD	I-NP	I-protein
protection	protection	NN	I-NP	O
employing	employ	VBG	B-VP	O
nuclear	nuclear	JJ	B-NP	O
extracts	extract	NNS	I-NP	O
from	from	IN	B-PP	O
B	B	NN	B-NP	B-cell_type
and	and	CC	O	I-cell_type
T	T	NN	B-NP	I-cell_type
lymphocytes	lymphocyte	NNS	B-NP	I-cell_type
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
B-cell-specific	B-cell-specific	JJ	I-NP	B-DNA
footprint	footprint	NN	I-NP	I-DNA
in	in	IN	B-PP	O
the	the	DT	B-NP	O
region	region	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
EBNA	EBNA	NN	I-NP	B-DNA
2-dependent	2-dependent	JJ	I-NP	I-DNA
enhancer	enhancer	NN	I-NP	I-DNA
.	.	.	O	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
support	support	VBP	B-VP	O
a	a	DT	B-NP	O
model	model	NN	I-NP	O
for	for	IN	B-PP	O
viral	viral	JJ	B-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
switching	switching	NN	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
initial	initial	JJ	I-NP	O
stages	stage	NNS	I-NP	O
of	of	IN	B-PP	O
infection	infection	NN	B-NP	O
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
Wp	Wp	NN	B-NP	B-DNA
activity	activity	NN	I-NP	O
leads	lead	VBZ	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
EBNA	EBNA	NN	B-NP	B-protein
2	2	CD	I-NP	I-protein
,	,	,	O	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
Cp	Cp	NN	B-NP	B-DNA
through	through	IN	B-PP	O
the	the	DT	B-NP	O
EBNA	EBNA	NN	I-NP	B-DNA
2-dependent	2-dependent	JJ	I-NP	I-DNA
enhancer	enhancer	NN	I-NP	I-DNA
.	.	.	O	O

=========a2017258.txt=========	=========a2017258.txt=========	LS	B-LST	O

Processing	Processing	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
precursor	precursor	NN	I-NP	O
of	of	IN	B-PP	O
NF-kappa	NF-kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
by	by	IN	B-PP	O
the	the	DT	B-NP	O
HIV-1	HIV-1	NN	I-NP	B-protein
protease	protease	NN	I-NP	I-protein
during	during	IN	B-PP	O
acute	acute	JJ	B-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

Transcription	Transcription	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	B-DNA
immunodeficiency	immunodeficiency	NN	I-NP	I-DNA
virus	virus	NN	I-NP	I-DNA
type-1	type-1	NN	I-NP	I-DNA
(	(	(	O	I-DNA
HIV-1	HIV-1	NN	B-NP	I-DNA
)	)	)	O	I-DNA
genome	genome	NN	B-NP	I-DNA
is	be	VBZ	B-VP	O
regulated	regulate	VBN	I-VP	O
in	in	IN	B-PP	O
part	part	NN	B-NP	O
by	by	IN	B-PP	O
cellular	cellular	JJ	B-NP	B-protein
factors	factor	NNS	I-NP	I-protein
and	and	CC	O	O
is	be	VBZ	B-VP	O
stimulated	stimulate	VBN	I-VP	O
by	by	IN	B-PP	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
latently	latently	RB	B-NP	B-cell_type
infected	infected	JJ	I-NP	I-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

T-cell	T-cell	NN	B-NP	O
activation	activation	NN	I-NP	O
also	also	RB	B-ADVP	O
correlates	correlate	VBZ	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
factor	factor	NN	I-NP	O
NF-kappa	NF-kappa	NN	I-NP	B-protein
B	B	NN	I-NP	I-protein
which	which	WDT	B-NP	O
binds	bind	VBZ	B-VP	O
to	to	TO	B-PP	O
two	two	CD	B-NP	O
adjacent	adjacent	JJ	I-NP	O
sites	site	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
HIV-1	HIV-1	NN	I-NP	B-DNA
long	long	JJ	I-NP	I-DNA
terminal	terminal	JJ	I-NP	I-DNA
repeat	repeat	NN	I-NP	I-DNA
.	.	.	O	O

This	This	DT	B-NP	O
factor	factor	NN	I-NP	O
consists	consist	VBZ	B-VP	O
of	of	IN	B-PP	O
two	two	CD	B-NP	O
DNA-binding	DNA-binding	JJ	I-NP	B-protein
subunits	subunit	NNS	I-NP	I-protein
of	of	IN	B-PP	O
relative	relative	JJ	B-NP	O
molecular	molecular	JJ	I-NP	O
mass	mass	NN	I-NP	O
50	50	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
(	(	(	O	O
50K	50K	CD	B-NP	O
)	)	)	O	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
two	two	CD	B-NP	O
65K	65K	CD	I-NP	B-protein
subunits	subunit	NNS	I-NP	I-protein
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
located	locate	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
nucleus	nucleus	NN	I-NP	O
in	in	IN	B-PP	O
mature	mature	JJ	B-NP	B-cell_type
B	B	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
but	but	CC	O	O
is	be	VBZ	B-VP	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
other	other	JJ	B-NP	O
cell	cell	NN	I-NP	O
types	type	NNS	I-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
inactive	inactive	JJ	I-NP	B-protein
cytoplasmic	cytoplasmic	JJ	I-NP	I-protein
complex	complex	NN	I-NP	I-protein
.	.	.	O	O

External	External	JJ	B-NP	O
stimuli	stimulus	NNS	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
those	those	DT	B-NP	O
that	that	WDT	B-NP	O
activate	activate	VBP	B-VP	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
result	result	VBP	B-VP	O
in	in	IN	B-PP	O
nuclear	nuclear	JJ	B-NP	O
translocation	translocation	NN	I-NP	O
of	of	IN	B-PP	O
active	active	JJ	B-NP	O
NF-kappa	NF-kappa	NN	I-NP	B-protein
B	B	NN	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
cloning	cloning	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
complementary	complementary	JJ	I-NP	B-DNA
DNA	DNA	NN	I-NP	I-DNA
for	for	IN	B-PP	O
the	the	DT	B-NP	O
50K	50K	NN	I-NP	B-protein
subunit	subunit	NN	I-NP	I-protein
helped	help	VBD	B-VP	O
to	to	TO	I-VP	O
identify	identify	VB	I-VP	O
an	an	DT	B-NP	O
exclusively	exclusively	RB	I-NP	O
cytoplasmic	cytoplasmic	JJ	I-NP	B-protein
105K	105K	CD	I-NP	I-protein
precursor	precursor	NN	I-NP	I-protein
(	(	(	O	O
p105	p105	NN	B-NP	B-protein
)	)	)	O	O
(	(	(	O	O
V.B.	V.B.	NNP	B-NP	O
,	,	,	O	O
P.K.	P.K.	NNP	B-NP	O
and	and	CC	O	O
A.I.	A.I.	NNP	B-NP	O
,	,	,	O	O
manuscript	manuscript	NN	B-NP	O
submitted	submit	VBN	B-VP	O
)	)	)	O	O
.	.	.	O	O

The	The	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
active	active	JJ	B-NP	O
NF-kappa	NF-kappa	NN	I-NP	B-protein
B	B	NN	I-NP	I-protein
might	might	MD	B-VP	O
therefore	therefore	RB	I-VP	O
also	also	RB	I-VP	O
be	be	VB	I-VP	O
regulated	regulate	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
extent	extent	NN	I-NP	O
of	of	IN	B-PP	O
processing	processing	NN	B-NP	O
of	of	IN	B-PP	O
p105	p105	NN	B-NP	B-protein
.	.	.	O	O

Because	Because	IN	B-SBAR	O
HIV-1	HIV-1	NN	B-NP	O
requires	require	VBZ	B-VP	O
active	active	JJ	B-NP	O
NF-kappa	NF-kappa	NN	I-NP	B-protein
B	B	NN	I-NP	I-protein
for	for	IN	B-PP	O
efficient	efficient	JJ	B-NP	O
transcription	transcription	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
tested	test	VBD	B-VP	O
the	the	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
HIV-1	HIV-1	NN	B-NP	O
infection	infection	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
processing	processing	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	B-protein
105K	105K	CD	I-NP	I-protein
precursor	precursor	NN	I-NP	I-protein
.	.	.	O	O

We	We	PRP	B-NP	O
show	show	VBP	B-VP	O
here	here	RB	B-ADVP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
HIV-1	HIV-1	NN	I-NP	B-protein
protease	protease	NN	I-NP	I-protein
can	can	MD	B-VP	O
process	process	VB	I-VP	O
p105	p105	NN	B-NP	B-protein
and	and	CC	O	O
increases	increase	VBZ	B-VP	O
levels	level	NNS	B-NP	O
of	of	IN	B-PP	O
active	active	JJ	B-NP	O
nuclear	nuclear	JJ	I-NP	B-protein
NF-kappa	NF-kappa	NN	I-NP	I-protein
B	B	NN	I-NP	I-protein
complex	complex	NN	I-NP	I-protein
.	.	.	O	O

=========a1901389.txt=========	=========a1901389.txt=========	LS	B-LST	O

A	A	DT	B-NP	O
study	study	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
circadian	circadian	JJ	I-NP	O
rhythm	rhythm	NN	I-NP	O
of	of	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
.	.	.	O	O

Circadian	Circadian	JJ	B-NP	O
rhythm	rhythm	NN	I-NP	O
in	in	IN	B-PP	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
(	(	(	O	O
GR	GR	NN	B-NP	B-protein
)	)	)	O	O
was	be	VBD	B-VP	O
studied	study	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
rat	rat	NN	I-NP	O
liver	liver	NN	I-NP	O
and	and	CC	O	O
human	human	JJ	B-ADJP	B-cell_type
peripheral	peripheral	JJ	I-ADJP	I-cell_type
leukocytes	leukocyte	NNS	B-NP	I-cell_type
.	.	.	O	O

For	For	IN	B-PP	O
rats	rat	NNS	B-NP	O
exposed	expose	VBN	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
natural	natural	JJ	I-NP	O
environmental	environmental	JJ	I-NP	O
photic	photic	JJ	I-NP	O
cycle	cycle	NN	I-NP	O
or	or	CC	O	O
a	a	DT	B-NP	O
12L	12L	NN	I-NP	O
:	:	:	I-NP	O
12D	12D	NN	I-NP	O
artificial	artificial	JJ	I-NP	O
light	light	JJ	I-NP	O
regime	regime	NN	I-NP	O
,	,	,	O	O
peak	peak	JJ	B-NP	O
values	value	NNS	I-NP	O
of	of	IN	B-PP	O
hepatic	hepatic	JJ	B-NP	B-protein
GR	GR	NN	I-NP	I-protein
were	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
between	between	IN	B-PP	O
23	23	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
and	and	CC	I-NP	O
02	02	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
h	h	NN	I-NP	O
.	.	.	O	O

Except	Except	IN	B-PP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
4-hour	4-hour	JJ	I-NP	O
advancement	advancement	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
peak	peak	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
similar	similar	JJ	I-NP	O
circadian	circadian	JJ	I-NP	O
rhythm	rhythm	NN	I-NP	O
of	of	IN	B-PP	O
hepatic	hepatic	JJ	B-NP	B-protein
GR	GR	NN	I-NP	I-protein
was	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
rats	rat	NNS	B-NP	O
reared	rear	VBN	B-VP	O
under	under	IN	B-PP	O
a	a	DT	B-NP	O
reversed	reverse	VBN	I-NP	O
lighting	lighting	NN	I-NP	O
regimen	regimen	NN	I-NP	O
(	(	(	O	O
12D	12D	NN	B-NP	O
:	:	:	O	O
12L	12L	NN	B-NP	O
;	;	:	O	O
lights	light	NNS	B-NP	O
on	on	IN	B-PP	O
between	between	IN	B-NP	O
18	18	CD	I-NP	O
:	:	:	O	O
30	30	CD	B-NP	O
and	and	CC	I-NP	O
06	06	CD	I-NP	O
:	:	:	O	O
30	30	CD	B-NP	O
h	h	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O

In	In	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
leukocytes	leukocyte	NNS	I-NP	I-cell_type
,	,	,	O	O
the	the	DT	B-NP	O
peak	peak	JJ	I-NP	O
value	value	NN	I-NP	O
of	of	IN	B-PP	O
GR	GR	NN	B-NP	B-protein
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
parallel	parallel	VB	I-VP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
plasma	plasma	NN	B-NP	O
cortisol	cortisol	NN	I-NP	O
with	with	IN	B-PP	O
high	high	JJ	B-NP	O
and	and	CC	I-NP	O
low	low	JJ	I-NP	O
values	value	NNS	I-NP	O
detected	detect	VBN	B-VP	O
at	at	IN	B-PP	O
04	04	CD	B-NP	O
:	:	:	O	O
00-08	00-08	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
h	h	NN	I-NP	O
and	and	CC	O	O
23	23	CD	B-NP	O
:	:	:	O	O
00-24	00-24	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
h	h	NN	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
.	.	.	O	O

In	In	IN	B-PP	O
patients	patient	NNS	B-NP	O
suffering	suffer	VBG	B-VP	O
from	from	IN	B-PP	O
Cushing	Cushing	NN	B-NP	O
's	's	POS	B-NP	O
syndrome	syndrome	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
circadian	circadian	JJ	I-NP	O
rhythm	rhythm	NN	I-NP	O
of	of	IN	B-PP	O
plasma	plasma	NN	B-NP	O
cortisol	cortisol	NN	I-NP	O
either	either	CC	O	O
disappeared	disappear	VBD	B-VP	O
or	or	CC	O	O
was	be	VBD	B-VP	O
inverted	invert	VBN	I-VP	O
while	while	IN	B-SBAR	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
GR	GR	NN	B-NP	B-protein
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
significantly	significantly	RB	I-VP	O
deviate	deviate	VB	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
normal	normal	JJ	I-NP	O
subjects	subject	NNS	I-NP	O
.	.	.	O	O

For	For	IN	B-PP	O
apoplexic	apoplexic	JJ	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
lesions	lesion	NNS	B-NP	O
localized	localized	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
base	base	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
brain	brain	NN	I-NP	O
as	as	IN	B-SBAR	O
indicated	indicate	VBN	B-VP	O
by	by	IN	B-PP	O
computerized	computerize	VBN	B-NP	O
tomography	tomography	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
diurnal	diurnal	JJ	I-NP	O
variation	variation	NN	I-NP	O
of	of	IN	B-PP	O
GR	GR	NN	B-NP	B-protein
was	be	VBD	B-VP	O
abolished	abolish	VBN	I-VP	O
.	.	.	O	O

Conversely	Conversely	RB	B-ADVP	O
,	,	,	O	O
diurnal	diurnal	JJ	B-NP	O
rhythmicity	rhythmicity	NN	I-NP	O
persisted	persist	VBD	B-VP	O
in	in	IN	B-PP	O
apoplexy	apoplexy	JJ	B-NP	O
patients	patient	NNS	I-NP	O
whose	whose	WP$	B-NP	O
lesions	lesion	NNS	I-NP	O
were	be	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
cerebral	cerebral	JJ	I-NP	O
cortex	cortex	NN	I-NP	O
.	.	.	O	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
postulated	postulate	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
circadian	circadian	JJ	I-NP	O
modification	modification	NN	I-NP	O
of	of	IN	B-PP	O
GR	GR	NN	B-NP	B-protein
was	be	VBD	B-VP	O
independent	independent	JJ	B-ADJP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
diurnal	diurnal	JJ	I-NP	O
fluctuations	fluctuation	NNS	I-NP	O
in	in	IN	B-PP	O
plasma	plasma	NN	B-NP	O
cortisol	cortisol	NN	I-NP	O
level	level	NN	I-NP	O
or	or	CC	O	O
the	the	DT	B-NP	O
circadian	circadian	JJ	I-NP	O
variations	variation	NNS	I-NP	O
in	in	IN	B-PP	O
environmental	environmental	JJ	B-NP	O
lighting	lighting	NN	I-NP	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
rhythmicity	rhythmicity	NN	I-NP	O
might	might	MD	B-VP	O
be	be	VB	I-VP	O
regulated	regulate	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
'	'	``	I-NP	O
circadian	circadian	JJ	I-NP	O
pacemaker	pacemaker	NN	I-NP	O
'	'	''	O	O
located	located	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
basal	basal	JJ	I-NP	O
brain	brain	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
diurnal	diurnal	JJ	I-NP	O
variations	variation	NNS	I-NP	O
in	in	IN	B-PP	O
GR	GR	NN	B-NP	B-protein
might	might	MD	B-VP	O
serve	serve	VB	I-VP	O
to	to	TO	I-VP	O
coordinate	coordinate	VB	I-VP	O
the	the	DT	B-NP	O
reactivity	reactivity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
target	target	NN	I-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
to	to	TO	B-PP	O
cortisol	cortisol	NN	B-NP	O
because	because	IN	B-SBAR	O
the	the	DT	B-NP	O
diurnal	diurnal	JJ	I-NP	O
rhythms	rhythm	NNS	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
GR-mediated	GR-mediated	JJ	I-NP	O
response	response	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
fractional	fractional	JJ	I-NP	O
inhibition	inhibition	NN	I-NP	O
of	of	IN	B-PP	O
chemotactic	chemotactic	JJ	B-NP	O
migration	migration	NN	I-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
polymorphonuclear	polymorphonuclear	JJ	B-NP	B-cell_type
leukocytes	leukocyte	NNS	I-NP	I-cell_type
by	by	IN	B-PP	O
cortisol	cortisol	NN	B-NP	O
,	,	,	O	O
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
synchronous	synchronous	JJ	B-ADJP	O
with	with	IN	B-PP	O
those	those	DT	B-NP	O
of	of	IN	B-PP	O
GR	GR	NN	B-NP	B-protein
.	.	.	O	O

=========a1988951.txt=========	=========a1988951.txt=========	LS	B-LST	O

Specific	Specific	JJ	B-NP	O
depletion	depletion	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
B-cell	B-cell	NN	I-NP	B-cell_line
population	population	NN	I-NP	I-cell_line
induced	induce	VBN	B-VP	O
by	by	IN	B-PP	O
aberrant	aberrant	JJ	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	B-DNA
interferon	interferon	NN	I-NP	I-DNA
regulatory	regulatory	JJ	I-NP	I-DNA
factor	factor	NN	I-NP	I-DNA
1	1	CD	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
in	in	IN	B-PP	O
transgenic	transgenic	JJ	B-NP	O
mice	mouse	NNS	I-NP	O
.	.	.	O	O

Interferons	Interferon	NNS	B-NP	B-protein
(	(	(	O	O
IFNs	IFN	NNS	B-NP	B-protein
)	)	)	O	O
are	be	VBP	B-VP	O
well	well	RB	I-VP	O
known	know	VBN	I-VP	O
both	both	CC	O	O
as	as	IN	B-PP	O
antiviral	antiviral	JJ	B-NP	B-protein
proteins	protein	NNS	I-NP	I-protein
and	and	CC	B-PP	O
as	as	IN	B-PP	O
potent	potent	JJ	B-NP	O
regulators	regulator	NNS	I-NP	O
of	of	IN	B-PP	O
cell	cell	NN	B-NP	O
growth	growth	NN	B-NP	O
and	and	CC	O	O
differentiation	differentiation	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
fact	fact	NN	B-NP	O
,	,	,	O	O
IFNs	IFN	NNS	B-NP	B-protein
inhibit	inhibit	VBP	B-VP	O
growth	growth	NN	B-NP	O
of	of	IN	B-PP	O
various	various	JJ	B-NP	O
normal	normal	JJ	I-NP	O
and	and	CC	I-NP	O
transformed	transform	VBN	I-NP	B-cell_type
cell	cell	NN	I-NP	I-cell_type
types	type	NNS	I-NP	I-cell_type
.	.	.	O	O

Previously	Previously	RB	B-ADVP	O
,	,	,	O	O
a	a	DT	B-NP	O
nuclear	nuclear	JJ	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
,	,	,	O	O
IRF-1	IRF-1	NN	B-NP	B-protein
(	(	(	O	O
interferon	interferon	NN	B-NP	B-protein
regulatory	regulatory	JJ	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
1	1	CD	I-NP	I-protein
)	)	)	O	O
,	,	,	O	O
which	which	WDT	B-NP	O
binds	bind	VBZ	B-VP	O
to	to	TO	B-PP	O
type	type	NN	B-NP	B-protein
I	I	CD	I-NP	I-protein
IFN	IFN	NN	I-NP	I-protein
and	and	CC	O	O
some	some	DT	B-NP	O
IFN-inducible	IFN-inducible	JJ	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
promoters	promoter	NNS	I-NP	I-DNA
,	,	,	O	O
was	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
and	and	CC	O	O
cloned	clone	VBN	B-VP	O
.	.	.	O	O

Since	Since	IN	B-SBAR	O
the	the	DT	B-NP	O
IRF-1	IRF-1	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
is	be	VBZ	B-VP	O
both	both	CC	O	O
virus	virus	NN	B-NP	O
and	and	CC	O	O
IFN	IFN	NN	B-NP	B-protein
inducible	inducible	JJ	B-ADJP	O
,	,	,	O	O
an	an	DT	B-NP	O
intriguing	intriguing	JJ	I-NP	O
issue	issue	NN	I-NP	O
is	be	VBZ	B-VP	O
raised	raise	VBN	I-VP	O
as	as	IN	B-PP	O
to	to	TO	I-PP	O
whether	whether	IN	B-SBAR	O
the	the	DT	B-NP	O
IRF-1	IRF-1	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
is	be	VBZ	B-VP	O
functioning	function	VBG	I-VP	O
in	in	IN	B-PP	O
IFN-mediated	IFN-mediated	JJ	B-NP	O
regulation	regulation	NN	I-NP	O
of	of	IN	B-PP	O
cell	cell	NN	B-NP	O
growth	growth	NN	B-NP	O
and	and	CC	O	O
differentiation	differentiation	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
generated	generate	VBD	B-VP	O
transgenic	transgenic	JJ	B-NP	O
mice	mouse	NNS	I-NP	O
carrying	carry	VBG	B-VP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	B-DNA
IRF-1	IRF-1	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
linked	link	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	B-DNA
immunoglobulin	immunoglobulin	NN	I-NP	I-DNA
heavy-chain	heavy-chain	JJ	I-NP	I-DNA
enhancer	enhancer	NN	I-NP	I-DNA
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
transgenic	transgenic	JJ	I-NP	O
mice	mouse	NNS	I-NP	O
,	,	,	O	O
all	all	PDT	B-NP	O
the	the	DT	I-NP	O
lymphoid	lymphoid	JJ	I-NP	O
tissues	tissue	NNS	I-NP	O
examined	examine	VBN	B-VP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
dramatic	dramatic	JJ	I-NP	O
reduction	reduction	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
B	B	NN	B-NP	B-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
(	(	(	O	O
B	B	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
)	)	)	O	O
.	.	.	O	O

Preparation	Preparation	NN	B-NP	O
and	and	CC	O	O
analysis	analysis	NN	B-NP	O
of	of	IN	B-PP	O
bone	bone	NN	B-NP	B-cell_type
marrow	marrow	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
from	from	IN	B-PP	O
the	the	DT	B-NP	O
chimeric	chimeric	JJ	I-NP	O
mice	mouse	NNS	I-NP	O
indicated	indicate	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
bone	bone	NN	I-NP	O
marrow	marrow	NN	I-NP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
effective	effective	JJ	I-NP	O
site	site	NN	I-NP	O
for	for	IN	B-PP	O
specific	specific	JJ	B-NP	O
depletion	depletion	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
B-cell	B-cell	NN	I-NP	B-cell_type
population	population	NN	I-NP	I-cell_type
.	.	.	O	O

In	In	IN	B-PP	O
fact	fact	NN	B-NP	O
,	,	,	O	O
transgenic	transgenic	JJ	B-NP	B-cell_type
bone	bone	NN	I-NP	I-cell_type
marrow	marrow	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
cocultured	coculture	VBN	B-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
bone	bone	NN	I-NP	B-cell_line
marrow-derived	marrow-derived	JJ	I-NP	I-cell_line
stromal	stromal	JJ	I-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
revealed	reveal	VBD	B-VP	O
an	an	DT	B-NP	O
altered	altered	JJ	I-NP	O
B-cell	B-cell	NN	I-NP	O
maturation	maturation	NN	I-NP	O
pattern	pattern	NN	I-NP	O
.	.	.	O	O

=========a2011512.txt=========	=========a2011512.txt=========	LS	B-LST	O

Multiple	Multiple	JJ	B-NP	O
Oct2	Oct2	NN	I-NP	B-protein
isoforms	isoform	NNS	I-NP	I-protein
are	be	VBP	B-VP	O
generated	generate	VBN	I-VP	O
by	by	IN	B-PP	O
alternative	alternative	JJ	B-NP	O
splicing	splicing	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
interaction	interaction	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Oct2	Oct2	NN	I-NP	B-protein
transcription	transcription	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
with	with	IN	B-PP	O
the	the	DT	B-NP	O
cognate	cognate	JJ	I-NP	B-DNA
octamer	octamer	NN	I-NP	I-DNA
motif	motif	NN	I-NP	I-DNA
ATGCAAAT	ATGCAAAT	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
critical	critical	JJ	I-NP	O
determinant	determinant	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
lymphoid-specific	lymphoid-specific	JJ	I-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
immunoglobulin	immunoglobulin	NN	B-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
.	.	.	O	O

Ectopic	Ectopic	JJ	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
cloned	clone	VBN	B-NP	B-DNA
Oct2	Oct2	NN	I-NP	I-DNA
cDNA	cDNA	NN	I-NP	I-DNA
was	be	VBD	B-VP	O
shown	show	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
sufficient	sufficient	JJ	B-ADJP	O
to	to	TO	B-VP	O
reconstitute	reconstitute	VB	I-VP	O
at	at	IN	B-NP	O
least	least	JJS	I-NP	O
some	some	DT	I-NP	O
aspects	aspect	NNS	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
regulation	regulation	NN	I-NP	O
in	in	IN	B-PP	O
non-lymphoid	non-lymphoid	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

We	We	PRP	B-NP	O
describe	describe	VBP	B-VP	O
the	the	DT	B-NP	O
isolation	isolation	NN	I-NP	O
and	and	CC	O	O
characterization	characterization	NN	B-NP	O
of	of	IN	B-PP	O
multiple	multiple	JJ	B-NP	B-DNA
cDNAs	cDNA	NNS	I-NP	I-DNA
encoding	encode	VBG	B-VP	O
mouse	mouse	NN	B-NP	B-protein
Oct2	Oct2	NN	I-NP	I-protein
from	from	IN	B-PP	O
a	a	DT	B-NP	O
mature	mature	JJ	I-NP	B-cell_line
B-cell	B-cell	NN	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
and	and	CC	O	O
we	we	PRP	B-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
a	a	DT	B-NP	O
variety	variety	NN	I-NP	O
of	of	IN	B-PP	O
isoforms	isoform	NNS	B-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
transcription	transcription	NN	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
is	be	VBZ	B-VP	O
generated	generate	VBN	I-VP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
single	single	JJ	I-NP	O
gene	gene	NN	I-NP	O
by	by	IN	B-PP	O
an	an	DT	B-NP	O
alternative	alternative	JJ	I-NP	O
splicing	splicing	NN	I-NP	O
mechanism	mechanism	NN	I-NP	O
.	.	.	O	O

All	All	PDT	B-NP	O
the	the	DT	I-NP	O
isoforms	isoform	NNS	I-NP	B-protein
retain	retain	VBP	B-VP	O
the	the	DT	B-NP	O
previously	previously	RB	I-NP	O
characterized	characterize	VBN	I-NP	O
POU-domain	POU-domain	NN	I-NP	B-protein
and	and	CC	O	O
are	be	VBP	B-VP	O
therefore	therefore	RB	B-ADVP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
bind	bind	VB	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
octamer	octamer	NN	I-NP	B-DNA
motif	motif	NN	I-NP	I-DNA
.	.	.	O	O

Different	Different	JJ	B-NP	O
amounts	amount	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
various	various	JJ	I-NP	O
isoforms	isoform	NNS	I-NP	B-protein
are	be	VBP	B-VP	O
present	present	JJ	B-ADJP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
B-cell	B-cell	NN	I-NP	B-cell_type
regardless	regardless	RB	B-ADVP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
developmental	developmental	JJ	I-NP	O
stage	stage	NN	I-NP	O
of	of	IN	B-PP	O
B-cell	B-cell	NN	B-NP	B-cell_type
differentiation	differentiation	NN	I-NP	O
and	and	CC	O	O
at	at	IN	B-ADVP	O
least	least	JJS	I-ADVP	O
some	some	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
isoforms	isoform	NNS	I-NP	B-protein
are	be	VBP	B-VP	O
conserved	conserve	VBN	I-VP	O
between	between	IN	B-PP	O
mouse	mouse	NN	B-NP	O
and	and	CC	O	O
humans	human	NNS	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
cotransfection	cotransfection	NN	B-NP	O
experiments	experiment	NNS	I-NP	O
we	we	PRP	B-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
all	all	PDT	B-NP	O
the	the	DT	I-NP	O
isoforms	isoform	NNS	I-NP	B-protein
are	be	VBP	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
activate	activate	VB	I-VP	O
an	an	DT	B-NP	O
octamer	octamer	NN	I-NP	B-DNA
containing	contain	VBG	B-VP	O
promoter	promoter	NN	B-NP	B-DNA
element	element	NN	I-NP	I-DNA
in	in	IN	B-PP	O
fibroblasts	fibroblast	NNS	B-NP	B-cell_type
revealing	reveal	VBG	B-VP	O
an	an	DT	B-NP	O
unexpected	unexpected	JJ	I-NP	O
functional	functional	JJ	I-NP	O
redundancy	redundancy	NN	I-NP	O
.	.	.	O	O

Finally	Finally	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
one	one	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
isoforms	isoform	NNS	I-NP	B-protein
encodes	encode	VBZ	B-VP	O
the	the	DT	B-NP	O
previously	previously	RB	I-NP	O
described	describe	VBN	I-NP	O
lymphoid-specific	lymphoid-specific	JJ	I-NP	B-protein
Oct2B	Oct2B	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
which	which	WDT	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
suggested	suggest	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
function	function	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
octamer	octamer	NN	I-NP	B-DNA
motif	motif	NN	I-NP	I-DNA
in	in	IN	B-PP	O
the	the	DT	B-NP	O
context	context	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
immunoglobulin	immunoglobulin	NN	I-NP	B-DNA
heavy-chain	heavy-chain	NN	I-NP	I-DNA
(	(	(	O	I-DNA
IgH	IgH	NN	B-NP	I-DNA
)	)	)	O	I-DNA
enhancer	enhancer	NN	B-NP	I-DNA
.	.	.	O	O

